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  “Ever	  tried,	  ever	  failed.	  
	  No	  matter.	  	  
Try	  again.	  	  
Fail	  again.	  Fail	  better.”	  
	  Samuel	  Becket	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ABSTRACT	  
	  
Helicobacter	   pylori,	   a	   Gram-­‐negative	   bacterium,	   has	   emerged	   as	   the	   causative	   agent	   in	  
chronic	  gastritis,	  peptic	  ulcer	  disease	  and	  is	  a	  risk	  factor	  for	  gastric	  carcinoma	  development,	  the	  
second	  leading	  cause	  of	  cancer	  related	  death	  in	  the	  world.	  It	  is	  estimated	  that	  this	  human-­‐specific	  
gastric	   pathogen	   colonizes	   half	   of	   the	   mankind,	   with	   an	   estimated	   80	   %	   prevalence	   in	   the	  
Portuguese	   population.	   Conventional	   therapy	   relies	   on	   a	   cocktail	   of	   antibiotics	   and	   other	  
pharmaceutical	   drugs,	   but	   its	   effectiveness	   has	   been	   declining,	   mainly	   due	   to	   the	   increase	   in	  
bacterial	   resistance	   to	   antibiotics,	   co-­‐infection	   with	  multiple	  H.	   pylori	   strains	   and	   patient	   poor	  
compliance	   to	   the	   complex	   treatment	   regimen.	   Bacterial	   adhesion	   to	   the	   gastric	  mucosa	   has	   a	  
central	   role	   in	   pathogenesis.	   H.	   pylori	   colonizes	   the	   host	   gastric	  mucosa	   via	   adhesion	   proteins	  
(adhesins)	  that	  enable	  adherence	  to	  glycosylated	  structures	  (Gly-­‐Rs)	  expressed	  on	  gastric	  mucosa.	  
Namely,	   it	   was	   determined	   that	   the	   bacterial	   Blood	   group	   Antigen	   Binding	   Adhesin	   (BabA)	  
recognizes	  the	  ABO	  series	  of	  fucosylated	  blood	  group	  antigens	  including	  the	  Lewis	  B	  (Leb)	  antigen.	  
The	  Sialic	  Acid	  Binding	  Adhesin	  (SabA)	  mediates	  aderence	  to	  sialylated	  structures,	  such	  as	  sialyl-­‐
Lewis	  x	  (sLex),	  that	  are	  expressed	  on	  the	  inflamed	  gastric	  mucosa.	  
The	  aim	  of	   the	  work	  presented	  here	  was	  to	  evaluate	   if	   the	  synthetic	  Gly-­‐Rs,	  Leb	  and	  sLex,	  
after	   immobilized	   onto	   a	   biomaterial,	   are	   still	   able	   to	   bind	  H.	   pylori	   via	   the	   specific	   interaction	  
with	  the	  BabA	  and	  SabA	  adhesins,	  respectively.	  
Self-­‐assembled	  monolayers	   (SAMs)	   of	   alkanethiols	   on	   gold	  were	   used	   in	   order	   to	   have	   a	  
better	   control	   over	   the	   chemical	   properties	   of	   the	   surface	   and	   to	   allow	   the	   study	   of	   the	  
interactions	  between	  bacteria	  and	  surfaces	  at	  the	  molecular	  level.	  
H.	  pylori	  non-­‐specific	  adhesion,	  morphology	  and	  viability	  were	  first	  studied	  using	  SAMs	  with	  
distinct	   chemical	   functionalities	   (OH-­‐;	   CH3-­‐	   and	   tetra(ethylene	   glycol)-­‐).	   Bacterial	   adhesion	  was	  
high	   on	   all	   the	   surfaces	   used	   excepted	   on	   tetra(ethylene	   glycol)-­‐terminated	   SAMs,	   where	  
adhesion	   was	   avoided.	   It	   was	   also	   verified	   that	   the	   morphology	   of	   non-­‐specifically	   adhered	  
bacteria	  was	  predominantly	  coccoid	  and	  that	  these	  surfaces	  did	  not	  induce	  a	  significant	  decrease	  
on	  the	  viability	  of	  adherent	  bacteria.	  
Biotinylated	   Gly-­‐Rs	   (Leb	   and	   sLex)	   were	   immobilized	   onto	   mixed	   biotin-­‐/tetra(ethylene	  
glycol)-­‐terminated	   SAMs	   (biotin-­‐SAMs),	   using	   neutravidin	   as	   the	  binding	  protein.	   Surfaces	  were	  
characterized	   by	   ellipsometry,	   X-­‐ray	   photoelectron	   spectroscopy	   (XPS)	   and	   contact	   angle	  
measurements.	   Quartz	   crystal	   microbalance	   with	   dissipation	   (QCM-­‐D)	   was	   used	   to	   follow	   and	  
quantify	  the	  Gly-­‐Rs	  immobilized	  on	  mixed	  SAMs.	  H.	  pylori	  strains	  with	  distinct	  adhesins	  expression	  
profile	   were	   used	   to	   evaluate	   bacterial	   specific	   recognition	   and	   binding	   to	   the	   functionalized	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SAMs.	   Results	   demonstrate	   that	  H.	   pylori	   binding	   to	   surfaces	   occur	   via	   interaction	   between	   its	  
adhesins	  and	  cognate	  (Gly-­‐R)-­‐SAMs	  and	  bounded	  H.	  pylori	  maintain	  its	  characteristic	  rod-­‐shaped	  
morphology	  only	  during	  conditions	  of	  specific	  adhesin-­‐glycan	  binding.	  
The	   binding	   force	   between	   the	   purified	  H.	   pylori	   BabA	   and	   its	   immobilized	   receptor	   Leb	  
onto	   biotin-­‐SAMs	   was	   evaluated	   by	   means	   of	   atomic	   force	   microscopy.	   Dynamic	   force	  
spectroscopy	   revealed	   two	   adhesive	   states,	   which	   suggests	   that	   the	   BabA	   adhesin	   may	   form	  
multivalent	   attachment	   to	   the	   host	   gastric	   mucosa.	   This	   feature	   is	   thought	   to	   enhance	   the	  
efficiency	   and	   stability	   of	   bacterial	   attachments,	   therefore	   contributing	   to	   the	   chronic	   infection	  
status.	  
The	  work	  presented	   in	   this	   thesis	   stresses	   that	   surface	   immobilized	   receptors	   towards	  H.	  
pylori	  adhesins	  are	  still	  recognized	  by	  the	  pathogen,	  demonstrating	  its	  usefulness	  for	  the	  design	  of	  
alternative	   therapeutic	   options.	  Moreover,	   the	   biophysical	   properties	   of	   the	   BabA/Leb	  complex	  
were	  disclosed,	  contributing	  to	  a	  deeper	  understanding	  of	  the	  BabA	  adhesin	  role	  in	  the	  biology	  of	  
infection	  and	  its	  possible	  applications	  in	  therapy.	  
Overall,	   the	   knowledge	   obtained	   from	   this	   work	   may	   be	   translated	   onto	   biomedical	  
mucoadhesive	   polymers,	   in	   order	   to	   develop	   a	   novel	   approach	   targeting	  H.	   pylori	   adhesion	   to	  
gastric	  mucosa	  and	  therefore	  improve	  the	  performance	  of	  classical	  treatments.	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RESUMO	  
	  
Helicobacter	   pylori	   é	   uma	   bactéria	   Gram	   negativa,	   identificada	   como	   sendo	   responsável	  
pelo	   desenvolvimento	   de	   doenças	   do	   foro	   gastroenterelógico,	   nomeadamente	   gastrite	   crónica,	  
úlcera	  péptica	  e	  um	  factor	  de	  risco	  para	  o	  desenvolvimento	  de	  cancro	  gástrico,	  a	  segunda	  causa	  
de	  morte	  por	   doença	  oncológica.	   Este	   agente	  patogénico,	   com	  especificidade	  para	  o	   estômago	  
humano,	   coloniza	   cerca	  de	  metade	  da	  população	  humana,	   estimando-­‐se	  que	   cerca	  de	  80	  %	  da	  
população	   Portuguesa	   esteja	   infectada.	   A	   terapia	   convencional	   reside	   na	   combinação	   de	  
diferentes	  antibióticos	  com	  outras	  substâncias	  farmacológicas.	  Contudo,	  a	  eficácia	  do	  tratamento	  
tem	  vindo	  a	  decair	  desde	  a	  descoberta	  desta	  bactéria	  no	  inicio	  dos	  anos	  80,	  devido	  ao	  aumento	  
da	   resistência	   bacteriana	   aos	   antibióticos,	   coinfecção	   com	   diferentes	   estirpes	   de	  H.	   pylori	   e	   a	  
baixa	   adesão	   por	   parte	   dos	   pacientes	   ao	   complexo	   regime	   terapêutico.	   A	   adesão	   bacteriana	   à	  
mucosa	   gástrica	   desempenha	   um	   papel	   central	   na	   patogénese.	   O	  H.	   pylori	   coloniza	   a	   mucosa	  
gástrica	   do	   hospedeiro	   através	   de	   proteínas	   de	   adesão	   (adesinas)	   que	   permitem	   a	   aderência	   a	  
receptores	   glicosilados	   (Gly-­‐Rs)	   expressos	   na	   superfície	   da	  mucosa	   gástrica.	   Nomeadamente,	   a	  
adesina	   ligante	   de	   antigénios	   sanguíneos	   (Blood	   group	   Antigen	   Binding,	   BabA)	   reconhece	   os	  
antigénios	   fucosilados	   do	   grupo	   ABO,	   incluindo	   o	   antigénio	   Lewis	   B	   (Leb).	   A	   adesina	   ligante	   de	  
ácidos	  sialicos	  (Sialic	  Acid	  Binding	  Adhesin,	  SabA)	  permite	  a	  adesão	  a	  estruturas	  sialiladas,	  como	  
ao	  sialil-­‐Lewis	  x	  (sLex),	  que	  é	  expresso	  na	  mucosa	  gástrica	  inflamada.	  
O	  objectivo	  do	  presente	   trabalho	  passou	  por	  avaliar	   se	  os	  Gly-­‐Rs	   sintéticos,	   Leb	   and	   sLex,	  
após	   imobilizados	   num	   biomaterial,	  mantêm	   a	   capacidade	   de	   ligar	   especificamente	   o	  H.	   pylori	  
através	  da	  interação	  específica	  com	  as	  adesinas	  BabA	  e	  SabA,	  respectivamente.	  
Para	   tal,	   foram	   usadas	   monocamadas	   auto-­‐estruturadas	   (Self-­‐assembled	   monolayers,	  
SAMs)	   de	   alcanotióis	   em	   ouro	   para	   um	   controlo	   superior	   sobre	   as	   propriedades	   químicas	   da	  
superfície	   e	   para	   permitir	   o	   estudo	   das	   interações	   entre	   o	   H.	   pylori	   e	   as	   superfícies	   a	   nível	  
molecular.	  
Parâmetros	   como	   a	   adesão	   não-­‐específica,	   morfologia	   e	   viabilidade	   do	   H.	   pylori	   foram	  
primeiro	   estudados	   utilizando	   SAMs	   com	   funcionalidades	   químicas	   distintas	   (OH-­‐;	   CH3-­‐	   e	  
tetra(etileno	   glicol)-­‐).	   A	   adesão	   não	   específica	   do	   H.	   pylori	   foi	   elevada	   em	   todas	   as	   superfícies	  
utilizadas,	  excepto	  nas	  SAMs	  terminadas	  em	  tetra(etileno	  glicol),	  onde	  a	  adesão	   foi	  evitada.	  Foi	  
ainda	   verificado	   que	   a	   morfologia	   da	   bactéria	   aderida	   de	   forma	   não	   especifica	   foi,	  
predominantemente,	   cocoide	   em	   qualquer	   uma	   das	   SAMs	   utilizadas	   e	   que	   nenhuma	   destas	  
superfícies	  induziu	  um	  decréscimo	  significativo	  na	  viabilidade	  das	  bactérias	  aderidas.	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Os	   Gly-­‐Rs	   biotinilados,	   Leb	   e	   sLex,	   foram	   imobilizados	   em	   SAMs	   mistas	   de	   biotina-­‐
/oligo(etileno	   glicol)	   (SAMs	   de	   biotina),	   utilizando	   a	   neutravidina	   como	   proteína	   de	   ligação.	   As	  
superfícies	   foram	   caracterizadas	   com	   diferentes	   técnicas	   analíticas	   como	   elipsometria,	  
espectroscopia	   de	   fotoelectrões	   de	   raios	   X	   (XPS)	   e	   medição	   de	   ângulos	   de	   contacto.	   A	  
microbalança	   de	   cristais	   de	   quartzo	   com	   dissipação	   (QCM-­‐D)	   foi	   empregue	   para	   seguir	   e	  
quantificar	   a	   adsorção	   dos	   Gly-­‐Rs	   nas	   SAMs	   de	   biotina	   em	   tempo	   real.	   Para	   avaliar	   a	  
especificidade	   bacteriana	   no	   reconhecimento	   e	   na	   ligação	   a	   SAMs	   funcionalizadas	   com	   Gly-­‐Rs	  
usaram-­‐se	   estirpes	   de	  H.	   pylori	   com	   diferente	   padrão	   de	   expressão	   de	   adesinas.	  Os	   resultados	  
obtidos	  demonstraram	  que	  a	  ligação	  do	  H.	  pylori	  às	  superfícies	  ocorre	  via	  interação	  entre	  as	  suas	  
adesinas	  e	  o	   respectivo	  Gly-­‐R	  presente	  na	   superfície	  da	  monocamada	  e	  que	  o	  H.	  pylori	   aderido	  
mantém	   a	   sua	   morfologia	   bacilar	   apenas	   nas	   condições	   em	   que	   existe	   uma	   ligação	   específica	  
entre	  adesina	  e	  o	  receptor.	  
A	  força	  de	  ligação	  entre	  a	  adesina	  BabA	  purificada	  e	  o	  receptor	  Leb,	   imobilizado	  em	  SAMs	  
de	  biotina,	   foi	  estudada	  através	  de	  microscopia	  de	  força	  atómica.	  Estudos	  de	  espectroscopia	  de	  
força	  dinâmica	  revelaram	  dois	  estados	  de	  adesão,	  o	  que	  sugere	  que	  a	  adesina	  BabA	  pode	  formar	  
ligações	  multivalentes	  à	  mucosa	  gástrica	  do	  hospedeiro.	  Este	  processo	  pode	  permitir	  aumentar	  a	  
eficiência	   e	   a	   estabilidade	   das	   ligações	   bacterianas	   à	   parede	   gástrica,	   contribuindo	   para	   que	   a	  
infecção	  reverta	  a	  crónica.	  
O	  trabalho	  apresentado	  nesta	  tese	  demonstra	  que	  receptores	  imobilizados	  em	  superfícies	  
são	   reconhecidos	   pelo	   H.	   pylori,	   demonstrando	   a	   utilidade	   do	   uso	   desta	   plataforma	   para	   o	  
desenho	  de	  novas	  opções	   terapêuticas.	  As	  propriedades	  biofísicas	  do	  complexo	  BabA/Leb	  foram	  
também	   estudadas,	   contribuindo	   assim	   para	   um	   conhecimento	  mais	   aprofundado	   do	   papel	   da	  
adesina	   BabA	   na	   biologia	   da	   infecção	   e	   as	   suas	   possíveis	   aplicações	   no	   âmbito	   do	  
desenvolvimento	  de	  novas	  terapias.	  
Em	  resumo,	  o	  conhecimento	  obtido	  com	  este	  trabalho	  pode	  ser	  transposto	  para	  polímeros	  
biomédicos,	   com	  capacidades	  muco-­‐adesivas,	   para	   a	   elaboração	  de	  novas	   terapias	  que	   tenham	  
como	  alvo	  preferencial	  o	  passo	  inicial	  de	  adesão	  do	  H.	  pylori	  à	  mucosa	  gástrica.	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1.	  -­‐	  MOTIVATION	  
Gastric	  carcinoma	  remains	   the	  second	   leading	  cause	  of	  cancer	   related	  death	   in	   the	  world	  
and	   has	   been	   associated	   with	   infection	   with	   the	   bacterium	  Helicobacter	   pylori	   (H.	   pylori).1,2	   In	  
1994,	  H.	  pylori	  was	  classified	  as	  a	   type	   I	  carcinogen	   for	  humans	  by	   the	   International	  Agency	   for	  
Research	  on	  Cancer	   (IARC).	  This	  bacterium	   is	  one	  of	   the	  most	   common	   infectious	  agents	   in	   the	  
world,	  colonizing	  approximately	  half	  of	  the	  world	  population.	  The	  majority	  of	  infected	  individuals	  
are	  asymptomatic,	  with	  only	  15	  %	  demonstrating	  symptoms	  of	   infection.	  Gastric	  cancer	  may	  be	  
an	  outcome	  of	  infection	  with	  this	  pathogen	  in	  1-­‐3	  %	  of	  the	  individuals.3	  Other	  pathologies,	  such	  as	  
gastric	  and	  duodenal	  ulcers,	  as	  well	  as	  gastric	  atrophy,	  have	  been	   reported	   to	  have	  H.	  pylori	   as	  
their	  causative	  agent.4	  
	  
Although	  infection	  with	  H.	  pylori	  has	  been	  decreasing	  worldwide,	  as	  a	  consequence	  of	  the	  
improvement	   of	   socioeconomic	   conditions	   and	   extensive	   pharmaceutical	   research	   leading	   to	  
more	   powerful	  medicines,	   this	   infection	   still	   remains	   a	   public	   health	   issue	   in	   several	   countries,	  
namely	  in	  Portugal	  with	  infection	  rates	  close	  to	  80	  %.4	  
	  
Adhesion	  of	  H.	  pylori	  to	  the	  gastric	  epithelium	  is	  a	  key	  event	  for	  establishment	  of	  persistent	  
infection.	   The	   adherence	   process	   is	   mediated	   by	   H.	   pylori	   outer	   membrane	   proteins	   that	  
recognize	   and	   bind	   to	   specific	   glycan	   structures	   (Gly-­‐R)	   expressed	   in	   the	   gastric	   mucosa.	   The	  
bacterial	   Blood	   group	   antigen	  binding	  Adhesin	   (BabA)	   recognizes	   the	  ABO	   series	   of	   fucosylated	  
blood	  group	  antigens	  including	  the	  difucosylated	  Lewis	  antigens,	  such	  as	  the	  Lewis	  B	  (Leb)	  antigen.	  
In	   addition,	   the	   Sialic	   acid	   binding	   Adhesin	   (SabA)	   mediates	   specific	   aderence	   to	   the	   inflamed	  
gastric	  mucosa	  by	  binding	  to	  sialylated	  glycoproteins	  such	  as	  sialyl-­‐Lewis	  x	  (sLex).5,6	  
	  
Eradication	  of	  H.	  pylori	  colonization	  and	  infection	  is	  extremely	  challenging	  due	  to	  the	  high	  
variability	  of	   the	  bacterium,	   its	   remarkable	  adaptation	   to	   the	  gastric	   environment	  as	  well	   as	   its	  
ability	   to	   resist	   antibiotic	   therapy.	   Strategies	   to	   overcome	   the	   problems	   associated	   with	   the	  
conventional	  antibiotic	  therapy	  have	  been	  studied.	  For	  instance,	  the	  natural	  polymer	  chitosan	  has	  
been	   investigated	  as	  a	  drug	   carrier	   to	   the	   stomach	  because	  of	   its	  mucoadhesive	  properties.7	   In	  
particular,	  chitosan	  microspheres	  loaded	  with	  tetracycline	  have	  been	  developed	  by	  Hejazi	  et	  al.8	  
to	  increase	  antibiotic	  residence	  time	  and	  penetration	  through	  the	  gastric	  mucus	  layer.	  However,	  
this	  strategy	  relies	  only	  on	  the	  antibiotic	  effectiveness,	  which	  has	  been	  declining	  throughout	  the	  
years.	  Anti-­‐adhesion	  compounds	  have	  also	  been	  explored	  in	  the	  quest	  for	  novel	  therapies,	  but	  not	  
contemplating	  the	  possibility	  of	  applying	  those	  compounds	  onto	  mucoadhesive	  polymers	  in	  order	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to	   obtain	   a	   more	   targeted	   approach	   to	   the	   gastric	   mucosa.9	   Preventive	   strategies,	   such	   as	  
vaccines,	  have	  been	  investigated.	  Nevertheless,	  the	  lack	  of	  deep	  knowledge	  and	  understanding	  of	  
how	   the	   initial	  H.	   pylori	   infection	   steps	   affect	   the	   host	   immune	   system	   is	   the	  main	   obstacle	   to	  
overcome	   in	   order	   to	   develop	   an	   effective	   vaccine	   against	   this	   pathogen.10	   Therefore,	  
mucoadhesive	  biomaterials	   coated	  with	   specific	   receptors	   for	  H.	  pylori	   adhesins,	  mimicking	   the	  
natural	   gastric	  mucosa,	   that	   can	  be	  used	  as	  decoys	   to	  attract,	   specifically	  bind	  and	   remove	   the	  
pathogen	   from	   infected	   individuals,	   are	  an	   innovative	   strategy	  as	  alternative	  or	   complement	   to	  
the	  conventional	  antibiotic	  therapies.	  
	   Chapter	  I	   Objectives	  &	  Thesis	  synopsis	  	  
	   5	  
2.	  -­‐	  OBJECTIVES	  &	  THESIS	  SYNOPSIS	  
Helicobacter	   pylori	   (H.	   pylori)	   adhesion	   to	   gastric	   mucosa	   is	   a	   highly	   specific	   process	  
between	  bacterial	  adhesins	  and	  glycosylated	  receptors	   (Gly-­‐Rs)	  expressed	  at	   the	  gastric	  mucosa	  
level	   and	   this	   is	   considered	   as	   crucial	   for	   the	   success	   of	   infection.	   Taking	   advantage	   of	   the	  
bacterial	   adhesion	   process	   to	   the	   gastric	   mucosa	   is	   an	   appealing	   approach	   for	   designing	   an	  
alternative/complement	  to	  conventional	  therapies.	  If	  similar	  receptors	  to	  those	  expressed	  on	  the	  
gastric	   surface	   can	   be	   immobilized	   onto	   a	   biocompatible	   mucoadhesive	   polymer	   (i.e	   chitosan)	  
while	   maintaining	   the	   ability	   to	   attract	   and	   bind	   the	   bacterium,	   this	   would	   constitute	   an	  
interesting	  strategy	  for	  H.	  pylori	  elimination	  from	  infected	  hosts.	  
	  
This	  work	  aims	   to	  evaluate	   if	   the	   synthetic	  Gly-­‐Rs,	   Leb	  and	   sLex,	   after	   immobilized	  onto	  a	  
biomaterial,	   are	   still	   able	   to	   bind	  H.	   pylori	   via	   the	   specific	   interaction	  with	   the	   BabA	   and	   SabA	  
adhesins,	  respectively.	  However,	  before	  transposing	  this	  concept	  onto	  polymeric	  biomaterials,	   it	  
is	   crucial	   to	  understand	   the	   interactions	  between	   the	  bacteria	   and	   immobilized	   receptors	  using	  
surfaces	   that	   can	   be	   controlled	   at	   molecular	   level.	   Self-­‐assembled	   monolayers	   (SAMs)	   of	  
alkanethiols	   on	   gold	   are	   the	   best	   approach,	   since	   they	   are	   stable,	   easy	   to	   produce,	   easy	   to	  
functionalize	   and	   allow	   to	   precisely	   control	   the	   structure,	   density	   and	   pattern	   of	   immobilized	  
ligands.11	  
	  
Chapter	   II	   gives	   an	   overview	   on	   H.	   pylori	   biology,	   namely	   virulence	   factors,	   on	   the	  
mechanism	  of	  infection	  and	  on	  the	  factors	  affecting	  treatment	  success.	  SAMs	  are	  also	  succinctly	  
reviewed	   in	   this	   chapter	   as	   well	   as	   Atomic	   Force	   Microscopy	   (AFM),	   the	   technique	   used	   to	  
characterize	  the	  biophysical	  properties	  of	  the	  H.	  pylori	  BabA	  adhesin-­‐	  Leb	  receptor	  bond.	  
	  
In	  Chapter	   III	   the	  effect	  of	   surface	   chemistry	   (using	  OH-­‐,	  CH3-­‐,	   and	   tetra(ethylene	  glycol)	  
(EG4)-­‐terminated	  SAMs	  and	  bare	  gold)	  on	  H.	  pylori	  adhesion	  was	  evaluated.	  The	  influence	  of	  the	  
surface	   terminal	   group	   on	   bacterial	  morphology	   and	   viability	   was	   also	   accessed.	   These	   studies	  
established	   that	   only	   surfaces	   terminated	   into	   EG4	   (EG4-­‐SAMs)	   were	   able	   to	   avoid	   bacterial	  
adhesion	  and	  therefore	  were	  suitable	  for	  the	  immobilization	  of	  H.	  pylori	  specific	  receptors	  in	  the	  
subsequent	  specific	  binding	  tests	  described	  at	  chapter	  IV.	  
	  
In	   Chapter	   IV	   mixed	   SAMs	   prepared	   with	   EG4-­‐	   and	   biotin-­‐EG3-­‐terminated-­‐thiols	   (biotin-­‐
SAMs)	  were	  used	  to	   immobilize	  biotinylated	  Leb	  and	  sLex,	  using	  neutravidin	  as	  a	  binding	  bridge.	  
SAMs	  were	  characterized	  using	  surface	  analytical	  techniques,	  as	  ellipsometry,	  water	  contact	  angle	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measurements,	   X-­‐ray	   photoelectron	   spectroscopy	   (XPS)	   and	   quartz	   crystal	   microbalance	   with	  
dissipation	  (QCM-­‐D).	  Studies	  with	  H.	  pylori	  strains	  with	  distinct	  adhesins	  expression	  profiles	  were	  
performed	   and	   the	   binding	   specificity	   between	   bacteria-­‐immobilized	  Gly-­‐Rs	  was	   demonstrated.	  
The	  effect	  of	  specific	  binding	  onto	  bacterial	  morphology	  was	  also	  evaluated	  and	  it	  was	  established	  
that	  mostly	  of	  bounded	  H.	  pylori	  mantain	   its	  natural	   rod	  morphology,	  only	  during	  conditions	  of	  
specific	  adhesin-­‐glycan	  binding.	  
	  
In	   Chapter	   V	   dynamic	   force	   spectroscopy	   studies	   between	   the	   purified	   H.	   pylori	   BabA	  
adhesin	   and	   its	   cognate	   receptor	   (Leb)	   immobilized	   onto	   SAMs,	   were	   performed.	   The	   bond	  
strength,	   bond	   length	   and	   dissociation	   rate	   were	   determined.	   Results	   point	   to	   a	   multivalent	  
interaction	  between	  bacterial	  BabA	  and	  immobilized	  Leb,	  establishing	  each	  bacterial	  adhesin	  two	  
bounds	  with	  the	  immobilized	  Gly-­‐R.	  	  
	  
Finally,	  Chapter	  VII	  provides	  the	  general	  discussion	  of	  the	  obtained	  results	  and	  concluding	  
remarks,	   correlating	   the	   overall	   obtained	   results	   and	   describing	   how	   this	   knowledge	   is	   being	  
translated	  to	  “real-­‐world”	  application.	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1.1.	  -­‐	  A	  quick	  overview	  on	  Helicobacter	  pylori’s	  history	  
In	  1892,	  Giulio	  Bizozzero,	  an	   Italian	   researcher,	  described	  helical	   shaped	  bacteria	   living	   in	  
the	   acidic	   environment	   of	   the	   stomach	   of	   dogs.1	   Later,	   in	   1899,	  Warley	   Jaworsky,	   Professor	   of	  
Medicine	  at	   the	   Jagiellonian	  University	  of	  Cracow,	  Poland,	   found	   in	  sediments	  of	  human	  gastric	  
washings	  what	   apparently	  was	   the	   same	  bacterium	  previously	  described	  and	  he	   called	   it	  Vibrio	  
rugula.	  He	  was	  the	  first	  to	  suggest	  a	  possible	  role	  of	  this	  microorganism	  in	  the	  etiology	  of	  gastric	  
diseases.2	   Despite	   these	   impressive	   assumptions,	   his	  work	  was	  written	   in	   Polish	   and	   it	   did	   not	  
have	  much	  impact	  in	  the	  scientific	  community	  of	  that	  time.	  
Until	   the	  early	  1980’s	  the	  progress	   in	  research	  on	  gastric	  microbes	  was	  dominated	  by	  the	  
concept	  that	  the	  stomach	  secretes	  acid	  “to	  keep	  its	  lumen	  sterile	  and	  that	  gastric	  acid	  may	  cause	  
mucosal	  lesions"	  in	  accordance	  to	  the	  1910	  Schwarz	  dictum	  "no	  acid,	  no	  ulcer".3	  
The	  major	  obstacle	  in	  recognizing	  the	  role	  of	  spiral	  bacteria	  in	  human	  gastric	  pathology	  was	  
the	  persistent	  failure	  to	  retrieve	  and	  culture	  the	  bacteria	  from	  the	  stomach.	  For	  instance,	  in	  1975	  
Steer	   found	   spiral	   bacteria	   closely	   attached	   to	   gastric	   surface	   epithelial	   cells	   but	   cultured	   only	  
Pseudomonas	  aeruginosa.4	  
In	  1982	  in	  the	  microbiology	  lab	  of	  the	  Royal	  Perth	  Hospital,	  Warren	  and	  Marshall	  heralded	  a	  
new	   era	   in	   basic	   and	   clinical	   gastroenterology.	   For	   the	   first	   time,	   culture	   of	   the	   spiral-­‐shaped	  
bacterium	  was	  successful.5,6	  The	  first	  culture	  obtained	  from	  a	  gastric	  biopsy	  of	  a	  duodenal	  ulcer	  
patient	  was	   initially	   called	  a	  Campylobacter-­‐Like	  Organism	  thinking	   that	   it	  was	  a	  Campylobacter	  
species,	  but	   it	   turned	  out	   to	  be	  a	  different	  genus,	  now	  named	  Helicobacter	  pylori.7	  H.	  pylori,	  by	  
being	  able	  to	  colonize	  the	  human	  stomach,	  induce	  acute	  and	  then	  chronic	  active	  gastritis	  and/or	  
chronic	  atrophic	  gastritis,	  and	  to	  respond	  with	  clearance	  or	  eradication	  to	  antibiotic	  therapy,	  fulfill	  
the	  Koch's	  postulates	  as	  infection	  agent,	  which	  are:	  
1.	   The	  microorganism	  must	   be	   found	   in	   abundance	   in	   all	   organisms	   suffering	   from	  
the	  disease,	  but	  not	  in	  healthy	  organisms;	  
2.	  The	  microorganism	  must	  be	  isolated	  from	  a	  diseased	  organism	  and	  grown	  in	  pure	  
culture;	  
3.	  The	  cultured	  microorganism	  should	  cause	  disease	  when	  introduced	  into	  a	  healthy	  
organism;	  
4.	  The	  microorganism	  must	  be	  reisolated	  from	  the	  inoculated,	  diseased	  experimental	  
host	  and	  identified	  as	  being	  identical	  to	  the	  original	  specific	  causative	  agent.	  
In	  their	  original	  paper,	  Warren	  and	  Marshall	  contend	  that	  most	  stomach	  ulcers	  and	  gastritis	  
were	  caused	  by	  infection	  by	  this	  bacterium	  and	  not	  by	  stress	  or	  lifestyle	  as	  it	  had	  been	  assumed	  
before.6	   The	   medical	   community	   was	   skeptical	   to	   recognize	   the	   role	   of	   this	   bacterium	   in	   the	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stomach	  ulcers	  and	  gastritis,	  believing	  that	  no	  microorganism	  could	  survive	  for	  long	  in	  the	  acidic	  
environment	  of	  the	  stomach	  but	  it	  began	  to	  come	  around	  after	  further	  independent	  studies	  were	  
done.8,9	  
In	   1994,	   the	   National	   Institutes	   of	   Health	   (NIH,	   United	   States	   of	   America)	   published	   an	  
opinion	  stating	   that	  most	   recurrent	  ulcers	  were	  caused	  by	   this	  bacterium	  and	  recommended	  to	  
include	  antibiotics	  in	  the	  treatment	  regimen.	  
In	  2005,	  Warren	  and	  Marshall	  were	  awarded	  the	  Nobel	  Prize	  in	  Medicine	  for	  their	  work	  on	  
H.	  pylori.	  In	  addition	  to	  this,	  the	  discovery	  of	  H.	  pylori	  has	  led	  to	  an	  increase	  in	  understanding	  the	  
association	  between	  chronic	  infection,	  inflammation	  and	  cancer.	  
	  
1.2.	  -­‐	  Helicobacter	  pylori,	  the	  gastric	  pathogen	  
H.	  pylori	  is	  a	  microaerophilic,	  Gram-­‐negative	  spiral	  shaped	  bacteria	  with	  2.5-­‐	  4	  μm	  long	  and	  
0.5-­‐	  1.0	  μm	  wide	  and	   it	   is	   the	  only	  human	  bacterium	  to	  persistently	   inhabit	   the	  gastric	  mucosa	  
(Figure	  1).10	  The	  spiral	  shape	  along	  with	  its	  four	  to	  six	  unipolar	  flagella	  allows	  for	  motility,	  a	  crucial	  
step	   to	   achieve	   successful	   colonization	   of	   the	   gastric	   mucosa	   and	   circumvent	   the	   host	  
defenses.11,12	   Environmental	   sensing,	   chemotaxis13	   and	   iron	   acquisition14	   are	   also	   important	  
factors	  for	  colonization.	  
	  
	   	  
Figure	  1.	  (a)	  Transmission	  electron	  micrograph	  of	  H.	  pylori	  and	  (b)	  coloured	  scanning	  electron	  micrograph	  of	  H.	  pylori.15	  
	  
Besides	  those	  colonization	  strategies,	  this	  bacterium	  must	  use	  other	  elegant	  ones	  to	  cope	  
with	  the	  high	  viscosity	  of	  the	  mucous	  gel	  layer,	  the	  mechanical	  and	  cell	  renewal	  process	  and	  the	  
extremely	  acidic	  pH	  of	  the	  lumen	  in	  order	  to	  infect	  the	  host.	  
(a)	   (b)	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Figure	   2.	   Antibacterial	   properties	   of	   the	   stomach.	   The	   stomach	   is	   intrinsically	   resistant	   to	   bacterial	   colonization.	  
Factors	   that	   contribute	   to	   this	   resistance	   include	   gastric	   acidity,	   lactoferrin,	   and	   antibacterial	   peptides.	   The	   gastric	  
epithelial	   layer	   constitutes	   a	   physical	   barrier	   that	   prevents	   entry	   of	   bacteria	   into	   the	   gastric	  mucosa.	   Adapted	   from	  
Algood	  et	  al.16	  	  
	  
Urease	   production,	   an	   enzyme	   that	   hydrolyzes	   urea	   to	   ammonia,	   provides	   the	  
indispensable	   skill	   for	   rising	   the	   acidic	   pH	   of	   the	   stomach	   and	   it	   is	   fundamental	   for	  
pathogenicity.17	  The	  increase	  in	  the	  pH	  subverts	  the	  mucous	  gel	  layer	  viscoelastic	  consistency	  to	  a	  
more	  permissible	  barrier,	  allowing	  the	  bacteria	  to	  penetrate	  the	  mucosa.	  Also,	  urea	  and	  sodium	  
bicarbonate	  are	  used	  by	  H.	  pylori	  as	  chemotactic	  attracts18	  and	  urease	   is	   the	  basis	   for	   the	  most	  
widely	   used	   biopsy-­‐based	   test	   (biopsy	   urease	   test)	   and	   the	  most	   widely	   used	   noninvasive	   test	  
(urea	   breath	   test)	   for	  H.	   pylori	   detection	   in	   the	   stomach.19	  H.	   pylori	   outer	  membrane	   proteins,	  
including	  BabA,	  SabA,	  AlpA,	  AlpB,	  and	  HopZ,	  function	  as	  adhesins	  to	  mediate	  bacterial	  adherence	  
to	  gastric	  epithelial	  cells.	  
	  
	  
Figure	  3.Colonization	  factors	  of	  H.	  pylori.	  Multiple	  bacterial	  factors	  contribute	  to	  the	  ability	  of	  H.	  pylori	  to	  colonize	  the	  
stomach.	  Urease	  contributes	  to	  the	  acid	  resistance.	  Flagella	  permit	  bacterial	  motility,	  which	  allows	  bacterial	  penetration	  
of	   the	   mucus	   layer.	   Several	   outermembrane	   proteins,	   including	   BabA,	   SabA,	   AlpA,	   AlpB,	   and	   HopZ,	   can	   mediate	  
bacterial	  adherence	  to	  gastric	  epithelial	  cells.	  Adapted	  from	  Algood	  et	  al.16	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1.3.	  -­‐	  The	  Human	  gastric	  mucosa	  
The	  mucosal	   surface	   is	   constituted	  majorly	   by	   water	   (>	   95	   %)	   and	   by	   a	   highly	   hydrated	  
mucus	  gel	  with	  a	   thickness	  of	   approximately	  300	  μm.	   It	   is	  organized	   in	   two	  distinct	   layers:	  one	  
that	  is	  firmly	  attached	  to	  the	  mucosa	  and	  other	  loosely	  bound.	  
	  
Figure	  4.	  Schematic	  representation	  of	  the	  mucosal	  barrier.	  Adapted	  from	  Lindén.20	  	  
	  
The	  thickness	  of	  the	  firmly	  attached	  layer	  changes	  among	  gastric	  regions,	  ranging	  from	  80	  
μm	   on	   the	   corpus	   (body)	   region	   to	   154	   μm	   on	   the	   antrum	   (pyloric	   area)	   portion	   of	   the	  
stomach.21,22	  
	  
Figure	  5.	  Schematic	  representation	  of	  the	  stomach	  regions	  and	  their	  incidence	  of	  gastric	  cancer.23	  
	  
Mucins	   are	   high	   molecular	   mass	   oligomeric	   glycoproteins	   that	   represent	   the	   interface	  
between	   the	   epithelial	   cell	   layers	   and	   the	   external	   environment.	   The	   carbohydrate	   content	   of	  
mucins	  provides	   to	   the	  mucus	  gel	   its	  protective	  properties,	  acting	  as	  a	  highly	  hydrated	  physical	  
barrier	   that	   lubricates	   and	   defends	   epithelial	   cells	   from	   external	   aggressions,	   such	   as	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microorganisms	  and	  mechanical	  damage.	  This	  layer	  is	  also	  responsible	  for	  the	  establishment	  of	  a	  
pH	  gradient,	  being	  the	  pH	  neutral	  at	  the	  cell	  surface	  and	  acidic	  at	  the	  gastric	  lumen	  (Figure	  2	  and	  
4).24	  
The	  carbohydrate	  chain	  of	  glycans	  is	  initiated	  with	  an	  N-­‐acetylgalactosamine	  (GlcNAc)	  and	  
terminated	  by	  e.g	  fucose	  (Fuc),	  galactose	  (Gal)	  or	  sialic	  acid	  residues,	  forming	  histo-­‐blood	  group	  
antigens	   such	   as	   Lewis	   a,	   Lewis	   b,	   Lewis	   x,	   Lewis	   y,	   as	   well	   as	   sialyl-­‐Lewis	   a	   and	   sialyl-­‐Lewis	   x	  
structures.25,26	   Some	   of	   these	   groups	   are	   responsible	   for	   the	   negative	   charge	   of	   the	   gastric	  
mucosa	  and	  are	   the	  preferential	  binding	  sites	   for	  microorganisms.	  This	  binding	  may	  benefit	   the	  
host	   since	   mucins	   can	   act	   as	   a	   decoy	   for	   them,	   becoming	   the	   pathogens	   trapped	   and	   latter	  
removed	  and	  eliminated.	  On	  the	  other	  hand,	  this	  same	  interaction	  can	  become	  a	  menace,	  since	  
the	  intimate	  contact	  with	  epithelial	  cells	  may	  favor	  colonization.	  
	  
1.4.	  -­‐	  Helicobacter	  pylori	  virulence	  factors	  
Although	   the	   final	   clinical	   outcome	   of	   H.	   pylori	   infection	   also	   depends	   on	   host	   and	  
environmental	  factors	  interplay,	  it	  has	  been	  observed	  that	  infection	  with	  distinct	  strains	  results	  in	  
different	   damage	   for	   the	   host.	   Therefore,	   it	   is	   possible	   to	   distinct	   between	   high	   and	   low	  
pathogenic	  strains	  by	  identification	  of	  bacterial	  features	  that	  increase	  the	  risk	  to	  develop	  gastric	  
disease.27	  
	  
1.4.1.	  -­‐	  Adherence	  to	  gastric	  epithelial	  cells	  
To	  establish	  a	  successful	   infection,	  adherence	  to	  gastric	  epithelial	  cells	  represents	  the	  key	  
step	   in	  colonization	  of	   the	  gastric	  environment.	  The	  adherence	  process	   is	  mediated	  by	  H.	  pylori	  
adhesin	  proteins	  that	  recognize	  specific	  glycan	  structures	  (Gly-­‐R)	  expressed	  in	  the	  gastric	  mucosa.	  
Once	  adhesion	  occurs	  it	  triggers	  the	  expression	  of	  many	  new	  bacterial	  genes,	  including	  some	  that	  
encode	  virulence	  factors.28	  	  
1.4.1.1.	  -­‐	  The	  Lewis	  antigens	  and	  the	  importance	  of	  the	  secretor	  status	  
H.	  pylori	  adhesion	  to	  gastric	  epithelial	  cells	  occurs	  trough	  binding	  between	  specific	  bacterial	  
surface	  proteins	  (adhesins)	  and	  blood	  group	  antigens	  expressed	  on	  the	  surface	  of	  these	  cells.	  
Karl	  Landsteiner	  and	  his	  colleagues	  discovered	  the	  ABO	  group	  system	  in	  the	  early	  1900s.29	  
They	  observed	  that,	  according	  to	  the	  presence	  or	  absence	  of	  serum	  components,	  agglutination	  of	  
red	   blood	   cells	   from	   other	   individuals	   occurred.	   Later,	   it	   was	   clarified	   that	   what	   determined	  
agglutination	  was	   the	   antibody	   recognition	   of	   the	   A,	   B	   and	   O	   (H)	   antigens	   present	   on	   the	   cell	  
surface.	   The	   A,	   B,	   and	   H	   antigens	   are	   complex	   fucosylated	   carbohydrates	   expressed	   on	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erythrocytes	   of	   all	   individuals	   of	   blood	   group	   A,	   B,	   or	   O,	   respectively.	   All	   share	   the	   Fuc	   α1.2-­‐
glycan,	  because	  the	  bone	  marrow	  (from	  where	  the	  erythrocytes	  originate)	  express	  the	  common	  
H-­‐(fucosyl)transferase	  (Figure	  6).	  Lack	  of	  fucosylated	  ABH	  antigens	  on	  erythrocytes	  in	  circulation	  
(Bombay	  phenotype)	  is	  extraordinarily	  rare.30	  Modification	  of	  the	  precursor	  chains	  with	  a	  terminal	  
α	  1,2-­‐	  linked	  fucose	  results	  in	  the	  H	  antigen.	  	  
	  
	  
Figure	  6.	  Schematic	  representation	  of	  A,	  B	  and	  O	  (H)	  antigens.	  Adapted	  from	  Magalhães.31	  	  
	  
There	   are	   two	   different	   α	   1,2-­‐	   fucosyltransferases:	   FUT1	   (encoded	   by	   the	  H	   blood	   group	  
locus)	   and	   FUT2	   (encoded	   by	   the	   Secretor	   locus).	   FUT1	   is	   responsible	   for	   the	   synthesis	   of	   H	  
antigens	   on	   erythrocytes	   and	   the	   FUT2	   is	   responsible	   for	   producing	   the	  H-­‐type	   1	   carbohydrate	  
present	  on	  the	  surface	  of	  epithelial	  cells	  and	  in	  mucosal	  secretions	  of	  secretor	  individuals.32	  Being	  
or	   not	   secretor	   is	   dependent	   of	   the	   activity	   of	   the	   FUT2	   enzyme.	  Mutations	   in	   the	   FUT2	   gene,	  
leading	  to	  its	  inactivation,	  are	  responsible	  for	  the	  nonsecretor	  phenotype,	  corresponding	  to	  20	  %	  
of	  human	  Caucasian	  population.33	   It	  has	  been	  shown	  that	  nonsecretor	   individuals	  have	  reduced	  
susceptibility	  to	  infections	  by	  Norwalk	  virus34,	  Campylobacter	  jejuni35	  and	  H.	  pylori.36	  
The	  Lewis	  blood	  group	  arises	  from	  a	  group	  of	  fucosylated	  glycans,	  built	  from	  type	  1	  or	  type	  
2	  precursor	  chains.	  Substitution	  of	  the	  terminal	  Gal	  with	  a	  α1,2-­‐fucose	  residue	  on	  type	  1	  or	  type	  2	  
chains	  results	  in	  H-­‐type	  1	  or	  H-­‐type	  2,	  respectively.	  These	  can	  undergo	  further	  modifications	  with	  
fucosyltransferases,	   adding	   fucose	   to	   the	   α1,4-­‐linkage	   in	   type	   1,	   producing	   the	   Lewis	   B	   (Leb)	  
antigen.	  Addition	  of	  fucose	  to	  the	  α1,3-­‐	  linkage	  in	  type	  2	  structures	  produces	  Lewis	  Y,	  an	  isomer	  
of	   the	   Leb	   antigen.	   Type	   1	   and	   2	   chains	   can	   also	   undergo	   another	   transformation.	  
Fucosyltransferases	   can	  modify	   type	   1	   and	   type	   2	   chains	   backbone,	   producing	   Lewis	   a	   (type	   1	  
chain)	  and	  Lewis	  x	  (type	  2	  chain).	  Moreover,	  syaliltransferases	  can	  act	  on	  the	  Gal	  residue	  of	  these	  
chains,	  adding	  a	  α2,3	  sialic	  acid	  residue,	  followed	  by	  addition	  of	  fucose.	  This	  results	  in	  production	  
of	  sialyl-­‐Lewis	  a	  (type	  1	  chain)	  or	  sialyl-­‐Lewis	  x	  (sLex)	  (type	  2	  chain).	  
	  
Figure	  7.	  Schematic	  representation	  of	  type	  1	  and	  type	  2	  chains.	  Adapted	  from	  Magalhães.31	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Production	   of	   Lewis	   antigens	   is	   dependent	   on	   expression	   of	   specific	   glycosyltransferases,	  
determined	  by	  each	   individual	   genotype.	   The	  H-­‐type	  1	   antigens	   are	  only	   expressed	  by	   secretor	  
individuals	  and	  Leb	  is	  only	  expressed	  by	  secretor	  and	  Lewis	  positive	  individuals.32	  
	  
1.4.1.2.	  -­‐	  Blood	  group	  antigen	  binding	  Adhesin	  (BabA)	  and	  Sialic	  acid	  binding	  Adhesin	  (SabA)	  
Bacterial	  BabA	  mediates	  adherence	  between	  H.	  pylori	  and	  human	  Leb	  blood	  group	  antigens	  
expressed	   on	   gastric	   epithelial	   cells	   (Figure	   8).37-­‐39	   Infections	   with	   strains	   expressing	   functional	  
BabA	   are	   associated	   with	   increased	   epithelial	   proliferation	   and	   inflammation	   and	   also	   with	  
increased	   risk	   for	   duodenal	   cancer,	   gastric	   atrophy,	   intestinal	   metaplasia	   and	   gastric	  
adenocarcinoma	   development.40-­‐42	   Geographical	   differences	   are	   observed	   in	   the	   frequency	   of	  
BabA	   expressing	   strains.	   European	   populations	   show	   35	   to	   70	   %	   of	   prevalence	   of	   expressing	  
strains	  while	  countries	  like	  Japan,	  Korea,	  Taiwan,	  Columbia	  and	  United	  States	  have	  more	  than	  60	  
%	  prevalence.39-­‐45	  
Persistent	  infection	  with	  H.	  pylori	  leads	  to	  gastric	  mucosa	  inflammation	  with	  concomitantly	  
de	   novo	   expression	   of	   charged	   sialylated	   antigens,	   such	   as	   sLex,	   on	   the	   gastric	   epithelial	   cells	  
surface	  (Figure	  8).46,47	  These	  sialylated	  antigens	  are	  recognized	  by	  the	  SabA	  adhesin	  expressed	  by	  
some	  H.	  pylori	  strains,	  mediating	  bacterial	  adherence	  to	  the	  inflamed	  mucosa.46,48	  The	  frequency	  
of	   SabA	   expression	   has	   not	   been	   so	   extensively	   studied	   as	   for	   BabA.	   Studies	   on	   European	  
populations	  suggest	  that	  around	  40	  %	  of	  clinical	  isolates	  express	  this	  adhesin:	  a	  study	  concerning	  
Swedish	  clinical	   isolates	  demonstrated	  that	  39	  %	  of	  the	  clinical	   isolates	  were	  able	  to	  bind	  to	  the	  
sialylated	  antigen	  and	  a	  similar	  study	  in	  a	  population	  of	  asymptomatic	  children	  and	  young	  German	  
adults	  demonstrated	  38	  %	  of	  binding	   to	   those	  antigens.43,46,49	  Also,	  a	   study	  with	  clinical	   isolates	  
from	   Taiwan	   showed	   that	   31	  %	   of	   the	   isolates	   expressed	   SabA.	   This	   same	   study	   suggests	   that	  
SabA	  interaction	  with	  the	  host	  sLex	  antigen	  is	  important	  in	  patients	  that	  express	  weak	  or	  no	  Leb,	  
enhancing	  H.	  pylori	  colonization.50	  
	  
Figure	  8.	  H.	  pylori	  adhesion	  to	  gastric	  cells.	  H.	  pylori	  binds	  to	  the	  gastric	  mucosa	  via	  interaction	  with	  Leb	  present	  on	  the	  
healthy	  gastric	  mucosa,	  via	  the	  BabA	  adhesin.	  sLex	  expression	  occurs	  post	  inflammation	  and	  the	  SabA	  adhesin	  binds	  to	  
it.	  Other	  bacterial	  adhesins	  (represented	  in	  yellow)	  are	  present	  on	  the	  bacterial	  surface	  although	  their	  specific	  receptors	  
have	  not	  yet	  been	  identified.	  Adapted	  from	  Magalhães	  and	  Reis.48	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H.	   pylori	   is	   able	   to	   modulate	   expression	   of	   these	   adhesins,	   allowing	   for	   a	   continuous	  
adaptation	   of	   the	   bacteria	   to	   the	   circumstances	   of	   the	   gastric	   mucosa.	   This	   is	   considered	   an	  
essential	  feature	  to	  achieve	  long-­‐term	  colonization.	  
These	  adhesins	  have	  also	  been	  implicated	   in	  binding	  to	  salivary	  proteins	  which	  assumes	  a	  
relevant	  status	  if	  we	  consider	  that	  the	  oral	  cavity	  represents	  the	  most	  probable	  open	  door	  for	  the	  
bacterium	  entry	  and	  may	  act	  as	  a	  reservoir	  for	  re-­‐infection.51,	  52	  
	  
1.4.2.	  -­‐	  CagA	  
The	  cagA	  protein	  is	  encoded	  by	  the	  cagPAI	  multigenic	  region,	  which	  contains	  approximately	  
30	  genes.53	  More	  virulent	  H.	  pylori	   strains	  are	  cagPAI+	  while	   less	  virulent	  strains	  are	  cagPAI-­‐.19,54	  
cagA+	   strains	   have	   been	   linked	   to	   both	   peptic	   ulceration	   and	   gastric	   adenocarcinomas	  whereas	  
cagA-­‐	  strains	  are	  considered	  rarely,	  if	  ever,	  to	  be	  disease-­‐associated.55-­‐57	  The	  frequency	  of	  cagPAI	  
varies	   among	   population	   groups,	   ranging	   from	   almost	   all	   strains	   in	   population	   from	   East	   Asia	  
population,	  to	  intermediate	  in	  Europe	  and	  completely	  absent	  in	  South	  Africa	  populations.58	  
The	   multigenic	   region	   encodes	   a	   type	   IV	   secretion	   system,	   used	   for	   translocation	   of	  
bacterial	   products	   directly	   into	   the	   cytoplasm	   of	   the	   host	   epithelial	   cell.	   Delivery	   of	   the	   CagA	  
protein	   results,	   after	   phosphorylation	   on	   tyrosine	   residues	   by	   host	   cell	   kinases,	   in	   activation	   of	  
numerous	  cell	   signaling	  –transduction	  pathways,	   including	   those	  of	   cytoskeletal	   rearrangement,	  
motility,	  proliferation	  and	  apoptosis.19,59,60	   In	  vitro,	   the	  most	  obvious	  effect	   is	   stimulation	  of	  cell	  
shape	   change,	   beginning	   the	   cell	   to	   elongate	   and	   develop	   long	   processes,	   termed	   the	  
hummingbird	  phenotype.59,	  61	  
CagA	  structure	  differs	  among	  strains	  in	  the	  active	  phosphorylation	  sites	  and	  the	  binding	  site	  
for	  the	  signaling	  protein	  SHP-­‐2.62,63	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Figure	   9.	  CagA	   interaction	  with	   epithelial	   cells.	   Infection	  with	   cagA+	   strains	   is	   linked	   to	   a	  more	   severe	   outcome	  of	  
infection,	  including	  atrophic	  gastritis,	  peptic	  ulcer	  disease	  and	  gastric	  adenocarcinoma	  development.56,57,64,65	  The	  cagA	  
product	   is	   injected	   into	   the	   cytoplasm	   of	   the	   host	   cell,	   where	   tyrosine	   (Y)	   residues	   near	   its	   COOH-­‐terminus	   are	  
phosphorylated.	   Phosphotyrosine-­‐CagA	   interacts	   with	   several	   major	   signal-­‐transduction	   pathways	   in	   the	   host	   cell,	  
affecting	  phenotypes	  including	  cell	  morphology,	  proliferation,	  and	  apoptosis.	  Adapted	  from	  Atherton.19	  
	  
1.4.3.	  -­‐	  Vacuolating	  cytotoxin	  (VacA)	  
The	  vacuolating	  cytotoxin	  (VacA)	  is	  a	  toxin	  that	  is	  secreted	  and	  causes	  damage	  to	  epithelial	  
cells	  by	  the	  formation	  of	  vacuoles	  (Figure	  10).66,67	  
	  
Figure	   10.	  VacA	   biological	   activities.	   Secreted	   VacA	   forms	  monomers	   and	   oligomers;	   the	  monomeric	   form	   binds	   to	  
epithelial	  cells	  both	  nonspecifically	  and	  through	  specific	  receptor	  binding,	  for	  example,	  to	  Ptprz,	  which	  may	  modulate	  
cell	   signaling.	   Membrane-­‐bound	   VacA	   forms	   pores.	   Following	   VacA	   endocytosis,	   large	   vacuoles	   form,	   but,	   although	  
marked	   in	  vitro,	  these	  are	  rarely	  seen	   in	  vivo.	  VacA	  also	   induces	  apoptosis,	   in	  part	  by	  forming	  pores	   in	  mitochondrial	  
membranes.	  	  VacA	  also	  has	  suppressive	  effects	  on	  immune	  cell	  function.	  Adapted	  from	  Blaser	  and	  Atherton.10	  
	  
The	  gene	  encoding	  for	  it	  is,	  unlike	  cagPAI,	  present	  in	  all	  H.	  pylori	  strains,	  being	  polymorphic	  
mostly	  in	  two	  regions,	  the	  mid-­‐	  and	  signal	  regions.68,69	  The	  main	  signal	  region	  types	  are	  s1	  and	  s2	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and	  the	  mid-­‐region	  types	  are	  m1	  and	  m2.	  The	  vacA	  gene	  may	  comprise	  any	  combination	  of	  these	  
regions,	   although	   the	   s2/m1	   combination	   is	   rare.69,70	   S1/m1-­‐	   and	   s1/m2-­‐type	   strains	   may	   be	  
disease	   associated	   and	   although	   both	   types	   are	   common,	   clinical	   isolates	   from	   patients	   with	  
gastric	  adenocarcinoma	  are	  usually	  s1/m1	  vacA	  type	  (Figure	  11).71-­‐73	  
	  
	  
Figure	  11.	  VacA	  polymorphism	   in	  H.	  pylori	   strains.	  The	  vac	  gene	  varies	  most	  markedly	  in	  the	  signal	  region	  (encoding	  
the	  signal	  peptide),	  which	  may	  be	  type	  s1	  or	  s2,	  and	  in	  the	  mid-­‐region	  (encoding	  part	  of	  the	  p58	  binding	  subunit),	  which	  
may	  be	  type	  m1	  or	  m2.	  Three	  types	  of	  toxin	  are	  commonly	  found:	  s1/m1,	  s1/m2,	  and	  s2/m2	  (the	  s2/m1	  combination	  
occurs	  but	  is	  rare).	  Adapted	  from	  Atherton.19	  
	  
Contact-­‐dependent	   or	   secretion	   may	   be	   the	   two	   ways	   by	   which	   VacA	   is	   transferred	   to	  
epithelial	   cells74	   and	   it	   is	   able	   to	   bind	   to	   several	   epithelial	   cell	   receptors,	   such	   as	   the	   receptor	  
protein	   tyrosine	   phosphatase	   (RPTP)	   β	   and	   α	   75	   and	   the	   epidermal	   growth	   factor	   receptor	  
(EGFR).76	  
VacA	  is	  dependent	  on	  acidic	  conditions	  to	  be	  activated,	  which	  makes	  this	  toxin	  well	  suited	  
for	  the	  gastric	  environment.77,78	  	  
	  
1.4.4.	  -­‐	  Antigenic	  disguise	  
H.	   pylori	   outer	   membrane	   proteins	   and	   other	   surface	   components	   are	   likely	   targets	   for	  
recognition	  by	  host	  immune	  defenses. H.	  pylori	  evades	  the	  immune	  recognition	  by	  a	  mechanism	  
of	  antigenic	  disguise	  in	  which	  bacteria	  are	  coated	  with	  host	  proteins.16	  The	  PgbA	  and	  PgbB	  outer	  
membrane	  proteins	  bind	  plasminogen	  and	  thereby	  the	  bacteria	  can	  be	  coated	  with	  host	  protein.79	  
Other	   mechanism	   for	   evading	   the	   host	   immune	   system	   involves	   antigenic	   variation	   of	  
surface	   components.	   The	   lipopolysaccharide	   (LPS)	   from	   most	   bacterial	   organisms	   serves	   as	   a	  
potent	   signal	   for	   developing	   an	   inflammatory	   response.	   An	   important	   H.	   pylori	   adaptation	   to	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counteract	  this	  is	  the	  synthesis	  of	  a	  LPS	  that	  is	  less	  proinflamatory	  than	  the	  LPS	  from	  many	  other	  
Gram-­‐negative	   species.	   This	   low	   biological	   activity	   is	   attributable	   to	  modifications	   of	   its	   lipid	   A	  
component.	   H.	   pylori	   strains	   commonly	   express	   LPS	   O	   antigens	   mimicking	   Lewis	   blood	   group	  
antigens	   found	   on	   host	   cells.	   This	   similarity	   in	   structure	   between	   the	   bacterial	   LPS	   and	   Lewis	  
blood	  group	  antigens	  may	  represent	  a	  form	  of	  molecular	  mimicry	  or	  immune	  tolerance.	  It	  allows	  
H.	   pylori	   LPS	   antigens	   to	   be	   shielded	   from	   immune	   recognition	   because	   of	   similarity	   to	   “self”	  
antigens.16	   This	   pathogen	   may	   change	   its	   Lewis	   phenotypes	   during	   long-­‐term	   colonization	   to	  
resemble	  the	  ones	  of	  the	  host	  gastric	  mucosa.80	  
	  
1.4.5.	  -­‐	  Others	  
There	   are	   other	   virulence	   factors	   contributing	   to	  H.	   pylori	   success	   as	   a	   gastric	   pathogen,	  
namely:	  	  
- Lipoprotein	  A	  and	  B	   (AlpA	  and	  AlpB)	   that	   are	  expressed	  by	  all	  H.	  pylori	   strains	   and	  
have	   been	   demonstrated	   to	   play	   an	   important	   role	   in	   the	   bacterium	   adhesion	   to	  
gastric	  cell	   lines	  and	  human	  gastric	  biopsies.81-­‐83	  So	  far,	  the	  host	  receptors	  for	  these	  
two	  proteins	  have	  not	  yet	  been	  identified.	  It	  still	  remains	  unclear	  if	  these	  proteins	  act	  
as	   adhesins	   or	   are	   necessary	   for	   function	   of	   other	   bacterial	   proteins	   involved	   in	  
adhesion;	  
- Neutrophil-­‐activating	   protein	   (NAP)	   is	   a	   bacterioferrin	   that	   binds	   to	   sulfated	  
oligosaccharide	   structures	   expressed	   on	   salivary	   mucins,	   inducing	   neutrophil	  
adhesion	  to	  endothelial	  cells;84,85	  
- Hsp70	   is	   a	   heat	   shock	   protein	   that	   is	   important	   in	   glycan	   recognition	   under	   stress	  
conditions;84,85	  
- Outer	  inflammatory	  protein	  A	  (OipA)	  is	  an	  outer	  membrane	  protein	  expressed	  by	  all	  
H.	  pylori	  strains	  that	  may	  be	  relevant	  in	  the	  bacterium	  adhesion	  process.	  Its	  activity	  
has	   been	   linked	   with	   increased	   bacterial	   density,	   higher	   IL-­‐8	   production	   and	  
augmented	   neutrophil	   infiltration.86,87	   In	   vitro	   studies	   demonstrated	   that,	   when	   a	  
mutation	  occurred	   in	  OipA,	  H.	  pylori	  adherence	  to	  gastric	  mucosa	  declined.	  Specific	  
receptors	  have	  yet	  to	  be	  identified.88	  
	  
1.5.	  -­‐	  Helicobacter	  pylori	  acquisition	  and	  infection	  	  
Despite	   the	   fact	   that	  H.	   pylori	   infection	   rate	   reaches	   an	   impressive	   50%	  worldwide,	   this	  
bacterium	   has	   not	   been	   consistently	   isolated	   outside	   the	   human	   GI	   tract,	   which	   raised	   the	  
question	   of	   how	   did	   this	   pathogen	   became	   so	   widespread.	   Epidemiologic	   studies	   have	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determined	  the	  socioeconomic	  status	  (levels	  of	  hygiene,	  sanitation,	  density	  of	  living,	  educational	  
opportunities)	  as	   the	  main	  determinant	   for	  acquiring	   infection,	  with	  poorer/lower	  social	   classes	  
exhibiting	   much	   higher	   prevalence.89	   Infection	   is	   mainly	   acquired	   in	   early	   childhood	   and	   it	   is	  
estimated	   that	  by	   the	  age	  of	  10,5	  %	  of	  children	  worldwide	  carry	   this	  pathogen90,	  with	  pediatric	  
infection	   rates	   ranging	   from	   10	   %	   in	   high	   income	   countries	   to	   80	   %	   or	   higher	   in	   low	   income	  
countries.	   It	  was	  hypothesized	   that	   treating	   infected	  children	  would	   reduce	   the	   transmission	  of	  
infection	   and	   would	   ultimately	   prevent	   or	   reduce	   the	   incidence	   of	   gastric	   cancer	   in	   adults.91	  
However,	  children	  are	  re-­‐infected	  more	  frequently	  than	  adults	  and	  close	  contact	  between	  young	  
children,	  especially	  among	  siblings	  and	  children	  younger	   than	  5	  years	  old,	  may	  be	  an	   important	  
risk	   factor	   at	   the	   time	  of	   eradication	   treatment.92	   Infection	   is	   rarely	   acquired	   in	   adulthood	   and	  
when	   it	   happens	   it	   is	   usually	   accompanied	  by	  profound	   gastritis	  with	   hypochlolydria,	   epigastric	  
discomfort	  and	  nausea.93,94	  In	  contrast	  it	  is	  unknown	  that	  if	  when	  colonization	  occurs	  in	  childhood	  
it	  is	  symptomatic.19	  
Infection	  is	  transmitted	  from	  person-­‐to-­‐person95,	  presumably	  from	  oral-­‐oral	  and/or	  faecal-­‐
oral	   routes,	   associated	   with	   gastroenteritis	   and	   vomiting.96-­‐99	   Water	   can	   also	   play	   a	   role	   as	   a	  
vehicle	   in	   transmission	   of	   this	   pathogen.100	   The	   suggested	   transmission	   routes	   pathways	   are	  
summarized	  in	  Figure	  12.	  
	  
Figure	   12.	  Suggested	   transmission	   routes	   pathways.	  The	   red	  squares	   identify	  possible	   reservoirs	  outside	   the	  human	  
body.	  Adapted	  from	  Azevedo.101	  
	  
Upon	  infection,	  all	  strains	  of	  H.	  pylori	  induce	  a	  clear	  immune	  response	  with	  local	  neutrophil,	  
lymphocyte	   and	   other	   inflammatory	   cell	   infiltration	   with	   both	   local	   and	   systemic	   antibody	  
production	  and	  cell	  mediated	  responses.19	  Although	  gastric	  inflammation	  is	  always	  present,	  most	  
of	   the	   infected	   hosts	   present	   mild	   or	   any	   symptoms	   and	   only	   few	   will	   develop	   severe	   gastric	  
disease.102-­‐104	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1.6.	  -­‐	  Outcome	  of	  infection	  with	  Helicobacter	  pylori	  	  
Outcome	  of	  H.	  pylori	  infection	  is	  difficult	  to	  predict,	  since	  it	  depends	  on	  the	  conjugation	  of	  
several	  factors	  such	  as:	  the	  host	  genetic	  susceptibility,	  environmental	  factors	  (mainly	  smoking	  and	  
diet)	  and	  the	  strain	  virulence	  characteristics.	  
Distribution	   and	   pattern	   of	   gastric	   inflammation	   are	   associated	   with	   the	   type	   of	   lesions	  
observed.	   Individuals	   with	   antral	   predominant	   gastritis	   have	   increased	   acid	   production	   and	  
therefore	  are	  more	  prone	  to	  develop	  duodenal	  ulcers.	  When	  gastritis	  is	  prevalent	  on	  the	  corpus,	  
acid	   production	   is	   normal	   or	   reduced	   and	   is	   associated	  with	   gastric	   ulcers,	   gastric	   atrophy	   and	  
gastric	  carcinoma.	   Individuals	  that	  develop	  duodenal	  ulcers	  H.	  pylori-­‐associated	  are	   less	   likely	  to	  
develop	  gastric	  carcinomas.103,105	  
Table	   I	   summarizes	   the	   evolution	  of	   pre-­‐malignant	   lesions	   induced	  by	  H.	   pylori	   to	   gastric	  
carcinoma.	  
	  
Table	  I.	  Evolution	  of	  pre-­‐malignant	  lesions	  induced	  by	  H.	  pylori	  to	  gastric	  carcinoma.	  Adapted	  from	  de	  Vries.106	  
Pre-­‐malignant	  lesion	   %	  of	  evolution	  to	  gastric	  cancer	  (per	  year)	  
Atrophic	  gastritis	   0-­‐1.8	  
Intestinal	  metaplasia	   0-­‐10	  
Gastric	  dysplasia	   0-­‐73	  
	  
1.6.1.	  -­‐	  Gastric	  cancer	  
A	  total	  of	  989.600	  new	  gastric	  cancer	  cases	  and	  738.000	  deaths	  were	  estimated	  to	  occur	  in	  
2008,	  accounting	  for	  8	  %	  of	  the	  total	  cancer	  cases	  and	  10	  %	  of	  the	  total	  cancer-­‐related	  deaths.107	  
Survival	   from	   gastric	   cancer	   is	   poor	   since	   patients	   are	   often	   diagnosed	   with	   advanced	   stage	  
disease.	   In	  the	  USA,	  the	  five-­‐year	  survival	  rate	   is	  only	  24	  %.	  Developing	  countries,	  such	  as	  those	  
from	  Eastern	  Asia,	  Eastern	  Europe	  and	  South	  America,	  show	  the	  highest	  rates	  of	  new	  cases	  and	  
deaths,	   accounting	   with	   70	   %	   for	   the	   total	   worldwide.108,109	   North	   America	   and	   most	   parts	   of	  
Africa	  have	  the	  lowest	  infection	  rates	  (Figure	  13).107	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Figure	  13.	  H.	  pylori	   infection	  distribution	  worldwide.	  N.D.	  stands	  for	  places	  where	  a	  consistent	  study	  about	  H.	  pylori	  
prevalence	  has	  not	  yet	  been	  conducted.	  In	  Azevedo.101	  
	  
Differences	   between	   geographical	   locations	   may	   be	   explained	   not	   only	   by	   the	  
socioeconomic	  conditions	  but	  also	  based	  on	  the	  diet.110	  
A	   risk	   factor	   for	   developing	   stomach	   cancer	   is	   chronic	   infection	   with	   the	   bacterium	   H.	  
pylori.	  The	  International	  Agency	  for	  Research	  in	  Cancer	  (IARC)	  classified	  this	  bacterium	  as	  a	  class	  I	  
carcinogen	   back	   in	   1994.111	   Animal	   experiments	   showed	   that	   H.	   pylori	   induced	   cancer	   in	  
Mongolian	  gerbils,	   clearly	  demonstrating	   the	  association	  between	   infection,	   the	  bacterial	   agent	  
and	   the	   development	   of	   gastric	   cancer.112	   Pelayo	   Correa	   suggested	   a	   sequential	   model	   of	  
intestinal	   type-­‐gastric	   carcinogenesis.113,114	   It	   proposes	   that	   H.	   pylori	   and	   possibly	   some	   other	  
environmental	  factors	  trigger	  a	  precancerous	  cascade.	  It	  starts	  with	  chronic	  gastritis,	  evolving	  to	  
atrophic	  gastritis,	  which	  leads	  to	  loss	  of	  glands.	  This	  change	  in	  the	  tissue,	  where	  gastric	  cells	  are	  
substituted	  with	  cells	  of	  intestinal	  phenotype,	  leads	  to	  intestinal	  metaplasia.	  The	  subsequent	  step	  
is	   denominated	   dysplasia,	   being	   characterized	   by	   changes	   in	   morphology	   and	   tissue	  
architecture.115	   The	  ultimate	   stage	  of	   this	   cascade	   caused	  by	   infection	  with	  H.	  pylori	   is	   invasive	  
carcinoma.116	  
	  
1.6.2.	  -­‐	  Gastric	  cancer	  in	  Portugal	  
Portugal	  has	  a	  high	   rate	  of	   infected	   individuals	  with	  H.	  pylori	   (between	  80	  %	  and	  90	  %	   in	  
people	   aged	   above	   30	   years)117	   and	   is	   one	   of	   the	   European	   Union	   leading	   countries	   in	   gastric	  
cancer	  incidence.	  Every	  year,	  2890	  new	  cases	  are	  diagnosed	  and	  2423	  people	  died	  in	  2008	  from	  
this	  oncological	  disease.109	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In	  1966,	  Portugal	  ranked	  12th	  out	  of	  36	  countries	  in	  what	  concerns	  mortality	  associated	  with	  
gastric	  neoplasia,	  occupying	  the	  7th	  position	  in	  1980.	  In	  1987	  it	  was	  considered	  the	  country	  with	  
the	  highest	  prevalence	  of	  gastric	  cancer	  within	  the	  European	  Union.117	  
Over	  the	  last	  years,	  the	  numbers	  of	  gastric	  carcinoma	  worldwide	  have	  been	  declining	  and	  
reduction	  in	  H.	  pylori	  infection,	  linked	  to	  improved	  socio-­‐economic	  conditions,	  largely	  contributed	  
to	   it.	   Despite	   the	   fact	   that	   Portugal	   and	   Japan	   rank	   9th	   and	   26th,	   respectively,	   in	   the	   Human	  
Development	  Index	  compiled	  by	  the	  United	  Nations	  Development	  program,	  these	  two	  countries	  
still	  are	  the	  most	  notable	  exceptions	  for	  the	  trend	  in	  declining	  rates	  of	  H.	  pylori	  infection.	  
	  
1.7.	  -­‐	  Treatment	  of	  Helicobacter	  pylori	  infection	  
H.	  pylori	  eradication	  treatment	  significantly	  reduces	  the	  risk	  of	  gastric	  cancer.118	  The	   ideal	  
eradication	  regimen	  of	  this	  pathogen	  should:	  (a)	  have	  cure	  rates	  of	  at	   least	  80	  %;	  (b)	  major	  side	  
effects	  should	  not	  be	  seen	  and	  (c)	  induction	  of	  bacterial	  resistance	  should	  be	  confined	  to	  minimal	  
values.103	  	  
Treatment	  to	  eradicate	  H.	  pylori	  is	  recommended	  on	  the	  following	  scenarios:	  	  
- Peptic	  ulcer;	  
- Atrophic	  gastritis;	  
- Gastric	  MALT	  lymphoma;	  
- Uninvestigated	  functional	  dyspepsia;	  
- Idiopathic	  thrombocytopenic	  pupura;	  
- Sideropenic	  anemia	  of	  unknown	  origin;	  
- Clinical	  history	  of	  gastric	  resection	  due	  to	  gastric	  cancer;	  
- Clinical	  history	  of	  first	  degree	  relatives	  with	  gastric	  cancer;	  	  
- Scheduled	  prolonged	  non-­‐steroid	  inflammatory	  drugs	  (NSAID)	  treatment;	  
- Long-­‐term	  proton	  pump	  inhibitor	  treatment;	  
- On	  patients	  request.119	  
Several	   drugs,	   alone	   or	   in	   combination	   have	   been	   used	   over	   the	   years	   to	   fight	   this	  
pathogen.	  A	  brief	  description	  on	  each	  is	  given	  in	  the	  following	  section.	  
	  
1.7.1.	  –	  Pharmaceutical	  substances	  used	  for	  Helicobacter	  pylori	  infection	  treatment	  
1.7.1.1.	  -­‐	  Penicillins	  
Amoxicillin	   is	   the	  most	   used	  penicillin	   applied	   in	   treatment	   of	  H.	   pylori	   infection.	   In	   vitro	  
test	   results	   of	  H.	   pylori	   antibiotic	   susceptibility	   are	   substantially	   different	   from	  what	   is	   seen	   in	  
vivo,	   where	   eradication	   rate	   is	   less	   than	   20	   %	   when	   this	   antibiotic	   is	   administered	   alone.	   If	   a	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proton	  pump	  inhibitor	  (PPI)	  is	  administered	  together	  for	  a	  period	  of	  7-­‐14-­‐days,	  eradication	  rates	  
of	  50-­‐60	  %	  may	  be	  achieved.120	  Other	  penicilins,	  such	  as	  ampicillin	  are	  inactivated	  in	  the	  stomach	  
and	  are	  useless	  to	  treat	  this	   infection.	  Also,	  the	  combination	  between	  amoxicillin	  and	  clavulanic	  
acid	  does	  not	  bring	  any	  advantage	  to	  the	  therapeutic,	  since	  this	  pathogen	  is	  not	  a	  beta-­‐lactamase	  
producer.121	  Primary	  and	  secondary	  resistance	  is	  rare	  worldwide.122	  
	  
1.7.1.2.	  -­‐	  Tetracyclines	  
Tetracycline	   is	   acid	   stable	   and	   maintains	   its	   activity	   at	   acid	   pH	   but	   it	   is	   ineffective	   in	  
eradicating	  infection.	  It	  has	  been	  suggested	  that	  its	  efficiency	  may	  be	  improved	  with	  concomitant	  
administration	  of	  bismuth	   salts	   and	  metronidazole.	  However,	  high	  dosage	  of	   tetracycline	   (1.5-­‐2	  
mg	  per	  day)	  is	  required	  and	  bismuth	  salts	  are	  unavailable	  in	  some	  countries,	  restricting	  the	  use	  of	  
this	  antibiotic.121	  
	  
1.7.1.3.	  -­‐	  Nitrofurans	  	  
These	  may	  be	  used	  as	   antibacterial	   agents,	  more	  usually	   in	   a	  quadruple	   regimen	   (proton	  
pump	  inhibitor	  +	  bismuth	  salts	  +	  amoxicillin	  +	  furazolidone	  or	  nifuratel).	  Low	  resistance	  rates	  are	  
observed	  to	  these	  compounds.	  Nifuratel	  is	  better	  tolerated	  than	  furazolidone,	  having	  only	  3	  %	  of	  
side	   effects	   vs	   21	   %	   reported	   for	   furazolidone.123	   However,	   the	   use	   of	   these	   compounds	   is	  
forbidden	  in	  European	  countries.121	  
	  
1.7.1.4.	  -­‐	  Bismuth	  salts	  
Bismuth	  salts	  were	   the	   first	  molecules	  used	  as	  monotherapy	  that	  obtained	  success	   in	   the	  
treatment	  of	  H.	  pylori.	  It	  detaches	  adhered	  bacteria	  from	  the	  mucosa	  and	  causes	  lysis.	  Usually,	  it	  
is	  used	   in	  combination	  with	   tetracycline	  and	  metronidazole	   for	  2	  weeks	   together	  with	  a	  proton	  
pump	   inhibitor	   for	   7	   days.124	   The	   major	   drawback	   of	   bismuth	   is	   that	   it	   must	   be	   administered	  
several	  times	  a	  day	  (3-­‐4),	  due	  to	  its	  short	  half-­‐life	  time	  on	  the	  gastric	  mucus.	  
	  
1.7.1.5.	  -­‐	  Macrolides	  
Clarithromycin	   is	   the	   best	   pharmaceutical	   drug	   against	   H.	   pylori,	   with	   a	   low	   minimum	  
inhibitory	  concentration	  (MIC)	  of	  0.01	  mg/L.122	  However,	  resistance	  has	  been	  rinsing	  over	  the	  last	  
years.	  Currently,	  is	  only	  used	  in	  combination	  with	  other	  drugs	  in	  triple	  or	  quadruple	  therapy	  for	  7-­‐
14	  days.121	  Azithromycin	  and	  erythromycin	  are	  also	  available	  for	  use	  in	  combined	  therapies	  (triple	  
or	  quadruple)	  but	  for	  the	  first	  one	  resistance	  rates	  are	  high	  and	  its	  effective	  eradication	  rate	  is	  low	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(<	   75	   %).	   Erythromycin	   is	   instable	   in	   gastric	   conditions,	   which	   leads	   to	   decrease	   of	   its	  
effectiveness.125	  
	  
1.7.1.6.	  -­‐	  Nitroimidazoles	  
Metronidazole	  and	  tinidazole	  are	  the	  two	  imidazole	  derivate	  used	  to	  treat	  H.	  pylori	  as	  part	  
of	   a	   triple	   or	   quadruple	   therapy.124,126	   Both	   are	   quite	   stable	   in	   the	   gastric	   juice.121	   However,	  
resistance	  rates	  to	  metronidazole	  are	  high	  (20-­‐40	  %),	  with	  higher	  values	   for	  women,	  due	  to	  the	  
use	  of	  these	  drugs	  on	  the	  treatment	  of	  vaginal	  infections.122	  
	  
1.7.1.7.	  -­‐	  Quinolones	  	  
In	  vitro	  results	  with	  this	  class	  of	  antibiotics	  are	  very	  promising	  but	  when	  in	  vivo,	  results	  are	  
disappointing,	  since	  some	  are	  inactivated	  by	  the	  gastric	  pH.	  The	  most	  used	  one	  is	  levofloxacin	  in	  a	  
triple	   therapy	   scheme.	   Despite	   having	   good	   eradication	   rates,	   levofloxacin	   is	   expensive	   and	  
resistance	  rates	  worldwide	  have	  been	  increasing.127,	  128	  
	  
1.7.1.8.	  -­‐	  Rifamycines	  	  
Rifabutin	  is	  considered	  to	  have	  good	  results	  in	  the	  treatment	  of	  H.	  pylori.	  Patients	  who	  have	  
failed	   two	   or	   more	   courses	   with	   standard	   proton	   pump	   inhibitors	   regimen	   are	   proposed	   to	  
treatment	  with	  a	  combination	  of	  both	  rifabutin	  and	  amoxicillin,	  which	  has	  an	  eradication	  rate	  of	  
71-­‐86.6	  %129	  after	  a	  7-­‐day	  regimen	  and	  90	  %	  after	  12	  days	  of	  treatment.130	  Besides	  its	  expensive	  
cost,	  this	  drug	  is	  used	  in	  the	  treatment	  of	  tuberculosis	  and	  therefore	  its	  use	  must	  be	  kept	  as	  a	  last	  
resource,	  i.e,	  only	  when	  other	  therapeutic	  approaches	  have	  failed	  and	  merely	  applied	  to	  patients	  
with	   multi-­‐resistant	   strains,	   in	   order	   to	   minimize	   resistance	   development.	   Also,	   myelotoxicity	  
reports	  have	  been	  observed	  after	  a	  rifabutin-­‐based	  therapy	  for	  H.	  pylori	  eradication.131	  
Table	   II	   summarizes	   the	   main	   pharmaceutical	   substances	   available	   and	   their	   associated	  
drawbacks.	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Table	  II.	  Main	  drugs	  used	  for	  H.	  pylori	  infection	  treatment	  and	  associated	  drawbacks.	  





Association	   with	   clavulanic	   acid	   does	   not	   improve	  
treatment	  





High	  dosage	  of	  tetracycline	  required	  
Nitrofurans	  
	  
	   Its	  use	  is	  forbidden	  in	  the	  E.U	  	  
Bismuth	  salts	   	   Several	  dosages/day	  required	  	  
Unavailable	  in	  some	  countries	  	  
Macrolides	   - Clarythromicin	  
	  
Increasing	  bacterial	  resistance	  rates	  over	  the	  years	  
- Azithromicin	  
	  
Low	  eradication	  rate	  (<	  75	  %).	  
- Erythromycin	  
	  
Unstable	  at	  the	  gastric	  pH	  	  
Nitroimidazoles	  
	  
- Metronidazole	   	  
Quinolones	  
	  
	   Inactivated	  in	  the	  gastric	  pH	  
Expensive	  




1.7.2.	  -­‐	  Current	  therapeutic	  scheme	  	  
The	  current	  therapeutic	  scheme	  is	  summarized	  in	  Figure	  14.	  
	  
Figure	  14.	  H.	  pylori	  infection	  treatment	  scheme.	  	  
The	  first	  line	  treatment	  is	  the	  PPI-­‐based	  triple	  therapy.	  Combination	  of	  clarithromycin	  500	  
mg,	   amoxicillin	   1g	   or	   metronidazole	   400/500	   mg	   plus	   a	   PPI	   twice	   daily	   is	   the	   first	   choice	   to	  
overcome	   infection	   with	  H.	   pylori	   and	   still	   is	   the	   recommended	   by	   the	   European	  Helicobacter	  
Study	  Group.132,133	  Controversy	  arises	  on	  the	  most	  effective	  length	  of	  the	  treatment.	  According	  to	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some	   studies,	   the	   14-­‐day	   treatment	   course	  may	  be	  more	   effective	   than	   a	   7	   or	   10	   -­‐day	   course.	  
However,	   the	   eradication	   rates	   with	   triple	   therapy	   are	   70-­‐80	   %,	   lower	   than	   what	   the	   Third	  
Maastricht	  Consensus	  Report	  agreed	  to	  be	  an	  acceptable	  eradication	  rate.133	  
If	  and	  when	  triple	  therapy	  fails,	  other	  antibiotic	  regimens	  may	  be	  used.	  The	  most	  promising	  
alternatives	  are	  sequential	  therapy	  and	  quadruple	  therapy	  quinolone-­‐based.	  	  Sequential	  therapy	  
consists	   in	   the	   uptake	   of	   a	   PPI+	   amoxicylin	   for	   5	   days,	   followed	   by	   PPI+	   clarythromicin	   and	  
tinidazole	  for	  another	  5	  days.	  In	  Italy,	  this	  therapy	  has	  show	  an	  eradication	  rate	  of	  over	  90	  %.132	  
Quadruple	  therapy	  (PPI+	  metronidazole	  +	  tetracycline	  +	  bismuth)	  is	  also	  an	  alternative	  as	  back-­‐up	  
treatment.	  
Adjuvant	   therapy	   based	   in	   probiotics	   can	   also	   be	   applied	   with	   the	   objective	   to	   enhance	  
treatment.	   The	   probiotics	   will	   stabilize	   the	   gastric	   barrier	   function	   and	   decrease	   mucosal	  
inflammation.	  Some	  probiotics	  species,	  such	  as	  Lactobacilli,	  release	  bacteriocins	  that	  may	  inhibit	  
H.	   pylori	   growth	   and	   its	   adherence	   to	   gastric	   epithelial	   cells.134-­‐136	   Side	   effects	   associated	   with	  
conventional	  therapy	  also	  tend	  to	  reduce	  significantly	  with	  adjuvant	  therapy.	  	  
1.7.3.	  -­‐	  Factors	  contributing	  to	  Helicobacter	  pylori	  treatment	  failure	  
Since	  the	  early	  1980s	  several	  efforts	  have	  been	  made	  to	   improve	  the	  treatment	  regimens	  
towards	  H.	  pylori.132	   Failure	  of	   treatment	  with	   standard	   therapies	  has	  been	   recurrent	   in	   clinical	  
practice	  for	  some	  years	  due	  to	  several	  factors.	  
	  
1.7.3.1.	  –	  Intrinsic	  pharmaceutical	  factors	  
Antibiotics	   are	   ingested	   orally	   which	   results	   in	   limited	   bioavailability	   in	   the	   gastric	  
environment	  not	  only	  because	  the	  gastric	  mucosa	  may	  act	  as	  a	  barrier	  to	  antibiotic	  delivery,	  but	  
also	  because	   they	  undergo	  degradation	   in	   the	   stomach	  by	   the	  action	  of	   acid	  and	  pepsin.137	   For	  
instance,	  amoxicilin	  is	  unstable	  at	  low	  pH,	  with	  a	  half-­‐life	  of	  15	  h	  at	  pH	  2.	  The	  same	  is	  observed	  for	  
clarithromycin,	  that	  exhibits	  a	  half-­‐life	  of	  less	  than	  1	  h	  on	  those	  acidic	  conditions.138,139	  Moreover,	  
the	   pH	   near	   the	   lumen	   of	   the	   stomach	   is	  maintained	   at	   2,	  whereas	   the	   cell-­‐mucus	   interface	   is	  
more	   alkaline,	  with	   a	   pH	   of	   approximately	   5.5	   and	   only	   very	   few	   antibiotics	   are	   active	   in	   both	  
these	  pH	  extremes.121	  Also,	  oral	  agents	  reach	  very	  high	  concentrations	  in	  gastric	  mucus,	  but	  levels	  
quickly	  fall	  as	  the	  stomach	  empties	  after	  a	  meal,	  which	  reinforces	  the	  importance	  of	  administering	  
drugs	   able	   to	   significantly	   increase	   the	   gastric	   pH,	   such	  as	   a	  PPI,	   in	  order	   to	  enhance	   antibiotic	  
efficiency.126	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1.7.3.2.	  -­‐	  Bacterial	  factors	  
H.	   pylori	   has	   evolved	   several	   mechanisms	   to	   enable	   the	   colonization	   of	   human	   gastric	  
epithelium.	  Due	  to	  its	  production	  of	  urease	  and	  the	  presence	  of	  flagella,	  it	  is	  able	  to	  survive	  over	  a	  
wide	  pH	  spectrum	  and	  to	  efficiently	  penetrate	  the	  gastric	  mucous	   layer	  reaching	  the	  underlying	  
gastric	  epithelium,	  where	  it	  can	  be	  found	  strongly attached	  to	  cells	  and	  even	  within	  cells,	  where	  
drug	  bioavailability	  is	  limited.140	  	  
The	   co-­‐infection	   with	   multiple	   strains	   is	   another	   reason	   that	   can	   contribute	   to	  
ineffectiveness	   of	   treatment,	   since	   it	   promotes	   the	   spread	   of	   genes	   encoding	   information	   for	  
virulence	  factors	  and	  antibiotics	  resistance.	  When	  infection	  is	  caused	  by	  multiple	  strains,	  one	  drug	  
may	  affect	  one	  particular	  strain	  and	  not	  the	  other	  due	  to	  differences	   in	  antibiotic	  susceptibility,	  
leading	  to	  the	  treatment	  fiasco.121	  
	  
1.7.3.2.	  -­‐	  Patient	  and	  environmental	  factors	  
Patient	  compliance	  with	  the	  treatment	  regimen	  is	  a	  limiting	  factor	  for	  the	  success	  of	  anti	  H-­‐
pylori	  therapy.	  Information	  on	  how	  many	  doses	  of	  medication	  may	  be	  missed	  before	  eradication	  
rates	  fall	  is	  limited.	  Treatment	  related	  side	  effects,	  namely	  taste	  disturbances	  with	  clarithromycin	  
and	   metronidazole,	   and	   diarrhea	   with	   amoxicillin,	   might	   account	   for	   decreasing	   compliance.	  
Complex	   regimens	   that	   require	  multiple	  doses	  of	  medication	  each	  day	  are	   also	   associated	  with	  
poor	  compliance.121	  
Patients	  diet	  and	  lifestyle	  are	  also	  associated	  with	  treatment	  failure.	  Smoking	  is	  considered	  
to	  be	  an	  independent	  risk	  for	  H.	  pylori	  treatment	  failure.141,142	  Also,	  when	  treatment	  is	  associated	  
with	  coffee	  intake	  its	  efficiency	  has	  been	  demonstrated	  to	  be	  reduced.143	  
	  
1.7.3.3.	  -­‐	  Other	  factors	  	  
Another	  point	   that	  may	  affect	   treatment	   is	   that	  resistance	  rates	  are	  different	  both	  within	  
and	   between	   countries.	   This	   makes	   the	   establishment	   of	   a	   gold	   standard	   therapy	   challenging.	  
Inadequate	  treatment	  regimens,	  with	  incorrect	  antibiotic	  selection,	  inadequate	  doses	  or	  therapy	  
length,	  are	   sometimes	  prescribed	   in	   clinical	   settings	  and	  all	  may	  affect	   the	   treatment	  outcome.	  
Surveys	   of	   the	  U.S.	   physicians	   have	   revealed	   the	   use	   of	   several	   outdated	   and	   inadequate	   drug	  
combinations	   in	   clinical	   practice.	   In	   particular,	   the	   use	   of	   the	   two-­‐drug	   therapy	   (PPI	   +	  
clarithromycin)	  must	  be	  strongly	  discouraged	  because	   it	   is	   less	  effective	  than	  triple	  one.	  Factors	  
such	   as	   the	   treatment	   length,	   antibiotics	   of	   choice,	   new	   drug	   combination,	   improved	   patient	  
compliance	  and	  novel	  agents,	  may	  help	  improving	  eradication	  rates.132	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1.8.	  -­‐	  New	  strategies	  that	  have	  been	  investigated	  to	  eradicate	  Helicobacter	  pylori	  
In	   order	   to	   improve	   the	   efficiency	   of	   the	   current	   antibiotic	   therapy,	   namely	   to	   increase	  
antibiotic	  residence	  time	  and	  allow	  more	  antibiotic	  to	  penetrate	  through	  the	  gastric	  mucus	  layer,	  
research	   has	   been	   conducted	   in	   order	   to	   develop	   a	   stomach-­‐specific	   drug	   delivery	   system.	   For	  
that	  purpose	  chitosan	  microspheres	  loaded	  with	  tetracycline	  have	  been	  developed144,145	  as	  well	  as	  
loaded	  with	   amoxicillin.146	   Chitosan	   has	   been	  widely	   investigated	   as	   a	   drug	   carrier	   to	   stomach	  
delivery	  because	  of	   its	  capacity	  to	  adhere	  to	  mucins	  and	  the	  fact	  that	   it	   is	  relatively	  non-­‐toxic	   if	  
administered	  orally.144,145	  
Preventive	  strategies	  have	  been	  also	  considered.	  Pig	  milk	   is	  known	  to	  express	  the	  Leb	  and	  
sLex	  receptors	  for	  H.	  pylori	  on	  various	  milk	  proteins	  and	  has	  demonstrated	  the	  capacity	  to	  inhibit	  
H.	  pylori	  binding.147	  The	  possible	  introduction	  of	  some	  H.	  pylori	  specific	  receptors	  in	  milk,	  in	  order	  
to	  prevent	  or	  reduce	  H.	  pylori	  binding	  to	  gastric	  mucosa	  by	  taking	  advantage	  of	  the	  specificity	  of	  
the	  bacterial	  binding	  towards	  those	  structures,	  has	  also	  been	  studied.148	  
The	  development	  of	  vaccines	  have	  also	  been	  considered	  since	  it	  is	  thought	  that	  vaccination	  
against	  H.	  pylori	  in	  childhood	  may	  help	  to	  reduce	  infection	  rates	  and	  therefore	  are	  a	  cost	  effective	  
option.149,150	   Moreover,	   vaccines	   would	   ideally	   be	   able	   to	   work	   both	   prophylactically	   and	  
therapeutically.151	   Different	   formulations	   have	   been	   tested,	   ranging	   from	   the	   conventional	  
approach	   using	   inactivated	   whole	   cells	   via	   oral	   route,152-­‐156	   to	   the	   antigen-­‐based	   vaccines	  
targeting,	   for	   instance:	  urease,	  VacA,	  CagA,	  NAP	  proteins,	  either	  alone	  or	  using	  combinations	  of	  
the	   different	   H.	   pylori	   well	   conserved	   antigens.151,157	   However	   and	   despite	   the	   impressive	  
progresses	  made	   in	   the	   last	   years,	   there	   is	   still	   a	   long	   road	   ahead	   in	   the	   vaccination	   against	  H.	  
pylori,	  mainly	  because	  there	  is	  still	  a	   lot	  to	  be	  known	  about	  the	  early	  natural	  course	  of	  infection	  
and	   the	   immune	   responses	   triggered	   by	  H.	   pylori	   infection.	   Defining	   better	  models	   to	   test	   the	  
vaccines	  efficiency	  will	  also	  be	  crucial	  for	  the	  success	  of	  vaccines	  design.151	  
The	   quest	   for	   novel	   therapeutics	   has	   been	   expanded,	   for	   fields	   such	   as	   phytotherapy,	  
resourcing	  to	  betulinic	  acid	  and	  mastic	  acid	  triterpenic	  compounds158,	  159	  or	  resveratrol	  obtained	  
from	  grapes160,	  which	  have	  been	   reported	   to	   inhibit	   the	  urease	  activity.	  Antimicrobial	  peptides,	  
such	  as	  Pexiganan161	  or	  Odorranain-­‐HP162	  also	  present	  anti-­‐H.	  pylori	  activity.	  The	  diet	   impact	  on	  
infection	  has	  also	  pointed	  research	  towards	  the	  role	  of	  fatty	  acids	  on	  infection	  management.163	  
The	  main	  innovation	  of	  the	  work	  here	  described	  is	  the	  attempt	  to	  engineer	  a	  strategy	  that	  
is	  able	  to	  biomimick	  the	  receptors	  expressed	  on	  the	  host	  gastric	  mucosa	  and	  therefore	  induce	  the	  
bacterium	  binding	  to	  the	  generated	  decoy,	  trapping	  it	  and	  allowing	  its	  removal	  from	  the	  infected	  
hosts.	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2.1.	  -­‐	  Self-­‐assembled	  monolayers	  (SAMs)	  
Understanding	   the	   adhesion	  mechanisms	   between	  H.	   pylori	   adhesins	   and	   the	   expressed	  
receptors	   on	   gastric	   epithelial	   cells	   is	   required	   before	   engineering	   a	   biomedical	   polymer	   with	  
specific	  receptors	  towards	  H.	  pylori,	  able	  to	  be	  employed	   in	  humans	   infected	  with	  this	  microbe.	  
To	  perform	  proof-­‐of-­‐concept	  studies	  at	  the	  molecular	  scale	  the	  utilization	  of	  well-­‐defined	  model	  
surfaces	  as	  self-­‐assembled	  monolayers	  (SAMs)	  is	  essential.	  
SAMs	  provide	  a	   convenient,	   flexible	  and	   simple	   system	   for	   fundamental	   studies	   involving	  
proteins	   or	   cells.	   They	   are	   “molecular	   assemblies	   that	   are	   formed	   spontaneously	   by	   the	  
immersion	   of	   an	   appropriate	   substrate	   into	   a	   solution	   of	   an	   active	   surfactant	   in	   an	   organic	  
solvent”.164	  The	  driving	  force	  for	  self-­‐assembly	  usually	  is	  the	  specific	  interaction	  between	  the	  head	  
group	  of	  the	  surfactant	  and	  the	  surface	  of	  the	  substrate.	  Surfactants	  can	  be	  divided	  in	  3	  parts:	  the	  
surface	  active	  headgroup	  that	  binds	  strongly	  to	  the	  surface;	  the	  tail	  group	  that	   is	   located	  at	  the	  
monolayer	  surface	  and	  determines	  the	  interfacial	  properties	  of	  the	  assembly;	  and	  the	  methylene	  
spacer	  that	  facilitates	  the	  packing	  of	  the	  molecules	  in	  the	  monolayer	  and	  serves	  as	  linker	  between	  
the	  head	  and	  the	  tail	  groups	  (Figure	  15).165	  
	  
	  
Figure	  15.	  Illustration	  of	  the	  three	  components	  of	  an	  ordinary	  thiol-­‐based	  self	  assembled	  monolayer.	  Adapted	  from	  
Srisombat.166	  
	  
Factors	   influencing	   the	   structure	  and	   stability	  of	   a	   SAM	  are:	   substrate	  quality,	   deposition	  
solvent,	  time	  of	  monolayer	  incubation,	  thiol	  concentration	  and	  deposition	  temperature.167	  
The	  most	  studied	  class	  of	  SAMs	  are	  the	  ones	  derived	  from	  the	  adsorption	  of	  alkanethiols	  on	  noble	  
metals,	  such	  as	  gold,	  silver	  and	  palladium,	  due	  to	  the	  high	  affinity	  between	  alkanethiols	  and	  these	  
metals,	  which	  generates	  well-­‐defined	  organic	  surfaces	  with	  useful	  and	  highly	  alterable	  chemical	  
functionalities	  displayed	  at	  the	  interface.168	  
	  
2.1.1.	  -­‐	  Alkanethiol	  SAMs	  on	  gold	  
Alkanethiol	   SAMs	  on	  gold	   are	   formed	  because	  of	   the	   creation	  of	   a	   strong	  bond	  between	  
sulfur	  and	  the	  gold	  surface.164	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Figure	  16.	  The	  self-­‐assembly	  process.	  An	  n-­‐alkane	  thiol	  is	  added	  to	  an	  ethanol	  solution.	  A	  gold	  surface	  is	  immersed	  in	  
the	  solution	  and	  the	  self-­‐assembled	  structure	  rapidly	  evolves.	  Adapted	  from	  Castner	  et	  al.169	  
	  
Gold	  has	  advantages	  over	  the	  other	  noble	  metals,	  because:	  	  
-­‐	  First,	  it	  is	  easy	  to	  obtain,	  either	  as	  a	  thin	  film	  or	  as	  colloid.	  Preparation	  of	  thin	  films	  by	  physical	  
deposition,	  sputtering	  or	  electrodeposition	  is	  straightforward;	  
-­‐	   Second,	   it	   is	   easy	   to	   pattern	   this	   metal	   using	   a	   combination	   of	   lithographic	   tools	   (such	   as	  
photolithography	  and	  micromachining	  among	  others)	  and	  chemical	  etchants;	  
-­‐	   Third,	   gold	   is	   considered	   to	   be	   reasonably	   inert,	   not	   undergoing	   oxidation	   at	   temperatures	  
below	  its	  melting	  point,	  reacting	  with	  atmospheric	  oxygen	  or	  with	  most	  chemicals,	  which	  allows	  a	  
simpler	  sample	  handling	  and	  manipulation.	  Moreover,	  the	  fact	  that	  association	  between	  gold	  and	  
thiols	  is	  a	  high	  affinity	  binding	  and	  unusual	  reactions	  are	  virtually	  absent,	  such	  as	  formation	  of	  a	  	  
substitutional	   sulfide	   interphase	   allows	   for	   the	   use	   of	   a	   wide	   range	   of	   thiols	   with	   different	  
functional	  groups;	  
-­‐	  Fourth,	  thin	  films	  of	  gold	  are	  substrates	  for	  a	  variety	  of	  spectroscopic	  and	  analytical	  techniques,	  
namely	   surface	   plasmon	   resonance	   (SPR)	   spectroscopy,	   quartz	   crystal	   balance	   (QCM),	   infrared	  
reflection	  absorption	  spectroscopy	  (IRAS)	  and	  ellipsometry;	  
-­‐	   Fifth,	   gold	   is	   non-­‐toxic	   to	   cells,	   allowing	   them	   to	   adhere	   and	  maintain	   their	   functions	   on	   this	  
substrate.168	  
	  
On	  the	  other	  hand,	  gold-­‐thiol	  monolayers	  also	  have	  some	  drawbacks,	  such	  as	  that	  surface	  
roughness	   is	   higher	   (varying	   accordingly	   to	   the	   deposition	   method)	   and	   their	   stability	   under	  
physiological	  conditions	  is	  also	  a	  controversial	  subject.	  This	  is	  covered	  in	  section	  2.1.2.	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2.1.1.1.	  -­‐	  Factors	  affecting	  SAMs	  structure	  
The	  most	  common	  protocol	  for	  preparing	  SAMs	  on	  gold	  is	  immersion	  of	  a	  freshly	  prepared	  
or	  clean	  substrate	  into	  a	  dilute	  (1-­‐10	  mM)	  ethanolic	  solution	  of	  alkanethiols	  for	  12-­‐18	  h	  at	  room	  
temperature.	   Dense	   coverage	   of	   the	   adsorbates	   are	   obtained	   quickly	   from	  millimolar	   solutions	  
(milliseconds	  to	  minutes)	  but	  a	  slow	  reorganization	  process	  requires	  times	  on	  the	  order	  of	  hours	  
to	  maximize	   the	  density	  of	  molecules	  and	  minimize	  defects	   in	   the	  SAM.	  There	  are	  a	  number	  of	  
experimental	  factors	  that	  can	  affect	  the	  structure	  of	  the	  resulting	  monolayer	  as	  well	  as	  the	  rate	  of	  
its	  formation,	  namely:	  solvent,	  temperature,	  concentration	  of	  adsorbate,	  immersion	  time,	  purity	  
of	   the	   adsorbate,	   concentration	   of	   oxygen	   in	   solution,	   cleanliness	   of	   the	   substrate	   and	   chain	  
length	  (or	  more	  generally,	  structure	  of	  the	  adsorbate).168	  
	  
Table	  III.	  Experimental	  factors	  that	  affect	  the	  SAMs	  structure.	  Adapted	  from	  Love	  et	  al.168	  
Factors	  	  
	  
	   Observations	  








-­‐	   Ethanol	   is	   the	   most	   used	   solvent	  
because	   it	   solvates	   a	   variety	   of	  
alkanethiols,	   is	   inexpensive,	   available	  
with	  high	  purity,	  low	  toxicity	  
	  
-­‐	   Solvent-­‐substrate	   interactions	   may	  
affect	   the	   kinetics	   of	   formation	   and	  
mechanism	  of	  self-­‐assembly	  
Temperature	   	  >25°C	   improve	   kinetics	   and	  
reduces	  the	  number	  of	  defects	  
-­‐	  The	  effect	  of	  T	  is	  more	  pronounced	  in	  
the	  first	  minutes	  
Concentration	  &	  immersion	  time	  	   Related	  inversely	  	   -­‐	   Low	   concentration	   of	   thiols	   requires	  
long	  immersion	  times	  
Oxygen	  content	  of	  solution	   Degassing	  the	  solvent	  with	  an	  inert	  
gas	  and	  preparing	  SAMs	  in	  an	  inert	  
environment	   improves	   the	  
reproducibility	   and	   unwanted	  
oxidation	  of	  thiols	  
-­‐	  Quantitative	  data	  on	  this	  parameter	  is	  
limited	  	  
Cleanliness	  of	  Substrate	   The	   rate	   of	   desorption	   of	   the	  
substrate	   contaminants	   and	  
impurities	   affects	   the	   kinetics	   of	  
formation	  	  
-­‐	   SAMs	   have	   reproducible	   properties	  
when	   formed	   on	   substrates	   that	   are	  
immersed	   into	   thiol	   solutions	  within	   1	  
h	  of	  preparation	  or	  cleaned.	  	  	  
2.1.1.2.	  -­‐	  “Mixed”	  SAMs	  
Monolayers	  comprising	  a	  well-­‐defined	  mixture	  of	  molecular	   structures	  are	  called	  “mixed”	  
SAMs.	   There	   are	   three	   easy	   methods	   for	   synthetizing	   mixed	   SAMs:	   (1)	   coadsorption	   from	  
solutions	   containing	   mixtures	   of	   thiols	   (RSH	   +	   R’SH),	   (2)	   adsorption	   of	   asymmetric	   disulfides	  
(RSSR’),	  and	  (3)	  adsorption	  of	  asymmetric	  dialkylsulfides	  (RSR’).168	  For	  the	  purpose	  of	  this	  thesis,	  
only	  the	  first	  one	  will	  be	  analyzed.	  
Exposure	  of	  a	  gold	   slide	   to	  a	  mixture	  of	   two	  different	   thiols	   results	   in	   the	   formation	  of	  a	  
mixed	   monolayer,	   in	   which	   both	   thiolate	   moieties	   are	   present.170	   The	   composition	   of	   such	   a	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monolayer	   (usually	   determined	   with	   X-­‐ray	   photoelectron	   spectroscopy	   (XPS))	   is	   generally	  
different	  from	  the	  composition	  of	  solution.171	  
	  
2.1.1.2.1.	  -­‐	  Mixed	  Biotin-­‐SAMs	  
The	   design	   of	   surfaces	   that	   exhibit	   specificity	   and	   recognition	   for	   certain	   biomolecules	   is	  
important	  for	  biosensors	  and	  biotechnological	  applications.	  	  
Mixed	  SAMs	  can	  be	  used	  to	   immobilize	  peptides,	  proteins,	  and	  other	  biomolecules	  to	  the	  




Figure	   17.	   Schematic	   representation	   of	   a	   mixed	   monolayer.	   The	   cartoon	   depicts	   how	   biomolecules	   (green)	  
functionalized	  with	  biotin	   groups	   (red)	   can	  be	   selectively	   immobilized	  onto	  a	   gold	   surface	  using	   a	   streptavidin	   linker	  
(blue)	   bound	   to	   a	  mixed	   biotinylated	   thiol/ethylene	   glycol	   thiol	   self-­‐assembled	  monolayer.	   Adpated	   from	  Castner	  et	  
al.169	  
	  
For	   instance,	   a	   mixed	   biotinylated	   thiol/oligo-­‐ethylene	   glycol	   thiol	   monolayer	   can	   be	  
assembled	  onto	  a	  gold	  surface.172	  Since	  protein	  molecules	  are	  significantly	  larger	  in	  size	  than	  the	  
thiol	   molecules	   in	   the	   SAM,	   the	   thiol	   molecule	   that	   contains	   the	   protein	   binding	   group	   (e.g.,	  
biotin)	   is	   typically	   diluted	   with	   a	   thiol	   that	   resists	   protein	   binding	   (e.g.,	   oligo-­‐ethylene	   glycol).	  
Mixed	  SAMs	  that	  present	  ligands	  and	  oligo-­‐ethylene	  glycol	  groups	  allow	  controlling	  the	  density	  of	  
the	   desired	   biomolecule.	   The	   non-­‐fouling	   group	   also	   prevents	   denaturation	   of	   an	   adsorbed	  
protein.173	  
Once	   the	  mixed	   biotinylated/oligo-­‐ethylene	   glycol	   SAM	   is	   prepared,	   then	   streptavidin	   or	  
another	  biotin-­‐binding	  protein	  may	  be	  bound	  to	  it.169	  
Biotin-­‐binding	  proteins,	  such	  as	  streptavidin,	  avidin	  and	  neutravidin,	  have	  four	  binding	  sites	  
on	  two	  opposite	  sites	  of	  the	  tetrameric	  protein	  and	  therefore	  have	  unique	  properties	  as	  adaptors	  
for	  binding	  of	   a	   second	   layer	  of	  biotinylated	  molecules.	   This	  makes	   this	   system	  based	  on	   thiols	  
terminated	  with	  biotin	  extremely	  versatile.174-­‐178	  
	   Chapter	  II	   Self-­‐assembled	  monolayers	  (SAMs)	  	  
	   41	  
2.1.2.	  -­‐	  SAMs	  for	  biological	  studies	  
SAMs	   are	   a	   valuable	   tool	   for	   studying	   the	   chemistry	   of	   biomolecular	   recognition.	   The	  
complexity	  and	  dynamic	  nature	  of	  biological	  events,	  such	  as	  the	  binding	  between	  bacteria/ligand,	  
can	   be	   better	   evaluated	   by	   using	   a	   simplified	   system	   that	   only	   allows	   one	   or	   a	   few	   type	   of	  
interactions	   to	   take	   place	   between	   species	   in	   solution	   and	   the	   engineered	   surfaces.	   The	  major	  
challenge	  is	  to	  still	  enable	  natural	  biological	  interactions	  to	  occur	  in	  such	  way	  that	  the	  results	  can	  
be	  interpreted	  clearly	  and	  related	  to	  the	  biology	  in	  vivo.168	  
Several	  aspects	  contribute	  to	  the	  convenience	  of	  monolayers	  in	  biological	  studies:	  
- Biological	  surfaces	  can	  be	  considered	  as	  being	  supermolecular	  assemblies	  of	  proteins,	  
glycoproteins,	   and	   large	   oligosaccharides	   anchored	   to	   or	   embedded	   in	   a	   fluid	   lipid	  
bilayer	   or	   protein	   coat.	   SAMs,	   as	   most	   biological	   surfaces,	   are	   also	   nanostructured	  
materials	   that	   form	   by	   self-­‐assembly.	   However,	   SAMs	   are	   static	  models,	   contrasting	  
with	  the	  dynamic	  nature	  of	  the	  biological	  environment;	  
- A	  wide	  range	  of	  organic	  functionality	  can	  be	  presented	  at	  the	  surface,	   including	  ones	  
that	  can	  resist	  the	  adsorption	  of	  proteins,	  facilitating	  the	  interpretation	  of	  results;	  
- It	   is	   easy	   to	   prepare	   SAMs	   functionalized	  with	   large	   and	  delicate	   ligands	   needed	   for	  
biological	  studies;	  
- SAMs	   are	   compatible	   with	   a	   number	   of	   techniques	   (SPR,	   QCM,	   ellipsometry,…)	   for	  
analyzing	  the	  composition	  and	  mass	  coverage	  of	  surfaces.168	  
	  
To	   study	   biological	   interactions	   it	   is	   required	   that	   the	  monolayer	   does	   not	   influence	   the	  
interpretation	  of	  the	  observed	  interactions.	  For	  that,	  SAMs	  must	  fulfill	  at	  least	  these	  features:	  
- SAMs	   ought	   prevent	   nonspecific	   adsorption	   of	   biomolecules	   on	   its	   surface,	   only	  
allowing	  interactions	  between	  the	  molecules	  of	  interest;	  
- They	   should	   allow	   modification	   to	   the	   composition	   and	   density	   of	   the	   immobilized	  
ligands	  and/or	  biomolecules;	  
- The	   ligand	   of	   interest	   should	   be	   presented	   in	   a	   structurally	   well	   defined	  manner	   in	  
order	  to	  minimize	  the	  influence	  of	  the	  surface	  (e.g.	  blocking	  binding	  sites);	  
- Preferentially,	   SAMs	   should	   be	   able	   to	   be	   used	   effortlessly	   with	   common	   analytical	  
methods	   without	   modifying	   the	   existing	   instrumentation	   or	   subjecting	   SAMs	   to	  
unnatural	  conditions	  such	  as	  dehydration	  in	  ultra	  high	  vacuum.168	  
	  
	  
	   Chapter	  II	   Self-­‐assembled	  monolayers	  (SAMs)	  	  
	  42	  
2.1.2.1.	  -­‐	  SAMs	  and	  biological	  conditions	  
The	   stability	   of	   SAMs	   under	   biological	   conditions	   has	   been	   a	   controversial	   subject	  
throughout	  the	  years.	  
Using	  SAMs	  for	  biological	  studies	   involves	  exposure	  to	  an	  aqueous	  environment	  with	  high	  
concentration	   of	   salts	   and	   biomolecules.	   The	   behavior	   of	   the	   exposed	   monolayer	   to	   those	  
solutions	   is	   critical	   to	   understand	   certain	   properties,	   such	   as	   the	   protein	   and	   cell	   adsorption	  
resistance	   in	   the	   specific	   case	   of	   poly-­‐ethylene	   glycol	   (PEG)	   SAMs.	   Grunze	   et	   al.	   have	  
demonstrated	   the	   occurrence	   of	   conformational	   changes	   at	   the	   exposed	   surface	   of	   SAMs	  
terminated	  with	  PEG	  (45	  subunits)	  upon	  exposure	  to	  water.179	  Each	  PEG	  at	  the	  surface	  adopts	  a	  
helical	   structure	   in	   air	   to	   form	   a	   quasi-­‐crystalline	   phase	   with	   the	   rods	   oriented	   nearly	  
perpendicular	   to	   the	   surface.	   The	   structure	   of	   the	   SAM	   changes	  when	   immersed	   in	  water:	   the	  
ends	   of	   the	   helical	   EG	   units	   transition	   to	   an	   amorphous	   state,	   and	   the	   amorphous	   interfacial	  
region	   is	   solvated	   in	   a	   manner	   equivalent	   to	   dissolved	   PEG	   chains.	   For	   SAMs	   terminated	   with	  
short	   oligomers	   of	   ethylene	   glycol	   (3-­‐6	   units),	   measurements	   suggest	   that	   the	   entire	   oligomer	  
becomes	  amorphous	  in	  water.180,181	  
	  
Figure	  18.	  Schematic	  illustration	  of	  the	  order-­‐disorder	  transition	  evidenced	  by	  SAMs	  of	  alkanethiols	  terminated	  with	  
triethylene	  glycol.	  Adapted	  from	  Love	  et	  al.168	  
	  
However,	   physiological	   conditions	   may	   also	   affect	   the	   long-­‐term	   stability	   of	   SAMs	   of	  
alkanethiols	   since	  when	  oxidized,	   the	   sulphur-­‐gold	  bond	   is	   broken,	   allowing	   the	   removal	  of	   the	  
alkanethiols	  in	  presence	  of	  a	  solution.182	  Contact	  angle	  analysis	  performed	  by	  Jones	  et	  al.	  revealed	  
instabilities	  in	  CH3-­‐	  and	  COOH-­‐	  terminated	  SAMs	  upon	  incubation	  in	  serum-­‐free	  media	  at	  37	  °C	  or	  
under	  dry,	  room	  temperature	  conditions,	  but	  not	  in	  OH-­‐	  terminated	  SAMs.	  Langer	  and	  co-­‐workers	  
have	   shown	   that	   SAMs	   terminated	   with	   EG	   develop	   substantial	   defects	   after	   immersion	   in	  
phosphate	  buffer	  solution	  or	  in	  calf	  serum	  for	  4-­‐5	  weeks.183	  The	  presence	  of	  cells	  at	  the	  surfaces	  
accelerates	   the	   process:	   the	   ability	   of	   EG-­‐terminated	   SAMs	   to	   prevent	   the	   adhesion	   of	   cells	   is	  
compromised	  in	  approximately	  7-­‐14	  days.184	  The	  loss	  of	  resistance	  is	  connected	  with	  oxidation	  of	  
bound	  thiolates	  and	  its	  subsequent	  desorption.185	  However,	  Maciel	  et	  al.	  reported	  that	  OH-­‐,	  CH3-­‐	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and	   EG4-­‐	   terminated	   SAMs	   did	   not	   suffer	   significant	   oxidation	   after	   immersion	   in	   cell	   culture	  
media	   (either	   serum	   free	   or	   10	   %	   FBS	   supplemented	   media)	   at	   37	   °C,	   for	   30	   min	   and	   that	  
oxidation	  was	  not	  detected	  during	  sterilization	  of	  SAMs	  in	  ethanol.182	  
SAMs	   are	   suitable	   for	   short-­‐term	   biological	   studies	   but	   to	   minimize	   the	   possibilities	   of	  
oxidation	  occurrence,	  SAMs	  should	  always	  be	  prepared	  immediately	  before	  use.	  
	  
2.1.3.	  -­‐	  SAMs	  characterization	  
SAMs	   can	   be	   characterized	   using	   extremely	   surface-­‐sensitive	   techniques	   such	   as:	   X-­‐ray	  
photoelectron	   spectroscopy	   (XPS),	   atomic	   force	   microscopy	   (AFM),	   contact	   angle	   goniometry,	  
ellipsometry	  and	  Quartz-­‐crystal	  microbalance	  (QCM).	  The	  general	  analytical	  capabilities	  of	  these	  
are	  presented	  at	  Table	  III	  and	  a	  brief	  description	  is	  given	  afterwards.	  
	  





	   Thickness	  	   Interfacial	  
tension	  








Ellipsometry	   ++	   -­‐-­‐	   0	   -­‐-­‐	   -­‐-­‐	   0	   0	  
XPS	   0	   -­‐-­‐	   ++	   ++	   +	   0	   -­‐-­‐	  
Contact	  Angle	  
Goniometry	   -­‐-­‐	   ++	   -­‐	   0	   +	   0	   +	  
QCM	   +	   -­‐-­‐	   ++	   -­‐-­‐	   -­‐-­‐	   0	   -­‐-­‐	  
AFM	   -­‐-­‐	   0	   +	   -­‐	   -­‐	   -­‐	   ++	  
Key:	  analytical	  capability:	  ++	  excellent,	  +	  good,	  0	  fair,	  -­‐	  poor,	  -­‐-­‐	  none.	  
	  
	  
2.1.3.1.	  -­‐	  Thickness	  and	  Coverage	  	  
Thickness	   is	   one	   of	   the	  most	   important	   characteristics	   to	   indicate	   that	   a	   layer	   is	   indeed	  
formed.	   Comparison	  of	   the	   experimental	   thickness	  with	   the	   theoretical	   value	   shows	  whether	   a	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2.1.3.1.1.	  –	  Ellipsometry	  
Ellipsometry	   is	   a	   non-­‐destructive	   optical	   method	   able	   to	   measure	   the	   thickness	   of	   thin	  
films.	   It	   is	   based	   on	   the	   fact	   that	   the	   state	   of	   polarization	   of	   the	   light	   reflected	   from	   a	   coated	  
surface	  depends	  on	  the	  thickness	  and	  refractive	  index	  of	  the	  coating.187	  
Experimentally,	   a	  plane-­‐polarized	   laser	  beam	   is	  usually	   reflected	   from	   the	   surface	   coated	  
with	  a	  monolayer	  and	  its	  polarization	  analyzed	  with	  a	  compensator/detector	  couple.187	  
	  
Figure	   19	   –Schematic	   representation	   of	   null	   ellipsometry	   in	   Polarizer-­‐Compensator-­‐Sample-­‐Analyzer	   (PCSA)	  
configuration.	  Adapted	  from	  Tompkins	  and	  McGahan.188	  	  
	  
The	   state	   of	   polarization	   is	   characterized	   by	   the	   amplitude	   ratio,	   Ep/Es,	   and	   the	   phase	  
difference	  (δp-­‐δs),	  of	  the	  light	  p-­‐	  and	  s-­‐components	  (p-­‐	  parallel	  and	  s-­‐	  perpendicular	  to	  the	  plane	  
of	   incidence).	  When	   light	   reflects	   from	  a	  surface	  both	  p-­‐	  and	  s-­‐	  components	  change	  and	  so	   the	  
light	  state	  of	  polarization	  (Figure	  19).	  The	  change	  of	  polarization	  is	  defined	  by:	  
Tan	  Ψ	  =	   	  	  and	  
Δ	  =	   	  
where	  Tan	  Ψ	  is	  the	  change	  in	  the	  amplitude	  ratio	  due	  to	  reflection	  and	  Δ	  is	  the	  change	  in	  
the	   phase	   difference	   of	   both	   light	   p-­‐	   and	   s-­‐	   components	   and	   the	   subscripted	   r	   and	   i	   are	   the	  
reflected	  and	  incident	  light.	  These	  two	  angles	  (Ψ	  and	  Δ)	  are	  related	  to	  the	  fundamental	  physical	  
properties	   of	   the	   reflecting	   surface	   such	   as	   the	   optical	   constants	   (refractive	   index	   (n)	   and	  
extinction	  coefficient	  (k))	  and	  the	  thickness	  of	  the	  material.188,189	  
Experimentally,	   ellipsometer	   can	   be	   setup	   in	   a	   PCSA	   (Polarizer-­‐Compensator-­‐Sample-­‐
Analyzer)	  configuration	  and	  operated	  under	  the	  null	  condition	  (Figure	  19).	  A	  monochromatic	  light	  
is	   linearly	  polarized	  by	  a	  polarizer,	  passes	  through	  a	  compensator	  (typically,	  quarter-­‐wave	  plate)	  
to	  become	  elliptically	  polarized	  and	  interacts	  with	  the	  surface.	  Light	  is	  reflected	  off	  the	  sample	  in	  
a	  linearly	  polarized	  form,	  passes	  an	  analyzer	  and	  falls	  into	  detector.	  By	  adjusting	  the	  angle	  of	  the	  
analyzer	   in	  order	   to	  achieve	  a	  perpendicular	  orientation	   relative	   to	   the	   linearly	  polarized	  wave,	  
the	   light	   intensity	   at	   the	   detector	   is	   minimized	   or	   ”nulled”	   –	   null	   ellipsometry.	   Therefore,	   the	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SAM,	   e.g.	   the	   complex	   refractive	   index	   N=n+ik.	   For	   alkanethiolates,	   the	   absorption	   is	   normally	  
very	  weak,	  meaning	   that	  k	   is	   set	   to	   zero	  and	  N=n.	  Thus,	   for	  a	   thiol	  SAM	  where	  n=1.5	   (a	   typical	  
value	   for	   an	   alkyl	   assembly)	   and	   by	   assuming	   a	   three-­‐layer	   parallel	   slab	   model	   for	   the	  
gold/SAM/air	  interface,	  it	  is	  possible	  to	  determine	  the	  thickness	  of	  the	  film.186,	  187,190,191	  
	  
2.1.3.1.2.	  -­‐	  Quartz	  Crystal	  Microbalance	  with	  Dissipation	  (QCM-­‐D)	  
The	   quartz	   crystal	  microbalance	   device	   (QCM)	   allows	   one	   to	  measure	   the	   change	   of	   the	  
mass	  of	  the	  films.	  This	  method	  is	  based	  on	  the	  ability	  of	  a	  piezoelectric	  quartz	  crystal	  to	  oscillate	  
at	   a	   resonance	   frequency	   determined	   by	   the	   mass	   of	   the	   crystal.187	   When	   an	   electric	   field	   is	  
externally	   applied	   to	   those	   materials,	   a	   mechanical	   strain	   is	   induced	   in	   the	   object.	   This	  
phenomenon,	  together	  with	  the	  relationship	  between	  the	  mechanical	  resonance	  frequency	  of	  an	  
object	   and	   its	   mass	   constitutes	   the	   fundament	   of	   the	   QCM	   technique,	   which	   uses	   changes	   in	  
resonance	  frequency	  to	  extract	   information	  about	  changes	   in	  the	  object.	  Due	  to	  the	   low	  energy	  
loss	  of	  single	  quartz	  crystals,	  ultra-­‐sensitive determinations	  of	  adsorbed	  or	  desorbed	  mass	  can	  be	  
made,	   corresponding	   to	   fractions	   of	   ng/cm2.	   QCM	   with	   dissipation	   option	   (QCM-­‐D)	   allows	   to	  
simultaneously	   measure	   the	   frequency	   and	   the	   energy	   dissipation,	   giving	   information	   on	   the	  
viscoelastic	   properties	   of	   the	   adsorbed	   molecules.192,193	   If	   the	   adsorbed	   mass	   is	   viscous	   and	  
sufficiently	  soft	  it	  does	  not	  follow	  the	  sensor	  oscillation	  perfectly,	  which	  leads	  to	  internal	  friction	  
(due	  to	  the	  deformation)	  in	  the	  added	  layer	  and	  thus	  to	  dissipation.	  
The	  QCM	   sensor	   is	   generally	   a	   thin	   circular	   piece	   of	   single	   crystalline	   quartz	   sandwiched	  
between	   a	   pair	   of	   circular	   metal	   electrodes	   (usually	   gold).	   With	   an	   applied	   electric	   field,	   a	  
mechanical	  strain	   is	   induced	   in	  the	  crystal,	   the	  direction	  being	  determined	  by	  the	  orientation	  of	  
the	  cut	  with	  respect	  to	  the	  crystal	  lattice.	  Commonly	  used	  in	  weighing	  device	  applications	  are	  cuts	  
resulting	   in	   thickness-­‐shear	   motion,	   of	   which	   the	   temperature-­‐compensated	   ‘AT	   cut’	   is	   a	  
particularly	  popular	  variant.194	  
The	   Sauerbrey	   equation	   or	   the	   Voigt	   model	   may	   be	   applied	   to	   QCM	   data	   in	   order	   to	  
estimate	  the	  adsorbed	  mass	  on	  the	  sensor,	  depending	  on	  the	  dissipation	  value	  of	  the	  system.	  
What	   makes	   this	   method	   valuable	   is	   that	   it	   can	   be	   used	   for	   molecular	  
adsorption/desorption	  at	   the	  surfaces	   in	   situ.187	  QCM	  has	  been	  used	  as	  an	   in	   situ	   technique	   for	  
the	  real	  time	  follow	  up	  of	  specific	  or	  non-­‐specific	  protein	  adsorption	  on	  SAMs.174,	  195-­‐197	  It	  can	  also	  
be	  used	  to	  quantify	  the	  amount	  of	  a	  specific	  protein	  adsorbed	  from	  complex	  mixtures	  as	  serum	  by	  
using	  quartz	  crystals	  modified	  with	  SAMs	  and	  immobilized	  antibodies.198	  	  
	   Chapter	  II	   Self-­‐assembled	  monolayers	  (SAMs)	  	  
	  46	  
2.1.3.2.	  -­‐	  Structure	  and	  Chemical	  Composition	  of	  the	  Film	  	  
2.1.3.2.1.	  –	  X-­‐ray	  photoelectron	  spectroscopy	  (XPS)	  
XPS	   provides	   information	   about	   the	   core	   electronic	   levels	   in	   atoms	   and	   molecules,	  
therefore	  permitting	  to	  study	  the	  elemental	  composition	  of	  SAMs.	  It	  measures	  the	  energy	  of	  the	  
inner	   shell	   electron	   ejected	   when	   the	   surface	   is	   irradiated	   with	   an	   X-­‐ray	   beam	   in	   ultra	   high	  
vacuum	  (to	  assure	  that	  other	  specimens	  are	  not	  present	  in	  the	  chamber)	  (Figure	  20).	  This	  energy	  
is	  specific	  for	  every	  chemical	  element	  and	  can	  be	  used	  to	  determine	  the	  composition	  of	  SAMs.190	  
	  
Figure	  20.	  Scheme	  of	  an	  X-­‐ray	  photoelectron	  spectroscopy	  system.199	  
	  
It	   is	  very	  useful	   in	  determining	  the	  composition	  of	  mixed	  SAMs	  prepared	  from	  mixtures	   if	  
thiol	  solutions	  with	  different	  terminal	  functional	  groups,	  allowing	  to	  find	  correlations	  between	  the	  
solution	  and	  the	  surface	  (SAM)	  composition.170,171,200	  
XPS	   can	   also	   provide	   data	   of	   the	   depth	   of	   the	   SAM,	   by	   studying	   the	   attenuation	   of	   the	  
photo-­‐emitted	   electrons	   at	   different	   take-­‐off	   angles	   relative	   to	   the	   substrate	   surface.186,	   190	  
Another	   important	   feature	   of	   the	   XPS	   spectra	   is	   that	   high	   resolution	   scans	   reveal	   differences	  
between	  elements	  in	  different	  oxidation	  states.	  Thus,	  XPS	  studies	  can	  indicate	  if	  the	  thiolate	  head	  
group	  in	  a	  monolayer	  has	  oxidized	  to	  a	  sulphonate	  group,	  RSO3.187	  
	  
2.1.3.3.	  -­‐	  Interfacial	  Properties	  	  
2.1.3.3.1.	  –	  Contact	  Angle	  Goniometry-­‐	  Sessile	  drop	  method	  	  
The	  sessile	  drop	  method	   is	  perhaps	  the	  simplest,	  and	  at	  the	  same	  time,	  the	  most	  elegant	  
method	   for	   characterizing	   SAMs	   in	   terms	   of	   surface	   wettability.	   It	   is	   a	   technique	   where	   the	  
contact	  angle	  (α)	  of	  a	  probing	  liquid	  is	  measured	  and	  correlated	  to	  the	  interfacial	  tensions	  of	  the	  
constituting	   phases	   (Figure	   21).	   This	   technique	   can	   provide	   information	   about	   the	   chemical	  
nature	  of	  the	  surface,	  as	  well	  about	  its	  morphological	  properties	  through	  the	  hysteresis,	  Dα=	  αa	  -­‐	  
αr,	  where	  αa	  and	  αr	  are	  the	  advancing	  and	  receding	  contact	  angles,	  respectively.186,	  187	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Figure	  21.	  Scheme	  of	  liquid	  contact	  angle	  in	  a	  surface.201	  
	  
SAMs	  presenting	  polar	  terminal	  functional	  groups,	  such	  as	  carboxylic	  acid	  and	  hydroxyl	  are	  
wetted	  by	  water.	  Those	  presenting	  polar	  organic	  groups,	  as	  methyl	  are	  autophobic	  and	  emerge	  
dry	  from	  water.	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3.1.	  -­‐	  Brief	  overview	  on	  Atomic	  Force	  Microscopy	  
Gerd	   Binnig	   and	   Heinrich	   Roher	   developed	   in	   the	   early	   1980s	   the	   scanning	   tunneling	  
microscope,	   the	   AFM	   precursor,	   a	   development	   awarded	   with	   the	   Nobel	   Prize	   for	   Physics.	   In	  
1986,	  Binnig,	  Quate	  and	  Gerber	  invented	  the	  first	  Atomic	  Force	  Microscopy	  (AFM)	  apparatus.202	  
The	   AFM	   is	   one	   of	   the	   foremost	   tools	   for	   imaging,	   measuring	   and	   manipulating	   at	   the	  
nanoscale	   level.	   Although	   it	   is	   denominated	   “microscopy”	   it	   is	   a	   misnomer,	   since	   microscopy	  
would	   imply	   looking	   while	   in	   fact	   using	   the	   AFM	   the	   information	   is	   gathered	   by	   “feeling”	   the	  
surface.	  
Over	  the	  years,	  it	  has	  become	  a	  powerful	  tool	  in	  biology	  and	  microbiology.203-­‐206	  Owning	  to	  
its	  capacity	  to	  allow	  observation	  and	  manipulation	  of	  biosurfaces	  under	  physiological	  conditions,	  
the	   AFM	   has	   revolutionized	   the	   way	   in	   which	   biological	   structures	   are	   explored	   at	   the	   single	  
molecule	  level,	  since	  it	  allows	  to	  image	  biological	  structures	  at	  high	  resolution	  and	  to	  measure	  the	  
forces	  within	  or	  between	  single	  molecules.207-­‐213	  Due	  to	  its	  high	  resolution	  and	  flexibility,	  AFM	  has	  
become	   a	   popular	   tool	   for	   studying	   biological	   problems,	   especially	   in	   probing	   biomolecules,	  
biosurface	  interactions,	  and	  biomechanics.	  
AFM	   was	   used	   in	   the	   context	   of	   this	   Doctoral	   Dissertation	   to	   study	   the	   biophysical	  
properties	  of	  the	  H.	  pylori	  BabA	  adhesin/Leb	  complex.	  
	  
3.2.	  -­‐	  AFM	  principle	  
As	   opposed	   to	   optical	   or	   electron	  microscopes,	   scanning	   probe	  microscopes	   such	   as	   the	  
AFM	  do	  not	  use	  glass	  or	  magnetic	   lenses	   for	  producing	  an	   image	  of	   the	   sample	  but	  a	   sharp	   tip	  
(probe)	  instead	  (Figure	  22).214	  The	  resolution	  of	  an	  AFM	  depends	  strongly	  on	  the	  shape	  of	  the	  tip:	  
the	   smaller	   the	   tip	   (sharper)	   the	   smaller	   is	   the	   surface	   area	   sampled	   by	   it,	   the	   high	   is	   the	  
resolution.	  An	  AFM	  tip	  consists	  of	  a	  microfabricated	  pyramidal	  Si	  or	  Si3N4	  tip	  attached	  to	  a	  flexible	  
cantilever	  with	  a	  specific	  spring	  constant.	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Figure	  22.	  General	  principle	  and	  setup	  of	  an	  AFM.	  AFM	  imaging	  is	  performed	  by	  scanning	  a	  very	  sharp	  tip	  across	  the	  
sample	  surface	  while	  the	  force	  of	  interaction	  between	  the	  tip	  and	  the	  sample	  is	  monitored	  with	  piconewton	  sensitivity.	  
The	  sample	   is	  mounted	  on	  a	  piezoelectric	  scanner,	  which	  ensures	  three-­‐dimensional	  positioning	  with	  high	  resolution,	  
and	   the	   force	  between	   tip	   and	   surface	   is	  monitored	  by	  measuring	   the	   cantilever	  deflection	  using	   an	  optical	  method	  
(laser,	  photodiode).	  Beside	  imaging	  surfaces,	  AFM	  can	  be	  used	  in	  the	  force	  spectroscopy	  mode,	  in	  which	  the	  cantilever	  
deflection	   is	  recorded	  as	  a	  function	  of	  the	  vertical	  displacement	  of	  the	  piezoelectric	  scanner,	  that	   is,	  as	  the	  sample	   is	  
pushed	  towards	  the	  tip	  and	  retracted	  from	  it	  (bidirectional	  arrow).	  Adapted	  from	  Hinterdorfer	  and	  Dufrene.211	  
	  
The	  main	  parts	  of	  the	  AFM	  are	  the	  cantilever,	  the	  sample	  stage	  and	  the	  optical	  deflection	  
system	  consisting	  of	  a	  laser	  diode	  and	  a	  photodetector.	  AFM	  images	  are	  created	  by	  scanning	  (in	  
the	   x	   and	   y	   directions)	   a	   sharp	   tip,	   mounted	   to	   a	   soft	   cantilever	   spring,	   over	   the	   surface	   of	   a	  
sample	   and	   by	   using	   the	   interaction	   force	   between	   the	   tip	   and	   the	   sample	   to	   probe	   the	  
topography	   of	   the	   surface.	   Force	   spectroscopy	   studies	  measure	   the	   force	   between	   the	   surface	  
and	   the	   cantilever	   with	   piconewton	   sensitivity,	   as	   the	   tip	   is	   pushed	   towards	   the	   sample	   and	  
retracts	   from	   it	   in	   the	   z	   direction.	   The	   sample	   is	   mounted	   on	   a	   piezoelectric	   scanner,	   which	  
ensures	  three-­‐dimensional	  positioning	  with	  high	  resolution.211	  
	  
3.3.	  -­‐	  AFM	  operating	  and	  imaging	  modes	  
The	   AFM	   allows	   the	   imaging	   of	   the	   topography	   of	   conducting	   and	   insulating	   surfaces,	   in	  
some	  cases	  even	  with	  atomic	  resolution.	  
AFM	  can	  operate	  in	  different	  imaging	  modes:	  contact	  mode,	  tapping	  mode,	  phase	  imaging,	  
force	  modulation	  and	  non-­‐contact	  mode	  as	  represented	  on	  Figure	  23.	  A	  brief	  description	  of	  each	  
one	  is	  given	  in	  the	  following	  sections.	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Figure	  23.	  Common	  AFM	  operating	  modes.	  	  Adapted	  from	  Jandt.214	  	  
3.3.1.	  -­‐	  Contact	  mode	  
The	  force	  between	  the	  tip	  and	  the	  surface	  of	  the	  sample	  is	  kept	  constant	  via	  an	  electronic	  
feedback	   loop,	   being	   the	   tip	   in	   permanent	   physical	   contact	   with	   the	   sample.	   Owing	   to	   the	  
permanent	   tip–sample	   contact,	   the	   shear	   forces	   applied	   to	   the	   sample	   during	   scanning	   are	  
significant	   and	  potentially	   damaging	   to	  weakly	   bound	  molecules,	   such	   as	   proteins	   adsorbed	  on	  
biomaterials.	  Therefore,	  contact	  mode	  can	  be	  used	  to	  image	  hard	  and	  stable	  samples	  that	  are	  not	  
affected	   by	   the	   frictional	   force	   components	   that	   the	   tip	   applies	   to	   the	   sample.	   Typical	   forces	  
applied	   in	   constant	   force	  mode	  are	   in	   the	  order	  of	  nN	  but	   can	  be	  varied	  over	  a	  wide	   range,	   as	  
cantilevers	   with	   different	   spring	   constants	   are	   available. Nevertheless,	   contact	   mode	   enables	  
extreme	  high-­‐resolution	  images.214	  
	  
3.3.2.	  -­‐	  Tapping	  mode	  
Tapping	  mode215	   uses	   an	   oscillating	   tip	   driven	   by	   an	   oscillation	   piezo.	   If	   the	   tip	   is	   driven	  
towards	   the	   surface	   it	   begins	   to	   touch	   or	   “tap”	   the	   surface.	   This	   surface	   contact	   leads	   to	   an	  
energy	  loss	  of	  the	  oscillating	  tip,	  which	  reduces	  the	  tip	  amplitude	  significantly. The	  reduction	  of	  
the	  oscillation	  amplitude	   is	  used	   to	   identify	  and	  measure	  surface	   topographic	   features.	  Tapping	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mode	   operates	   also	   in	   fluid	   environments.	   Therefore,	   this	   AFM	   mode	   is	   most	   often	   used	   in	  
biomaterials	   science,	   due	   to	   the	   relatively	   small	   interactions	   between	   the	   tip	   and	   the	   sample,	  
being	  the	  shear	  force	  applied	  to	  it	  by	  the	  tip	  negligible.214	  
	  
3.3.3.	  -­‐	  Phase	  imaging	  
AFM	   phase	   imaging	   allows	   extracting	   non-­‐quantitative	   information	   about	   hardness	   and	  
elasticity	  of	   samples	   at	   the	   same	   time	   that	   a	   topographic	   image	   is	  being	  acquired	  with	   tapping	  
mode. Phase	  imaging	  can	  also	  act	  as	  a	  real-­‐time	  contrast	  enhancement	  technique	  because	  phase	  
imaging	  highlights	  edges.	  Fine	  features,	  such	  as	  surface	  steps	  or	  edges,	  which	  can	  be	  obscured	  by	  
a	  rough	  topography,	  are	  revealed	  more	  clearly	  through	  phase	  imaging.214	  
	  
3.3.4.	  -­‐	  Force	  Modulation	  Mode	  
Force	  modulation	  mode	  (FMM)	  is	  closely	  related	  to	  tapping	  mode.	  In	  this	  mode,	  however,	  
an	  additional	   sinusoidal	  modulation	   is	   applied	   to	   the	   cantilever	  while	   the	   tip	   scans	   the	   surface.	  
Thus,	  the	  contact	  force	  applied	  to	  the	  sample	  is	  modulated.	  From	  the	  root-­‐mean-­‐square	  (RMS)	  of	  
the	  cantilever	  amplitude	  of	  deflection,	  information	  about	  the	  mechanical	  properties	  (stiffness)	  of	  
the	   sample	   can	   be	   obtained	   with	   a	   lateral	   resolution	   of	   about	   10	   nm	   or	   better.	   For	   a	   given	  
amplitude	  modulation,	  the	  resulting	  RMS	  cantilever	  deflection	  for	  a	  soft	  material	  will	  be	  less	  than	  
for	   a	   hard	  material.	   Thus,	   the	  measured	  RMS	  amplitude	   at	   each	  point	   of	   the	   sample	   surface	   is	  
used	   to	  measure	   local	   differences	   in	   the	   elasticity	   of	   the	   sample.	   FMM	  does	   not	   give	   absolute	  
values	  of	   sample	   stiffness.	   Rather,	   different	   stiffness	  of	   the	   sample	   surface	   appears	   as	   areas	  of	  
different	  image	  brightness	  in	  the	  FMM	  image.214	  
	  
3.3.5.	  -­‐	  Non-­‐contact	  mode	  
The	  amount	  of	   force	  applied	  by	   the	  AFM	   tip	   to	   the	   sample	   can	  be	  even	  more	   reduced	   if	  
non-­‐contact	  AFM	  modes	  are	  used	  for	  operation.	  In	  non-­‐contact	  modes,	  the	  cantilever	  tip	  is	  placed	  
at	   the	   attractive	   force	   region	   (i.e.,	   attractive	   van	   der	   Waals	   forces),	   and	   force	   gradients	   are	  
detected.216	  This	  is	  done	  since	  the	  attractive	  forces	  are	  usually	  small	  (below	  1	  pN217	  at	  tip–sample	  
distances	  larger	  than	  0.6	  nm)	  compared	  to	  repulsive	  forces.	  The	  force	  gradients	  can	  be	  detected	  
either	  from	  shifts	  in	  the	  resonance	  frequency	  of	  the	  cantilever216	  or	  the	  amplitude	  and	  the	  phase	  
of	   the	   cantilever.218	   The	   advantages	   of	   these	   approaches	   are	   the	   high	   sensitivity	   of	   gradient	  
measurements	  and	  that	  small	  forces	  are	  applied	  to	  the	  sample,	  which	  make	  non-­‐contact	  modes	  
suitable	   for	   AFM	   imaging	   of	   soft	   biomaterial–biomolecule	   interfaces.	   Although	   the	   operation	  
range	  of	  the	  cantilever	  amplitude	  of	  the	  non-­‐contact	  mode	  is	  much	  smaller	  than	  for	  the	  tapping	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mode,	  non-­‐contact	  AFM	  is	  more	  complicated	  than	  the	  tapping	  mode.	  The	  real	  non-­‐contact	  mode	  
offers	  the	  lowest	  possible	  interaction	  between	  sample	  and	  tip,	  which	  is	  an	  advantage	  for	  work	  on	  
many	  soft	  biomaterials	  systems.214	  
	  
3.4.	  -­‐	  Force	  spectroscopy	  
3.4.1.	  -­‐	  Overview	  on	  single	  molecule	  force	  spectroscopy	  
Besides	   imaging	   of	   surface	   topography	   and	   exploring	   chemical	   and	   non-­‐quantitative	  
mechanical	  properties	  of	  samples,	  AFM	  can	  be	  used	  to	  perform	  force	  spectroscopy	  studies.	  This	  
AFM	  operation	  mode,	  allows	  measurement	  of	  piconewton	  (10-­‐12	  N)	  forces	  associated	  with	  single	  
molecules219,220,	   thereby	   providing	   fundamental	   insights	   into	   the	   molecular	   basis	   of	   biological	  
phenomena	  and	  properties	  as	  diverse	  as	  molecular	  recognition	  and	  cell	  adhesion.210,221-­‐223	  
Single	   molecule	   force	   spectroscopy	   technique	   is	   based	   on	   a	   simple	   principle.	   Basically,	  
ligands	  of	  interest	  are	  attached	  to	  the	  tip	  of	  the	  force	  transducer	  and	  the	  corresponding	  receptors	  
are	  attached	  to	  the	  surface	  of	  the	  substrate.	  The	  modified	  transducer	  is	  brought	  into	  contact	  with	  
the	   surface,	   allowing	   the	   adhesive	   bond	   to	   form.	  When	   pulling	   the	   transducer	   away	   from	   the	  
surface,	   the	  spring	  deflects	  under	   the	   tension	  once	  a	  bond	   forms.	  The	  bond	   ruptures	   if	  enough	  
force	  or	  time	  is	  applied.	  
The	  method	  that	  is	  commonly	  adopted	  to	  study	  these	  forces	  is	  to	  perform	  what	  is	  referred	  
to	   as	   a	   force–distance	   curve.	  Here,	   the	   tip	   is	   approached	   towards	   the	   sample,	   contact	   is	  made	  
with	  a	  controllable	  level	  of	  applied	  force	  and	  then	  the	  tip	  is	  retracted	  from	  the	  surface. During	  this	  
tip	   approach-­‐retract	   cycle	   the	   deflection	   of	   the	   cantilever	   is	   recorded	   to	   provide	   a	  measure	   of	  
applied	  force	  (when	  deflection	  of	  the	  cantilever	  has	  been	  converted	  to	  force	  using	  the	  cantilever	  
spring	  constant) versus	  distance.	  A	  simplified	  force–distance	  curve	  is	  shown	  in	  Figure	  24.	  
	  
	  
	  Chapter	  II	   Atomic	  Force	  Microscopy	  	  
	  56	  
	  
Figure	  24.	  A	  typical	  force	  distance	  curve	  showing	  the	  approach	  and	  retract	  parts	  of	  the	  cycle:	  A,	  tip	  is	  a	  large	  distance	  
from	  the	  surface	  and	  no	  interaction	  is	  measured;	  B,	  the	  tip	  contacts	  the	  surface;	  C,	  the	  cantilever	  is	  bent	  and	  a	  repulsive	  
force	   (positive)	   is	   measured;	   D,	   the	   cantilever	   holder	   is	   retracted	   from	   the	   surface	   and	   an	   adhesive	   interaction	  
(negative)	  between	  tip	  and	  surface	  is	  observed;	  E,	  the	  pull-­‐off	  point.	  Adapted	  from	  Smith	  et	  al.224	  
	  
In	  part	  A	  of	   the	  curve,	   the	   tip	   is	   sufficiently	   far	   from	  the	  surface	  so	   that	  no	   interaction	   is	  
experienced	  until	  at	  point	  B	  the	  cantilever	  contacts	  the	  surface.	  Beyond	  this	  point,	  in	  section	  C	  of	  
the	  curve,	  the	  deflection	  of	  the	  cantilever	  corresponds	  to	  a	  repulsive	  force.	  In	  section	  D,	  the	  tip	  is	  
being	  retracted	  and	  some	  hysteresis	  may	  be	  observed	  principally	  due	  to	  the	  characteristics	  of	  the	  
piezoactuators.	   If	  there	   is	  an	  adhesion	  between	  the	  tip	  and	  sample,	  as	  shown	  in	  the	  example	   in	  
Figure	   24,	   then	   an	   attractive	   force	   is	   observed	   (negative	   in	   this	   diagram)	   until	   a	   critical	   force	  
(point	  E)	  at	  which	   the	  tip	  suddenly	  breaks	  away	   from	  the	  surface	   (commonly	   referred	  to	  as	   the	  
pull-­‐off	  point).224	  
The	   force	   experiments	   are	   usually	   performed	   as	   follows:	   a	   probe	   decorated	  with	   a	   small	  
amount	  of	  ligand	  and	  a	  substrate	  studded	  with	  specific	  receptors	  is	  repeatedly	  touched	  together	  
through	   steady	   precision	   movement	   to/from	   contact.	   Under	   controlled	   touch,	   infrequent	  
attachment	   ensures	   a	   high	   probability	   for	   formation	   of	   single	   bonds	   (approximately	   95	   %	  
confidence	  when	  1	  attachment	  occurs	  out	  of	  10	  touches).	  This	  is	  achieved	  by	  sparsely	  modifying	  
the	   tip	   and	   sample	  with	   the	   ligand	  of	   interest.	   At	   this	   low	  binding	   frequency,	   Poisson	   statistics	  
show	  that	  the	  majority	  of	  these	  binding	  events	  result	  from	  single	  bonds.225	  After	  attachment,	  the	  
force	   transducer	   exhibits	   an	   extension	   or	   deflection	   during	   surface	   separation.	   Bond	   rupture	   is	  
signaled	  by	   rapid	   recoil	   at	  breakage	  and	   the	   rupture	   force	   is	  given	  by	   the	  maximum	  transducer	  
extension.225	  
The	   rupture	   force	   can	  be	   calculated	  using	   the	  distance	   that	   the	   spring	   recoils	   after	   bond	  
rupture	  ΔD	  (deflection),	  and	  the	  spring	  constant	  ks,	  applying	  Hooke’s	  law	  (1):	  
F	  =	  ks*ΔD	  (1)	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mapping surface forces with very high spatial, force
and chemical resolution.
In this review, we shall briefly describe the method-
ologies for chemically functionalising the AFM probe
so that specific molecular interactions can be mea-
sured. We shall also review our recent work concern-
ing the interactions between surfaces of well known
chemistry and then discuss the application of the
technique of chemical force microscopy (CFM) to the
study of the surface chemistry of skeletal tissue min-
eral and relate the findings to the binding of matrix
proteins to these surfaces.
2. Experimental methods
2.1. Force–distance measurements with the AFM
The origins of the interaction between tip and sam-
ple during imaging can be very complex [1]. Depend-
ing on the nature of the sample (and tip) there may
be many interactions including capillary, electrostatic,
magnetic, hydrophobic and van der Waal’s forces.
Consequently, the unequivocal assignment of the ori-
gin of the forces that are observed presents a chal-
lenge. Despite this, the ability of the AFM to probe
Fig. 1. A typical force distance curve showing the approach and retract parts of the cycle: A, tip is a large distance from the surface and no
interaction is measured; B, the tip contacts the surface; C, the cantilever is bent and a repulsive force (positive) is measured; D, the cantil ver
holder is retracted from th surface and an adhesive interaction (negative) between tip and surface is observed; E, the pull-off point.
forces at a surface with high resolution is one of great
value and the AFM has found extensive application
recently as a force measuring device.
The method that is commonly adopted is to per-
form what is referred to as a force–distance curve.
Here the tip is approached towards the sample, con-
tact is made with a controllable level of applied force
and then the tip is retracted from the surface. Dur-
ing this tip approach-retract cycle the deflection of the
cantilever is recorded to provide a measure of applied
force (when deflection of the cantilever has been con-
verted to force using the cantilever spring constant)
versus distance. A simplified force–distance curve is
shown in Fig. 1. In part A of the curve, the tip is suf-
ficiently far from the surface that no interaction is ex-
perienced until at point B the cantilever contacts the
surface. Beyond this point, in section C of the curve,
the deflection of the cantilever corresponds to a repul-
sive force. In section D, the tip is being retracted and
some hysteresis may be observed principally due to
the characteristics of the piezoactuators. If there is an
adhesion between the tip and sample, as shown in the
example in Fig. 1, then an attractive force is observed
(negative in this diagram) until a critical force (point
E) at which the tip suddenly breaks away from the sur-
face (commonly referred to as the pull-off point). In its
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The	  formation	  and	  forced	  rupture	  of	  bonds	  between	  the	  tip	  and	  the	  sample	  is	  a	  stochastic	  
process.	  Therefore,	  thousands	  of	  force-­‐extension	  curves	  are	  collected	  to	  obtain	  a	  representative	  
distribution	   of	   the	   data.	   The	   number	   of	   bond	   ruptures	   at	   each	   pulling	   follows	   Poisson	  
distribution.225	   After	  many	   hundreds	   of	   touches,	   detachment	   forces	   are	   then	   cumulated	   into	   a	  
histogram.	  It	  is	  recommended	  to	  record	  several	  hundred	  of	  force	  curves	  on	  different	  locations	  of	  
the	   sample	  and	   the	  histogram	  must	   reflect	   the	  distribution	  of	   at	   least	   100	  unbinding	  events.211	  
The	  peak	   in	   the	  distribution	   is	   the	  most	   likely	   rupture	   force	   that	  defines	  bond	  strength.225	  Also,	  
the	   reliability	  and	   reproducibility	  of	   the	  measured	  unbinding	   forces	   should	  be	  demonstrated	  by	  
comparing	   data	   obtained	   using	   many	   independent	   tips	   and	   samples.	   Finally,	   unbinding	   force	  
histograms	  should	  be	  generated	  while	  varying	  the	  loading	  rate.211	  
The	   cantilever	   deflection	   (vertical	   bending)	   is	   detected	   by	   focusing	   a	   laser	   light	   on	   the	  
backside	   of	   the	   cantilever.	   The	   light	   is	   then	   reflected	   towards	   a	   position	   sensitive	   photodiode	  
(PSPD).	  A	  piezo-­‐electric	  actuator	  into	  contact	  with	  the	  underlying	  substrate	  drives	  the	  AFM	  tip.	  A	  
deflection	  of	  the	  cantilever	  causes	  the	  laser	  beam	  to	  shift	  on	  the	  PSPD.	  Thus,	  the	  PSPD	  tracks	  the	  
movement	  of	  the	  cantilever	  surface	  by	  sensing	  changes	  in	  the	  position	  of	  the	  reflected	  light.	  
The	  force	  resolution	  of	  the	  AFM	  is	  in	  first	  approximation	  limited	  by	  the	  thermal	  noise	  of	  the	  
cantilever	  that,	  in	  turn,	  is	  determined	  by	  its	  spring	  constant.	  In	  addition,	  the	  resonance	  frequency,	  
the	   quality	   factor,	   and	   the	   measurement	   bandwidth	   can	   also	   substantially	   contribute	   to	   the	  
overall	   resolution.226	   Therefore,	   for	   single-­‐molecule	   force	   measurements,	   best	   results	   are	  
generally	  obtained	  with	  cantilevers	  exhibiting	  small	  spring	  constants	  (that	  is,	  in	  the	  range	  of	  0.01	  
to	   0.10	   N/m)	   and	   short	   lengths	   (<	   50	   μm),	   because	   they	   exhibit	   lower	   force	   noise.	   The	   “real”	  
spring	  constants	  may	  differ	  substantially	  from	  values	  given	  by	  the	  manufacturer,	  meaning	  that	  it	  
must	   be	   determined	   experimentally	   to	   get	   accurate	   knowledge	   of	   the	   measured	   forces.	   The	  
cantilevers	  spring	  constant	  is	  usually	  calibrated	  with	  the	  thermal	  method.227	  The	  power	  spectrum	  
density	   (PSD)	   of	   the	   cantilever	   deflection	   due	   to	   thermal	  motion	   is	   fit	   with	   a	   simple	   harmonic	  
oscillator	  model228	  and	  the	  spring	  constant	  is	  derived	  from	  the	  equipartition	  theorem.	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Figure	   25.	   (A)	   Schematic	   of	   the	   atomic	   force	   microscope	   and	   (B)	   the	   calibration	   of	   the	   spring	   constant	   with	   the	  
thermal	  method.	   In	  AFM	  measurements,	   the	  optical	   lever	   in	  which	  a	   laser	   reflects	   from	  the	  cantilever	  back	   to	  PSPD	  
(position	  sensitive	  photodiode)	  detects	  the	  cantilever	  deflection.	  To	  calibrate	  the	  cantilever	  spring	  constant,	  the	  power	  
spectrum	  density	  (PSD)	  of	  the	  cantilever	  in	  water	  due	  to	  thermal	  fluctuation	  (B)	   is	  generated	  and	  fitted	  with	  a	  simple	  
harmonic	   oscillator	   (SHO)	   model228,	   from	   which	   the	   spring	   constant	   of	   the	   cantilever	   is	   determined,	   using	   the	  
equipartition	  theorem.	  
	  
This	  calibration	  method	  is	  straightforward,	  non-­‐destructive	  to	  cantilevers	  and	  considered	  to	  
be	   reasonably	   accurate.	   The	   power	   spectrum	   density	   (PSD)	   of	   the	   cantilever	   deflection	   due	   to	  
thermal	  motion	  is	  fit	  with	  a	  simple	  harmonic	  oscillator	  model.228	  
	  
3.4.2.	  -­‐	  AFM	  tip	  functionalization	  	  
Force	  distance	  curves	  can	  be	  acquired	  directly	  between	  a	  tip	  and	  a	  sample	  or	  between	  a	  tip	  
functionalized	   with	   a	   molecule	   of	   interest	   and	   a	   surface.	   By	   using	   functionalized	   tips	   with	  
biomolecules,	  chemical	  sensitivity	  and	  molecular	  recognition	  abilities	  are	  achieved	  with	  an	  AFM,	  
since	   specific	   chemical	   interactions	   occur	   between	   the	   tip	   and	   sample.229	   Force	  measurements	  
with	  modified	  (‘‘functionalized’’)	  tips	  are	  also	  denominated	  ‘‘chemical	  force	  microscopy”.	  
The	  main	  purpose	  of	  modifying	  the	  tip	  is	  to	  effectively	  detect	  complementary	  molecules	  on	  
the	   material/surface	   of	   interest	   by	   optimizing	   the	   interaction	   between	   the	   molecules	   on	   the	  
sample	  surface	  and	  those	  on	  the	  probe.	  
Probably	   the	   method	   with	   the	   highest	   reliability	   of	   getting	   a	   predetermined	   density	   of	  
specific	  groups	  is	  a	  gold-­‐thiol	  coating.	  To	  coat	  tips	  with	  thiols,	  they	  first	  have	  to	  be	  coated	  with	  a	  
layer	  of	  gold	  either	  by	  evaporation	  or	  sputtering,	  with	  a	  typical	  gold	  layer	  thickness	  of	  30–100	  nm.	  
To	  enhance	  the	  adhesion	  of	  the	  gold	  layer	  to	  the	  silicon	  nitride	  or	  oxide	  composing	  the	  tip,	  a	  2–5	  
nm	  thick	  layer	  of	  titanium	  or	  chromium	  is	  first	  deposited.230	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Figure	  26.	  Modification	  of	  a	  tip	  with	  a	  molecular	  monolayer	  by	  thiol	  self-­‐assembly:	  (a)	  -­‐functionalized	  alkyl	  thiols	  with	  
functional	   group	   R,	   (b)	   these	   molecules	   spontaneously	   form	   a	   monolayer	   by	   adsorption	   to	   a	   gold	   film	   with	   the	  
functional	  group	  R	  at	  the	  surface	  represented	  by	  the	  bold	  line,	  (c)	  electron	  micrograph	  of	  a	  typical	  contact	  mode	  AFM	  
probe	   and	   (d)	   a	   gold	   layer	   can	   be	   applied	   to	   an	   AFM	   probe	   tip	   by	   thermal	   evaporation	   or	   sputtering	   allowing	   the	  
formation	  of	  a	  molecular	  monolayer	  as	  in	  (b)	  to	  create	  a	  probe	  with	  a	  specific	  surface.	  Adapted	  from	  Smith	  et	  al.224	  
	  
One	  problem	  of	  chemically	  modified	  tips	  is	  that	  they	  might	  be	  destroyed	  by	  the	  interaction	  
with	  another	  surface.	  Therefore	  the	  approach	  of	  the	  tip	  to	  the	  surface	  needs	  to	  be	  done	  carefully	  
and	  force	  curves	  should	  be	  taken	  with	  controlled	   load.	  Otherwise	  the	  tip	  gets	  damaged	  and	  the	  
analysis	  of	  force	  curves	   is	  erratic.231	  Other	  concerns	  with	  this	  approach	  to	  tip	  functionalizing	  are	  
that	  the	  process	  of	  gold	  coating	  may	  structurally	  damage	  the	  AFM	  probe	  blunting	  it	  and	  the	  fact	  
that	   the	   thin	   film	   of	   gold	   may	   not	   withstand	   the	   mechanical	   stress	   that	   the	   AFM	   probe	   goes	  
through.	  
Linear	  polymers,	  such	  as	  poly(ethylene	  glycol)	  chains	  (PEG),232-­‐234,	  have	  regularly	  been	  used	  
as	  flexible	  tethers	  between	  the	  tip	  and	  the	  probe	  molecule,	  resulting	  in	  much	  higher	  probability	  
for	   binding	   between	   the	   probe	   molecule	   on	   the	   tip	   and	   the	   target	   molecules	   on	   the	   sample	  
surface. Tethering	  of	  probe	  molecules	  via	   linear	  polymers	   is	  usually	  performed	   in	   three	   stages.	  
First,	  reactive sites	  are	  generated	  on	  the	  tip	  surface.	  Second,	  a	  linear	  polymer	  (“cross-­‐linker”)	   is	  
attached	  with	  one	  reactive	  end	  while	  reserving	  the	  other	  end	  for	  the	  probe	  molecule.	  Third,	  the	  
probe	  molecule	  is	  coupled	  to	  the	  free	  end	  of	  the	  polymer	  chain.235 
	  
3.4.3.	  -­‐	  Achieving	  single	  molecular	  interaction	  detection	  
There	   are	   several	   factors	   that	   should	   be	   considered	   when	   single	   molecular	   interaction	  
detection	   is	  aimed.	  First,	   the	  binding	  of	   the	  molecules	   to	   the	  surfaces	  should	  be	  much	  stronger	  
than	  the	  intermolecular	  force	  being	  studied.	  This	  is	  best	  achieved	  by	  using	  covalent	  bonds	  as	  they	  
are	  at	  least	  ten	  times	  stronger	  (1–2	  nN)	  than	  typical	  receptor-­‐ligand	  bonds.236	  Second,	  the	  surface	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density	  of	  the	  molecules	  should	  be	  sufficiently	  low	  to	  ensure	  single-­‐molecule	  interactions.	  Third,	  
the	   molecules	   should	   retain	   sufficient	   mobility	   so	   that	   they	   can	   freely	   interact	   with	  
complementary	  molecules,	  which	  are	  usually	  achieved	  by	  attaching	  the	  molecules	  on	  the	  surfaces	  
via	  a	   flexible	  molecular	   spacer.	  Forth,	  unspecific	  adsorption	  on	   the	  modified	  surfaces	   should	  be	  
inhibited	   to	  minimize	   the	   contribution	  of	  unspecific	   adhesion	   to	   the	  measured	   forces.	   Fifth,	   for	  
oriented	  systems,	  site	  directed	  coupling	  in	  which	  the	  molecule	  has	  a	  defined	  orientation	  may	  be	  
desired.211	  
	  
3.4.4.	  -­‐	  Measuring	  single	  molecule	  recognition	  forces	  
In	   a	   typical	   AFM	   experiment,	   the	   force	   on	   a	   bond	   increases	   at	   a	   constant	   rate	   (pulling	  
rate)	  until	  the	  bond	  breaks.	  In	  these	  studies,	  the	  bond	  rupture	  is	  measured	  at	  a	  range	  of	  pulling	  
rates,	  giving	  characteristic	  parameters	  defining	  the	  bond	  potential	  energy	  landscape.	  
The	  interaction	  potential	  for	  a	  non-­‐covalent	  bond	  is	  shown	  in	  Figure	  27.	  
	  
Figure	  27.	  Schematic	  of	  pulling	  a	  bond	  out	  of	  a	  potential	  well	  (A)	  and	  the	  energy	  profile	  of	  molecular	  interaction	  under	  
the	  force	  (B).	  Adapted	  from	  Evans.	  237	  
	  
At	   or	   near	   equilibrium	   (the	   dashed	   blue	   line)	   molecules	   are	   free	   in	   solution	   and	   are	  
constantly	  associating	  and	  dissociating	  over	  time.	  However,	   in	  the	  AFM	  studies,	  applying	  a	  force	  
to	  the	  bond	  shifts	  the	  potential	  energy	  landscape	  far	   from	  equilibrium.	  The	  height	  of	  the	  energy	  
barrier	  is	  lowered	  due	  to	  this	  applied	  external	  force,	  and	  this	  increases	  the	  dissociation	  rate.	  Here	  
the	  application	  of	  force	  creates	  a	  transient	  capture	  well	  (the	  solid	  red	  line).	  If	  the	  applied	  force	  is	  
great	   enough,	   this	   well	   can	   be	   deeper	   than	   the	  minimum	   of	   the	   bound	   state	   at	   Emin,	   favoring	  
dissociation.	  Once	  the	  bond	  breaks,	  it	  has	  no	  chance	  to	  rebind	  in	  most	  AFM	  measurements.	  The	  
behavior	   of	   molecular	   bonds	   under	   an	   external	   force	   can	   be	   understood	   using	   the	   theory	  
originally	  developed	  by	  Kramers	  to	  describe	  barrier	  crossing	  in	  a	  dissipative	  environment.238	  
For	  a	  first	  order	  reaction:	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  (2)	  
the	  master	  equation	  is	  :	  
(3)	  
Considering	   a	   bound	   state	   confined	   by	   a	   sufficiently	   high-­‐energy	   barrier	   (Eb),	   Kramer’s	  




D	  is	  the	  diffusion	  coefficient,	  kB	  is	  the	  Boltzmann	  constant,	  and	  ΔEb	  =	  Emax	  –	  Emin	  is	  the	  height	  
of	  the	  energy	  barrier	  in	  the	  absence	  of	  force.238,239	  
When	  an	  external	  force	  f	  is	  applied	  to	  the	  bond,	  the	  energy	  barrier	  is	  lowered	  and	  the	  off-­‐	  




and	   tD,	   known	   as	   diffusive	   relaxation	   time,	   is	   the	   pre-­‐factor	   in	   equation	   4.240,241	   If	   we	  
assume	   that	   the	  external	   force	  does	  not	   significantly	   change	   the	  position	  of	   the	  energy	  barrier,	  
which	   is	   reasonable	   for	   potential	   landscapes	  with	   a	   high	   and	   sharp	   energy	   barrier,	   equation	   6	  
reduces	  to:	  
	   	   (8)	  
where	  koff	  is	  the	  intrinsic	  dissociation	  rate	  and	  fβ	  is	  the	  thermal	  force.	  It	  is	  expressed	  as:	  
(9)	  
With	  a	   steep	  energy	  barrier	   and	  Δx	   independent	  of	   the	  external	   force,	   equation	  6	   shows	  
that	  the	  rate	  of	  bond	  dissociation	  under	  force	  koff	  increases	  exponentially	  with	  the	  force.	  
When	  molecular	  bonds	  are	   subjected	   to	  a	  constant	   force,	   the	  dissociation	   rate	  koff	  of	   the	  
bond	  is	  constant.	  The	  master	  equation	  governing	  the	  dynamics	  is	  reduced	  to	  the	  following:	  
(10)	  
The	   survival	  probability	  P(t),	  defined	  by	   the	  probability	  of	  a	  bond	   ruptured	  at	   time	   larger	  
than	  this:	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(11)	  
This	  is	  the	  expression	  for	  the	  probability	  of	  survival	  that	  will	  be	  used	  in	  the	  analysis	  of	  the	  
constant	  force	  experiments.	  
For	   simple	   bonds,	   i.e.	   ones	   with	   only	   1	   energy	   barrier,	   at	   forces	  much	   greater	   than	   the	  
thermal	   force,	   the	   rate	   of	   re-­‐association	   vanishes.	   By	   solving	   equations	   10	   and	   11,	   the	   rupture	  
forces	  are	  distributed	  according	  to	  the	  probability	  distribution	  function	  P(f).239,	  241	  
(12)	  
And	  the	  probability	  density	  function	  is	  
(13)	  
The	   theoretical	   model	   used	   to	   derive	   equation	   13	   includes	   two	   unknown	   parameters:	  
namely,	   the	   unstressed	   off	   rate	   koff	   and	   the	   distance	   xβ	   from	   the	   free	   energy	  minimum	   to	   the	  
energy	  barrier.	  The	  most	  probable	  rupture	  force	  is	  derived	  from	  this	  probability	  function:	  
(14)	  
This	  predicts	  that	  the	  most	  probable	  rupture	  forces	  increases	  linearly	  with	  the	  logarithm	  of	  
pulling	   rates.	   The	   intrinsic	   dissociation	   rate	   and	   the	   thermal	   force	   can	   be	   obtained	   from	   the	  
dependence	  of	  the	  most	  probable	  rupture	  forces	  on	  the	  logarithm	  of	  the	  pulling	  rates	  (equation	  
14).	   Such	   plots	   are	   popularly	   referred	   to	   as	   “dynamic	   force	   spectra”.	   Equation	   14	   is	   used	   to	  
analyze	  the	  data	  from	  single	  bond	  rupture	  measurements,	  especially	  when	  the	  rupture	  forces	  are	  
narrowly	  distributed	  with	  clearly	  defined	  peaks.	  
	  
3.5.	  -­‐	  Comparison	  of	  AFM	  to	  Other	  Microscopes	  &	  Instruments	  
The	   AFM	   can	   be	   compared	   to	   traditional	   microscopes	   such	   as	   the	   optical	   or	   scanning	  
electron	  microscopes	   for	  measuring	   dimensions	   in	   the	   horizontal	   axis.	   However,	   it	   can	   also	   be	  
compared	   to	   profilers	   for	   making	   measurements	   in	   the	   vertical	   axis	   to	   a	   surface.	   A	   great	  
advantage	  of	  the	  AFM	  is	  the	  ability	  to	  magnify	  in	  the	  x,	  y	  and	  z	  axes.	  
One	   of	   the	   limiting	   characteristics	   of	   the	   AFM	   is	   that	   it	   is	   not	   practical	   to	   make	  
measurements	  on	  areas	  greater	  than	  100	  μm.	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Figure	  28.	  Comparison	  of	  the	  imaging	  “length	  scale”	  of	  many	  types	  2-­‐D	  and	  3-­‐D	  profiling	  and	  imaging	  instruments.	  An	  
AFM	  is	  capable	  of	  resolving	  features	  in	  the	  dimensions	  of	  a	  few	  nanometers	  with	  scan	  ranges	  up	  to	  a	  hundred	  microns.	  
Adapted	  from	  Eaton	  and	  West.	  242	  
	  
The	  length	  scale	  of	  an	  optical	  microscope	  overlaps	  nicely	  with	  an	  AFM.	  Thus,	  an	  AFM	  may	  
be	  combined	  with	  an	  optical	  microscope.	  With	  this	  combination	  it	   is	  possible	  to	  have	  a	  dynamic	  
field	   of	   view	   ranging	   from	   mm	   to	   nm.	   In	   practice,	   an	   optical	   microscope	   is	   typically	   used	   for	  
selecting	   the	   spot	   for	  AFM	  scanning.	  The	  AFM	   is	  most	  often	   compared	  with	   the	  electron	  beam	  
techniques	   such	  as	   the	  SEM	  or	  TEM.	   In	  general,	   it	   is	  easier	   to	   learn	   to	  use	  an	  AFM	  than	  a	  SEM	  
because	  there	  is	  minimal	  sample	  preparation	  required	  with	  an	  AFM.	  
A	  comparison	  between	  SEM/TEM	  and	  AFM	  follows:	  
Table	  V.	  Comparison	  of	  an	  AFM	  and	  SEM.	  Adapted	  from	  Eaton	  and	  West.242	  
	   SEM/TEM	   AFM	  
Samples	   Must	  be	  conductive	   Insulating/Conductive	  
Magnification	   2	  Dimensional	   3	  Dimensional	  
Environment	   Vacuum	   Vacuum/Air/Liquid	  
Time	  for	  image	   0.1-­‐1	  minute	   1-­‐5	  minute	  
Field	  of	  view	   100	  nm	  (TEM)	  
1mm	  (SEM)	  
100	  µm	  
Depth	  of	  field	   Good	   Poor	  
Contrast	  on	  flat	  samples	   Poor	   Good	  
	  
Although	  the	  time	  required	  for	  making	  a	  measurement	  with	  the	  SEM	  is	  typically	   less	  than	  
with	  an	  AFM,	  the	  amount	  of	  time	  required	  to	  get	  meaningful	  images	  is	  similar.	  This	  is	  because	  the	  
SEM/TEM	  often	  requires	  substantial	  time	  to	  prepare	  a	  sample.	  With	  the	  AFM	  little	  and	  often	  no	  
sample	  preparation	  is	  required.	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1.	  -­‐	  ABSTRACT	  
Helicobacter	  pylori	  (H.	  pylori)	  is	  one	  of	  the	  most	  common	  infectious	  agents	  in	  the	  world	  and	  
it	  is	  thought	  to	  colonize	  the	  gastric	  mucosa	  of	  about	  half	  of	  the	  world’s	  population	  causing	  several	  
gastric	  diseases.	   In	   this	  work,	   the	  effect	  of	   surface	   chemistry	  on	  H.	  pylori	   nonspecific	   adhesion,	  
viability	   and	   morphology	   was	   evaluated	   using	   three	   H.	   pylori	   strains	   with	   different	   adhesins	  
expression	  profile.	  Self-­‐assembled	  monolayers	  (SAMs)	  of	  alkanethiols	  on	  gold	  were	  used	  to	  obtain	  
surfaces	   exposing	   different	   functional	   groups:	   OH,	   CH3	   and	   ethylene	   glycol	   (EG4).	   Bacterial	  
adhesion	   onto	   the	   surfaces	   reached	   a	   plateau	   at	   2	   hours.	   There	   was	   a	   correlation	   between	  
adhesion	  and	  the	  exposed	  surface	  group,	  with	  bacterial	  cells	  adhering	  preferentially	  to	  CH3-­‐SAMs	  
while	  EG4-­‐SAMs	  prevented	  H.	  pylori	  adhesion	  during	  the	  entire	  adhesion	  test	  (24	  hours).	  Surfaces	  
that	  presented	  the	  EG4	  group	  were	  also	  the	  only	  ones	   that	  significantly	   reduced	  the	  viability	  of	  
adhered	  bacteria.	  Surface	  chemistry	  also	  influenced	  the	  morphology	  of	  adhered	  bacteria.	  The	  H.	  
pylori	  rod	  shape	  observed	  in	  the	  control	  (Tissue	  Culture	  Polyethylene	  -­‐	  TCPE)	  was	  only	  retrieved	  
on	  CH3-­‐SAMs.	  This	  work	  demonstrates	  that	  surface	  chemistry,	  namely	  specific	  functional	  groups	  
on	  the	  material,	   influence	  the	  nonspecific	  adsorption	  of	  H.	  pylori.	  Moreover,	  the	  features	  of	  the	  
bacterial	   strain	   and	   the	   surface	   chemistry	   can	   alter	   the	   adhesion	   kinetics,	   as	   well	   as	   the	  
morphology	  and	  viability	  of	  attached	  bacteria.	  
	  
Keywords:	   Bacterial	   adhesion,	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2.	  -­‐	  INTRODUCTION	  
Helicobacter	  pylori	   (H.	  pylori)	   is	  a	  spiral	  shaped	  Gram	  negative	  bacterium,	  which	  colonizes	  
the	  gastric	  mucosa,	  and	  was	  discovered	  by	  Warren	  and	  Marshall.1,2	  
H.	  pylori	  infection	  has	  an	  estimated	  prevalence	  of	  about	  half	  the	  world’s	  population3,	  making	  this	  
pathogen	   one	   of	   the	  most	   successful	   human	   pathogens.	   Infection	   by	   this	   bacterium	   has	   been	  
associated	  with	   increased	   risk	   for	   the	  development	  of	   gastritis,	   peptic	   ulcer	  disease	   and	  gastric	  
adenocarcinomas.4	  Since	  1994,	  H.	  pylori	   is	  classified	  by	  the	  International	  Agency	  for	  Research	  on	  
Cancer	  as	  a	  class	  I	  carcinogenic	  agent.	  
In	   the	   last	   years,	   an	   increase	   in	   antimicrobial	   resistance	   has	   led	   to	   the	   partial	   failure	   of	  
standard	   therapeutic	   treatments	   with	   antibiotics,	   mainly	   due	   to	   high	   frequency	   of	   resistant	  
bacteria,	   which	   differs	   between	   countries,	   and	   according	   to	   the	   H.	   pylori	   strain.5,6	   Alternative	  
treatments	  must	  be	  developed	  to	  counteract	  the	  problems	  faced	  when	  treating	  infection	  by	  this	  
pathogen.	  
The	  adhesion	  of	  the	  bacteria	  to	  the	  gastric	  mucosa	  is	  a	  key	  step	  in	  the	  establishment	  of	  a	  
successful	   infection.	   Glycan	   structures	   expressed	   by	   the	   gastric	   epithelial	   cells,	   including	  
fucosylated	  ABO	  blood	  group	  antigens7,8	  and	  glycans	  carrying	  charged	  groups	  such	  as	  sialic	  acid9,	  
have	   been	   identified	   as	   receptors	   for	   the	   bacterial	   adhesins.	   Among	   the	   large	   spectrum	   of	  H.	  
pylori	   putative	   adhesins,	   the	   receptor	   specificities	   have	   been	   described	   for	   two	   adhesins.	   The	  
blood	   group	   antigen	   binding	   adhesin	   (BabA)	   binds	   to	  H	   type-­‐1	   and	   Lewis	   b	   antigens,	  while	   the	  
sialic	   acid	   binding	   adhesin	   (SabA)	   recognizes	   the	   sialyl-­‐Lewis	   a	   and	   sialyl-­‐Lewis	   x	   antigens.9,10	  
Considering	   the	   crucial	   role	   of	   carbohydrate-­‐mediated	   H.	   pylori	   adhesion	   in	   infection,	   the	  
development	   of	   alternative	   strategies	   for	   inhibiting	   adhesion	   is	   an	   attractive	   therapeutic	  
approach.	  
Studies	  of	  nonspecific	  H.	  pylori	  adhesion	  to	  synthetic	  materials,	  such	  as	  polypropylene	  and	  
stainless	   steel11	   and	   to	   abiotic	   surfaces12	   have	   been	   reported.	   However,	   very	   little	   is	   known	  
regarding	   the	   effect	   of	   different	   surface	   chemistry	   on	   H.	   pylori	   adhesion,	   viability	   and	  
morphology.	   This	   study	   evaluated	   the	   effects	   of	   surface	   chemistry,	   using	   self-­‐assembled	  
monolayers	   (SAMs),	  which	   provide	   an	   effective	   approach	   to	   control	   the	   surface	   chemistry	   of	   a	  
material	   at	   the	  molecular	   level.13	   Particularly,	   alkanethiols	   self-­‐assemble	   into	  ordered	  arrays	  on	  
gold	   films,	   and	   the	  ω-­‐terminal	   groups	   determine	   the	   interfacial	   properties	   of	   the	   monolayers.	  
Several	   studies	   with	   proteins	   and	   cells	   have	   demonstrated	   the	   utility	   of	   using	   SAMs	   of	   long	  
alkanethiols	  on	  gold.14-­‐17	   The	  effect	  of	   the	   surface	   chemistry	  on	   the	  adhesion	  of	  other	  bacteria,	  
namely	   Pseudomonas	   sp18,	   Staphylococcus	   epidermidis19,	   20	   and	   aureus21	   and	   Escherichia	   coli22	  
have	  been	  widely	  studied	  using	  SAMs.	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In	  this	  study	  self-­‐assembled	  monolayers	  were	  used	  to	  evaluate	  the	  effect	  of	  defined	  surface	  
chemistries,	  including	  hydrophobic	  CH3-­‐SAMs,	  hydrophilic	  OH-­‐SAMs	  and	  typically	  non-­‐fouling	  and	  
protein	   resistant	   EG4-­‐SAMs,	   on	   the	   bacterial	   adhesion	   kinetics,	   as	   well	   as	   on	   the	   viability	   and	  
morphology	  of	  H.	  pylori	  strains	  with	  different	  expression	  profiles	  for	  specific	  adhesins.	  	  
3.	  -­‐	  METHODS	  
3.1.	  -­‐	  Self-­‐Assembled	  Monolayers	  (SAMs)	  
Gold	   substrates	   were	   prepared	   as	   described	   previously	   by	   our	   group.14	   Briefly,	   a	   5	   nm	  
chromium	  adhesion	   layer	   and	  a	  25	  nm	  gold	   layer	  were	  deposited	  by	   ion	  beam	  sputtering	   from	  
chromium	   and	   gold	   targets	   (99.9	  %	   purity)	   on	   silicon	  wafers	   (AUREL,	   Gmbh).	   The	   thin	   layer	   of	  
chromium	   improves	  adhesion	  of	  gold	   to	   silicon.	   Just	  before	  used,	  gold	   substrates	  were	  cleaned	  
with	   “piranha”	   solution	   (7	   parts	   of	   H2SO4	   and	   3	   parts	   of	   30	   %	   H2O2)	   for	   5	   min	   (caution:	   this	  
solution	   reacts	   violently	   with	   many	   organic	   materials	   and	   should	   be	   handled	   with	   care),	  
thoroughly	   rinsed	   with	   ethanol,	   and	   dried	   with	   a	   gentle	   argon	   stream.	   After	   cleaning,	   gold	  
substrates	  were	   immersed	   in	   the	   alkanethiol	   solutions	   prepared	   in	   ethanol	   (Merck,	   99.8	  %).	   1-­‐
Mercapto-­‐11-­‐undecyl	  tetra	  (ethylene	  glycol)	  (SH-­‐(CH2)11-­‐O-­‐(CH2-­‐CH2-­‐O)4-­‐H;	  EG4;	  Asemblon,	  99	  %),	  
1-­‐hexadecanethiol	   (SH-­‐(CH2)15CH3;	   CH3;	   Aldrich,	   92	   %;)	   and	   11-­‐mercapto-­‐1-­‐undecanol	   (SH-­‐
(CH2)11OH;	  OH;	  Aldrich,	   97	  %;)	  were	  used	  as	   received,	   in	  order	   to	  prepare	   alkanethiol	   solutions	  
with	  a	  concentration	  of	  0.1	  mM	  for	  EG4-­‐thiol	  and	  1	  mM	  for	  CH3-­‐	  and	  OH-­‐thiols.	  
The	   thiol	   self-­‐assembly	  was	   carried	   out	   at	   room	   temperature	   for	   24	   hours	   in	   a	   nitrogen	  
environment.	  The	  SAMs	  were	  then	  washed	   in	   fresh	  ethanol,	  dried	  with	  a	  gentle	  stream	  of	  pure	  
argon,	  and	  then	  maintained	  in	  an	  argon	  environment	  until	  use.	  
	  
3.2.	  -­‐	  Bacterial	  Strains	  
The	   H.	   pylori	   strains	   17875/Leb,	   17875babA1::kan	   babA2::cam	   (17875babA1A2)	   and	   J99	  
were	  obtained	   from	   the	  Department	  of	  Medical	  Biochemistry	   and	  Biophysics,	  Umeå	  University,	  
Sweden.	   These	   H.	   pylori	   strains	   have	   been	   previously	   characterized	   regarding	   BabA	   and	   SabA	  
expression.8-­‐10,23	  The	  17875/Leb	  and	  J99	  strains	  express	  both	  BabA	  and	  SabA	  adhesins	  while	  the	  
17875babA1A2	  mutant	  strain	  only	  expresses	  the	  SabA	  adhesin.	  The	  H.	  pylori	  17875/Leb	  although	  
expressing	  both	  adhesins	  is	  a	  spontaneous	  mutant	  unable	  to	  bind	  to	  sialylated	  antigens.9	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3.3.	  -­‐	  Bacterial	  Culture	  and	  Growth	  Curve	  
H.	  pylori	   strains	  were	   routinely	   cultured	   in	  Trypticase	  Soy	  Agar	  plates	   supplemented	  with	  
5%	  sheep	  blood	  (BioMérieux),	  in	  a	  microaerophilic	  environment	  at	  37	  °C	  for	  48	  hours.	  Afterwards,	  
some	   colonies	  were	   transferred	   to	   Pylori	   Agar	   plates	   (BioMérieux)	   and	   incubated	   for	   24	   hours	  
under	  identical	  conditions.	  
For	  each	  strain,	  growth	  curves	  were	  performed	  in	  three	  independent	  experiments.	  Colonies	  
from	   Pylori	   Agar	   plates	   were	   harvested	   with	   liquid	   medium	   composed	   of	   BHI	   (Brain	   Heart	  
Infusion;	   Oxoid)	   with	   an	   antibiotic	   cocktail	   of	   Polymixine	   B,	   Vancomycin,	   Anphotericin	   B	   and	  
Trimethroprim	  (Sigma)	  and	  supplemented	  with	  inactivated	  Fetal	  Bovine	  Serum	  (Lonza).	  The	  initial	  
optical	   density	   of	   each	   bacteria	   strain	   was	   adjusted	   to	   0.1	   in	   the	   referred	   media	   (λ=600	   nm)	  
(Shimadzu	   UV-­‐1201).	   T-­‐flasks	   containing	   media	   and	   bacterial	   inoculums	   were	   incubated	   with	  
agitation	   (150	   rpm)	   at	   37	   °C	   under	   microaerobic	   conditions	   in	   an	   anaerobic	   jar	   with	   a	   carbon	  
dioxide	   generator	   without	   catalyst.	   At	   different	   time	   points	   samples	   were	   taken	   and	   optical	  
density	  was	  measured	  at	  λ=600	  nm.	  
In	   order	   to	   correlate	   the	   values	   obtained	   when	   performing	   the	   culture	   in	   liquid	   media	  
versus	  in	  solid	  media,	  colony-­‐forming	  units	  (CFU)	  were	  counted	  in	  Pylori	  Agar	  plates	  at	  different	  
time	  points	   for	  both	  culture	  conditions.	  Bacteria	  were	  harvested	   from	  solid	  and	   liquid	  media	  at	  
different	  time	  points,	  serial	  dilutions	  were	  done	  (10-­‐2	  until	  10-­‐7)	  and	  10	  µL	  of	  each	  dilution	  plated	  
in	   Pylori	   Agar.	   Incubation	   was	   done	   as	   previously	   referred.	   The	   number	   of	   colonies	   was	  
determined	  after	  72	  hours.	  
	  
3.4.	  -­‐	  Bacterial	  adhesion	  	  
Bacteria	  were	  harvested	  from	  Pylori	  Agar	  plates	  with	  sterile	  PBS	  (phosphate	  buffer	  saline;	  
pH	   7.4;	   Sigma).	   Before	   incubation	  with	  H.	   pylori	   strains,	   the	   SAMs	   (EG4-­‐;	   OH-­‐;	   CH3-­‐SAMs)	   and	  
bare	  gold	  were	  hydrated	  with	  sterile	  PBS	  for	  15	  min.	  Bacterial	  suspensions	  with	  an	  optical	  density	  
of	  0.080	  were	  mixed	  with	  PBS	  in	  the	  wells	  to	  achieve	  a	  final	  optical	  density	  of	  0.040	  (~107	  cfu/mL).	  
Bacterial	   concentration	  was	   selected	   based	  on	  previous	  work	   by	  Azevedo	  et	   al.11	   Incubation	   of	  
bacteria	  with	  the	  surfaces	  was	  done	  at	  37	  °C,	  and	  plates	  were	  agitated	  at	  120	  rpm	  for	  5	  min;	  10	  
min;	  15	  min;	  30	  min;	  1	  hour;	  2	  hours;	  6	  hours;	  12	  hours;	  and	  24	  hours.	  After	   incubation,	  SAMs	  
were	  rinsed	  3	   times	  with	  PBS	   to	   remove	  non-­‐adherent	  bacteria	  and	  then	   fixed	  with	  4%	  (v/v)	  p-­‐
formaldehyde.	   Bacteria	   were	   labelled	   with	   10	   µg/mL	   DAPI	   (4',6-­‐Diamidino-­‐2-­‐phenylindole	  
dihydrochloride;	  Sigma)	  for	  30	  minutes	  and	  mounted	  with	  Vectashield®	  Mounting	  Medium	  (Vector	  
Laboratories).	  Adherent	  bacteria	  were	  visualized	  with	  an	  Inverted	  Fluorescence	  Microscope	  (Zeiss	  
Axiovert	   200	   MOT),	   at	   630x	   magnification.	   Bacterial	   counts	   were	   performed	   based	   on	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photographs	   from	   6	   random	   fields	   per	   sample	   (Area=35272.18	   µm2)	   and	   were	   expressed	   as	  
number	  of	  bacteria/m2.	  Results	  are	  representative	  of	  3	  independent	  assays	  using	  4	  replicates	  for	  
each	  condition.	  
	  
3.5.	  -­‐	  Bacterial	  viability	  
The	   viability	   of	   surface-­‐attached	   bacteria	   was	   accessed	   using	   BacLight	   Kit	   (Invitrogen).	  
SAMs	  and	  TCPE	  (Tissue	  Culture	  Polyethylene,	  Sarstedt)	  were	  incubated	  with	  each	  H.	  pylori	  strain,	  
with	  the	  same	  optical	  density	  as	  described	  for	  bacterial	  adhesion	  assays.	  The	  incubation	  was	  for	  2	  
hours	  at	  120	  rpm	  and	  37	  °C.	  After	   incubation,	  samples	  were	  rinsed	  three	  times	  with	  sterile	  PBS	  
and	   the	   procedure	   was	   continued	   according	   BacLight	   Kit	   manufacter’s	   protocol	   (Invitrogen).	  
Bacteria	   were	   visualized	   with	   an	   Inverted	   Fluorescence	  Microscope,	   under	   400x	  magnification,	  
and	   were	   counted	   in	   4	   random	   fields	   per	   sample.	   For	   each	   strain	   and	   surface	   four	   replicate	  
samples	  were	  counted.	  
	  
3.6.	  -­‐	  Bacterial	  morphology	  (Scanning	  Electron	  Microscopy)	  
Bacterial	  morphology	  was	   imaged	   after	   adhesion	   onto	   gold,	   TCPE	   and	   SAMs	  by	   Scanning	  
Electron	   Microscope	   (SEM;	   JEOL	   JSM-­‐6310F),	   at	   magnifications	   of	   5000x	   and	   20000x.	   Bacteria	  
were	  incubated	  with	  SAMs	  as	  previously	  described	  for	  5	  min;	  15	  min;	  30	  min;	  1	  hour	  and	  2	  hours.	  
After	   incubation,	   the	   samples	   were	   rinsed	   three	   times	   with	   sterile	   PBS,	   fixed	   with	   1.5	   %(v/v)	  
glutaraldehyde	   (Merck)	   in	   0.14	   M	   sodium	   cacodylate	   (Merck),	   dehydrated	   with	   an	   increasing	  
ethanol/water	  gradient	   (50	  %	  v/v	   to	  99	  %	  v/v),	  and	   then	  subjected	   to	  critical	  point	  drying	   (CPD	  
7501,	  Polaron).	  TCPE	  samples	  were	  coated	  with	  a	  gold/palladium	  film	  over	  100	  seconds.	  
	  
3.7.	  -­‐	  H.	  pylori	  contact	  angle	  measurements	  
The	  water	  contact	  angle	  of	   the	  different	  H.	  pylori	   strains	  was	  determined	  using	  a	  contact	  
angle	  measuring	  system	  from	  Data	  Physics,	  model	  OCA	  15,	  equipped	  with	  a	  electronic	  syringe,	  a	  
video	   CCD-­‐camera	   and	   SCA	   20	   software.	   The	   contact	   angle	  measurements	   were	   performed	   at	  
room	   temperature	   (25	   °C)	  using	   the	   sessile	  drop	  method	  with	  Milli-­‐Q	   (Millipore)	  water.	  Briefly,	  
bacteria	  were	  cultured	  as	  referred	  before	  and	  were	  harvested	  from	  Pylori	  Gelose	  with	  sterile	  PBS.	  
Measurements	  were	  performed	  on	  bacterial	   layers	  deposited	  on	  membrane	   filters	  according	   to	  
the	  method	  described	  by	  Busscher	  et	  al.24	  Since	  subsequent	  dehydration	  of	  the	  filters,	  because	  of	  
evaporation	  of	  water,	  was	  expected	  to	  influence	  the	  results,	  water	  contact	  angles	  were	  measured	  
after	  20	  min	  of	  drying	  time.	  Results	  were	  expressed	  as	  average	  values	  of	  four	  measurements.	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3.8.	  -­‐	  Zeta	  Potential	  Determination	  
3.8.1.	  -­‐	  H.	  pylori	  
The	  zeta	  potential	  of	  different	  H.	  pylori	   strains	  was	  determined	  using	  a	  Zetasizer	  Nano	  ZS	  
(Malvern	   Instruments,	  U.K.)	  equipped	  with	  a	  4	  mW	  HeNe	   laser	  beam	  with	  a	  wavelength	  of	  633	  
nm	   and	   a	   scattering	   angle	   of	   173°.	   Bacteria	   were	   cultured	   as	   previously	   described	   and	   were	  
harvested	   from	   Petri	   plates	   with	   sterile	   PBS	   and	   used	   in	   a	   concentration	   of	   107	   cfu/mL.	  
Measurements	  were	  performed	  at	  37	  °C	  in	  polycarbonate	  folded	  capillary	  cells	  incorporated	  with	  
gold	   plated	   electrodes	   (DTS1060C)	   in	   PBS,	   using	   the	   “Auto-­‐mode”	   analysis	   model.	   The	   zeta	  
potentials	   were	   automatically	   calculated	   using	   the	   Henry	   equation	   with	   the	   Smoluchowski	  
approximation.	   Values	   are	   reported	   as	   average	   based	   on	   three	   individual	   measurements.	   The	  
results	  were	  further	  corrected	  to	  PBS	  as	  the	  dispersant	  agent,	  using	  the	  Software	  DTS	  Nano	  v.6.20	  
to	  estimate	  the	  Viscosity,	  Dielectrical	  constant	  and	  Refraction	  index	  from	  water.	  
	  
3.8.2.	  -­‐	  SAMs	  
Zeta	   potential	   of	   SAMs	   was	   determined	   from	   streaming	   potential	   measurements	   with	   a	  
commercial	  electrokinetic	  analyzer	  (EKA)	  (Anton	  Paar	  GmbH,	  Austria)	  using	  a	  special	  rectangular	  
cell	  for	  small	  flat	  samples,	  with	  a	  variable	  channel	  height	  as	  previously	  described.25	  
Two	   samples	   (1x1	   cm)	  were	   glued	   on	   each	   poly-­‐methyl	  methacrylate	   (PMMA)	   block	   and	  
mounted	  in	  parallel	  on	  each	  side	  of	  the	  cell	  creating	  a	  rectangular	  (2	  x	  1	  cm2)	  slit	  channel	  between	  
the	   sample	   surfaces.	   The	   height	   of	   the	   slit	   channel	   was	   maintained	   constant	   for	   all	   the	  
measurements	   using	   a	   micrometer	   screw.	   Streaming	   potential	   was	   measured	   using	   Ag/AgCl	  
electrodes	   installed	  at	  both	  ends	  of	   the	   streaming	  channel.	  The	  electrolyte	  used	  was	  1	  mM	  KCl	  
(Sigma–Aldrich)	  with	  the	  pH	  of	  7.4	  ±	  0.1.	  Experiments	  were	  performed	  at	  25	  °C.	  The	  conductivity	  
of	  the	  electrolyte	  solution	  was	  measured	  during	  the	  assay.	  The	  streaming	  potential	  was	  measured	  
while	   applying	   an	   electrolyte	   flow	   in	   alternating	   directions	   and	   pressure	   ramps	   from	   0	   to	   400	  
mbar.	  For	  each	  surface,	  six	  pressure	  ramps	  were	  performed	  (three	  in	  each	  flow	  direction)	  and	  in	  
triplicates.	  The	  Smoluchowski	  model	  was	  applied	  for	  zeta	  potential	  determination.	  
	  
3.9.	  -­‐	  Atomic	  Force	  Microscopy	  (AFM)	  
AFM	   measurements	   of	   SAMs	   were	   performed	   using	   an	   Agilent	   5500	   PicoPlus	   scanning	  
probe	  microscope.	  Each	  sample	  was	  imaged	  with	  a	  10	  x	  10	  µm2	  piezoscanner.	  Image	  Acquisition	  
was	  done	  using	  Tapping	  Mode®,	  in	  air	  and	  at	  room	  temperature	  (25	  °C).	  A	  silicon	  nitride	  cantilever	  
FORT	   model	   (AppNano,	   USA)	   was	   used	   with	   a	   spring	   constant	   of	   1–5	   N/m	   (according	   to	   the	  
manufacture	   information).	   Images	  and	   the	   surface	   roughness	   (Sa)	  were	  obtained	   from	  scanned	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areas	   of	   2500	   x	   2500	   nm2	   on	   three	   randomly	   chosen	   locations	   for	   each	   sample.	   Results	   were	  
expressed	  as	  Roughness	  average	  (Sa),	  which	  was	  calculated	  using	  the	  WSxM	  v5.0	  software.26	  
	  
3.10.	  -­‐	  Statistics	  
The	   experimental	   results	   were	   presented	   as	   mean	   values	   and	   standard	   deviation.	   The	  
significance	   of	   differences	   between	   mean	   values	   was	   assessed	   using	   a	   one-­‐way	   ANOVA	   or	  
independent	  T	  sample	  test	   (SPSS	  Software).	  Significance	  was	  defined	  at	  p	  <0.05.	  Mann-­‐Whitney	  
test	   was	   applied	   to	   analyze	   bacterial	   water	   contact	   angle,	   bacterial	   Zeta	   Potential	   and	   AFM	  
results.	  
	  
4.	  -­‐	  RESULTS	  
4.1.	  -­‐	  Bacterial	  Growth	  Curve	  
Growth	   curves	   were	   obtained	   for	   the	   three	  H.	   pylori	   strains	   used	   in	   these	   experiments.	  
Different	  phases	  that	  compose	  a	  growth	  curve,	  Latency	  (1),	  Exponential	  Growth	  (2),	  Stationary	  (3)	  
and	  Death	  (4),	  are	  illustrated	  in	  Figure	  1.	  H.	  pylori	  J99	  showed	  a	  higher	  growth	  compared	  to	  the	  
other	  two	  strains.	  Both	  H.	  pylori	  17875/Leb	  and	  17875	  babA1A2	  had	  a	  similar	  behavior.	  H.	  pylori	  




Fig.1	   -­‐	   Bacterial	   growth	   curve	   of	   H.	   pylori	   J99,	   H.	   pylori	   17875/Leb	   and	   H.	   pylori	   17875	   babA1A2	   (1)	   Latency;	   (2)	  
Exponential	  Growth;	  (3)	  Stationary;	  (4)	  Death.	  
	  
Figure	  2	  shows	  the	  same	  growth	  tendency	  in	  both	  liquid	  and	  solid	  media	  for	  all	  the	  H.	  pylori	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strains	  when	  bacteria	  were	  grown	  in	  solid	  media.	  Considering	  growth	  in	  liquid	  media,	  there	  were	  
some	   differences	   in	   the	   number	   of	   CFUs,	   namely	   for	   J99	   strain,	   which	   presented	   a	   lower	   CFU	  
number.	  Adhesion	  tests	  were	  performed	  with	  bacteria	  grown	  from	  solid	  medium	  with	  inocula	  of	  




Fig.2	  -­‐	  Correlation	  between:	  optical	  density	  and	  CFU	  in	  liquid	  and	  solid	  media.	  (a)	  H.	  pylori	  J99;	  (b)	  H.	  pylori	  17875/Leb;	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4.2.	  -­‐	  Kinetics	  of	  bacterial	  adhesion	  to	  SAMs	  
The	   kinetics	   of	  H.	   pylori	   adhesion	   to	   gold	   and	   SAMs	   are	   illustrated	   in	   Figure	   3	   (a-­‐f).	   The	  
kinetics	  of	  adhesion	  was	  evaluated	  for	  the	  adhesion	  of	  the	  three	  bacteria	  strains	  (J99,	  17875/Leb	  
and	  17875	  babA1A2)	  to	  the	  different	  surfaces	  for	  up	  to	  24	  hours.	  The	  surface	  coatings	  used	  and	  
their	  properties	  have	  been	  previously	  described.15,16,27	  These	  substrates	  had	  different	  wetabilities,	  
ranging	  from	  more	  hydrophilic	  OH-­‐SAMs	  to	  more	  hydrophobic	  CH3-­‐SAMs,	  as	  described	  at	  Table	  1.	  
Regardless	  of	  the	  H.	  pylori	   strain	  used,	  adhesion	  onto	  EG4-­‐SAMs	  was	  extremely	   low	  at	  all	  
times	  up	  to	  24	  hours,	  in	  accordance	  with	  the	  general	  non-­‐fouling	  nature	  of	  EG4-­‐SAMs.17,22,28	  
The	   initial	   rate	   of	   adhesion	   of	   the	   J99	   strain	   to	   bare	   gold,	   OH-­‐	   and	   CH3-­‐SAMs	   prior	   to	  
plateauing	  at	  2	  hours,	  is	  fast	  (Figure	  3b).	  After	  2	  hours,	  cell	  adhesion	  was	  unchanged	  for	  at	  least	  
24	  hours	  (Figure	  3a).	  
The	  adhesion	  kinetics	  of	  the	  17875/Leb	  strain	  to	  bare	  gold,	  OH-­‐	  and	  CH3-­‐SAMs	  was	  similar	  
to	   the	   J99	   strain,	   and	   demonstrated	   a	   rapid	   increase	   up	   to	   a	   plateau	   at	   2	   hours	   (Figure	   3d).	  
However,	  at	  12	  hours,	  there	  was	  a	  decrease	  of	  bacterial	  adhesion	  on	  bare	  gold	  and	  on	  OH-­‐SAMs.	  
The	  number	  of	  cells	  attached	  to	  CH3-­‐SAMs	  remained	  stable	  until	  the	  end	  of	  the	  assay	  (24	  hours)	  
(Figure	  3c).	  
The	   kinetics	   of	   adhesion	   of	   the	   17875	   babA1A2	   strain	   to	   bare	   gold,	   OH	   and	   CH3-­‐SAMs	  
differed	  from	  the	  other	  two	  strains	  studied,	  because	  the	  number	  of	  attached	  bacteria	  plateaued	  
after	  2	  hours	  only	  on	  OH-­‐SAMs	  (Figure	  3e).	  The	  number	  of	  attached	  bacteria	  on	  bare	  gold	  after	  2	  
hours	  decreased,	  whereas	  the	  number	  attached	  to	  CH3-­‐SAMs	  continued	  to	  increase	  until	  the	  end	  
of	  the	  assay	  at	  24	  hours.	  Nevertheless,	  during	  the	  first	  2	  hours,	  the	  adhesion	  kinetics	  of	  H.	  pylori	  
17875	  babA1A2	  was	  similar	  with	  the	  other	  H.	  pylori	  strains	  used	  (Figure	  3f).	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Fig.3	   -­‐	  Adhesion	  kinetics	  of	  H.	  pylori	   	  to	  SAMs	  and	  gold.	  (a)	  H.	  pylori	  J99	  adhesion	  kinetics	  up	  to	  24h;	  (b)	  H.	  pylori	  J99	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Fig.3	  (continuation)	  -­‐	  Adhesion	  kinetics	  of	  H.	  pylori	  	  to	  SAMs	  and	  gold.	  (c)	  H.	  pylori	  17875/Leb	  adhesion	  kinetics	  up	  to	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Fig.3	  (continuation)	  -­‐	  Adhesion	  kinetics	  of	  H.	  pylori	  	  to	  SAMs	  and	  gold.	  (e)	  H.	  pylori	  17875	  babA1A2	  adhesion	  kinetics	  up	  
to	  24h;	  (f)	  H.	  pylori	  17875	  babA1A2	  adhesion	  kinetics	  until	  2h.	  
	  
Table	  I-­‐	  Water	  contact	  angle,	  Zeta	  potential	  and	  surface	  roughness	  results	   






Surface	   Au	   63	  ±	  3	  14	   -­‐44	  ±	  4	  	   0.65	  ±	  0.10	  
	   EG4-­‐SAMs	   38	  ±	  1	  17	   -­‐38	  ±	  7	  (*)	   0.60	  ±	  0.06	  
	   OH-­‐SAMs	   18	  ±	  1	  14	   -­‐38	  ±	  6	  (*)	   0.58	  ±	  0.05	  
	   CH3-­‐SAMs	   107	  ±1	  14	   -­‐43	  ±	  10	   0.76	  ±	  0.28	  
H.	  pylori	  strain	   J99	   50	  ±	  2(**)	   -­‐7	  ±	  2	   ______	  
	   17875/Leb	   53	  ±	  3	   -­‐7	  ±	  1	   ______	  
	   17875	  babA1A2	   57	  ±	  4(**)	   -­‐7	  ±	  1	   ______	  
(*)	  Significantly	  different	  from	  Au	  (p	  <0.05)	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The	   number	   of	   bacteria	   attached	   for	   all	   three	   strains	   of	   H.	   pylori	   to	   bare	   gold	   (control	  
surface)	  and	  model	  surfaces	  (SAMs)	  at	  2	  hours	  is	  shown	  in	  Figure	  4.	  Adhesion	  to	  EG4-­‐SAMs	  was	  
very	  low	  for	  all	  bacterial	  strains	  used.	  With	  exception	  of	  the	  17875/Leb	  strain,	  bacterial	  adhesion	  
was	  higher	  on	  CH3-­‐SAMs.	  The	  number	  of	  attached	  17875/Leb	  bacteria	  was	  higher	  on	  gold	  and	  on	  
OH-­‐SAMs,	  followed	  by	  CH3-­‐SAMs,	  and	  finally	  EG4-­‐SAMs.	  The	  17875	  babA1A2	  strain	  was	  the	  only	  
strain	  that	  exhibited	  different	  adhesion	  levels	  at	  2	  hours	  to	  all	  of	  the	  surfaces	  tested	  compared	  to	  




Fig.4	  -­‐	  H.	  pylori	  adhesion	  to	  model	  surfaces	  and	  gold	  at	  2h.	  #	  -­‐	  Significantly	  different	  from	  Au	  (p	  ≤	  0,05)	  *-­‐	  Significantly	  
different	  (p	  ≤	  0,05).	  
	  
4.3.	  -­‐	  Bacterial	  Viability	  on	  SAMs	  
The	   comparison	   of	   bacterial	   viability	   after	   2	   hours	   of	   adhesion	   to	  model	   surfaces	   versus	  
adhesion	   to	  TCPE	   (control	   surface)	   is	   shown	   in	  Figure	  5.	  Viability	  was	  defined	  as	   the	  number	  of	  
live	  attached	  bacterial	  cells	  to	  total	  adhered	  cells.	  
The	  different	  strains	  exhibited	  no	  statistically	  significant	  differences	   in	  viability;	  EG4-­‐SAMs	  
were	  the	  only	  coatings	   that	  showed	  a	  significant	  decrease	   in	  bacterial	  viability,	  when	  compared	  
with	   TCPE,	   which	   is	   the	   control	   surface.	   The	   viability	   of	   the	   attached	   bacteria	   decreased	   from	  
approximately	  80	  %	  on	  TCPE	  to	  50	  %	  on	  EG4-­‐SAMs.	  These	  results	  demonstrated	  that	  the	  viability	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Fig.5	  -­‐	  H.	  pylori	  viability	  on	  model	  surfaces	  at	  2h.	  #	  -­‐	  Significantly	  different	  from	  TCPE	  (p	  ≤	  0,05).	  
	  
4.4.	  -­‐	  Bacterial	  Morphology	  on	  SAMs	  
The	  influence	  of	  the	  bacterial	  adherence	  to	  the	  model	  surfaces	  (bare	  gold;	  EG4-­‐;	  CH3-­‐	  OH-­‐
SAMs	  and	  TCPE)	  on	  the	  cell	  morphology	  was	  also	  evaluated.	  Altering	  morphology	  is	  an	  adaptive	  
response	  that	  occurs	  in	  order	  to	  overcome	  stress	  conditions	  and	  to	  enable	  survival	  under	  adverse	  
conditions.	  SEM	  images	  of	  bacterial	  morphology	  were	  obtained	  over	  time	  for	  the	  different	  strains	  
when	  attached	  to	  different	  surfaces.	  
Figure	  6	  shows	  H.	  pylori	  J99	  strain	  adhered	  to	  different	  surface	  coatings.	  The	  morphologies	  
of	  all	  bacterial	  strains	  in	  the	  different	  model	  surfaces	  evaluated	  were	  similar,	  so	  that	  these	  images	  
are	  representative	  of	  all	  three	  H.	  pylori	  strains	  tested.	  
	  
Fig.	   6	   -­‐	  H.	  pylori	   J99	  morphology	  when	   in	  contact	  with	  bare	  gold;	  EG4-­‐;	  CH3-­‐;	  OH-­‐SAMs	  and	  TCPE,	  at	  5	  min	  and	  2	  hr	  
adhesion	  times.	  
Obs:	  A	  small	  number	  of	  pits	  with	  a	  diameter	   lower	   than	  100	  nm	  were	  always	  observed	   in	  all	   samples.	  The	  “pattern”	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The	  different	  surface	  coatings	  did	  influence	  the	  morphologies	  of	  bacteria	  when	  they	  were	  
adhered	   to	   the	   substrate	   surfaces.	  On	   gold,	   none	  of	   the	   adhered	  bacteria	   exhibited	   the	   typical	  
spiral	   shape	   that	   is	   characteristic	  of	   this	  pathogen.	   For	   the	  H.	  pylori	   strains	   tested	   few	  bacteria	  
adhered	  to	  the	  EG4-­‐SAMs.	  Bacteria	  adherent	  to	  CH3-­‐SAMs	  exhibited	  spiral	  shapes	  in	  co-­‐existence	  
with	  coccoid	  H.	  pylori.	  On	  OH-­‐SAMs,	  attached	  bacteria	  were	  all	  in	  coccoid	  form	  during	  the	  entire	  
range	   of	   time.	   On	   the	   control	   TCPE	   substrate,	   both	   spiral	   and	   coccoid	   bacterial	   forms	   were	  
observed.	  
	  
4.5.	  -­‐	  H.	  pylori	  water	  contact	  angle	  determination	  
Water	  contact	  angles	  for	  each	  H.	  pylori	  strain	  used	  are	  described	  at	  Table	  1.	  Similar	  values	  
were	   obtained	   for	   the	   three	   strains	   used,	   although	   there	   is	   a	   lower	  water	   contact	   angle	   of	  H.	  
pylori	   J99	   comparing	   to	   H.	   pylori	   17875babA1A2	   (p<0.05).	   H.	   pylori	   17875/Leb	   and	   H.	   pylori	  
17875babA1A2	   are	   both	   variants	   of	   the	   CCUG17875	   strain	   so	   share	   the	   same	   genetic	  
background.8-­‐10	  Therefore,	   it	   is	  not	   surprising	   that	  no	  differences	  were	  observed	  between	  these	  
two	  strains.	  
	  
4.6.	  -­‐	  Zeta	  Potential	  Determination	  
Regarding	   H.	   pylori	   strains,	   as	   expected,	   the	   surface	   potential	   for	   bacterial	   cells	   was	  
negative	  (Table	  I).29-­‐31	  No	  significant	  differences	  were	  observed	  between	  the	  three	  strains	  used	  in	  
our	  study.	  
Table	  I	  encloses	  the	  average	  zeta	  potential	  of	  gold	  and	  SAMs	  used	  in	  this	  work.	  Both	  gold	  
and	  SAMs	  were	  stable	  at	   the	  experimental	   conditions	  and	  gave	   reproducible	   results.	   Significant	  
differences	   (p<	   0.05)	  were	  observed	  between	  gold	  and	  EG4-­‐	  and	  OH-­‐SAMs.	  Despite	   statistically	  
significant	  differences	  were	  observed,	  values	  can	  be	  considered	  close	  enough	  and	  therefore	  can	  
not	  be	  accounted	  for	  the	  differences	  observed	  in	  bacterial	  adhesion	  to	  our	  model	  surfaces.	  
	  
4.7.	  -­‐	  Atomic	  Force	  Microscopy	  (AFM)	  
Surface	  Roughness	  average	  (Sa)	  of	  all	  the	  surfaces	  used	  are	  described	  at	  Table	  I.	  Statistically	  
significant	  differences	  were	  not	  observed	  between	  gold	  surface	  and	  SAMs.	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5.	  -­‐	  DISCUSSION	  
It	  is	  well	  known	  that	  bacterial	  adherence	  to	  materials	  is	  influenced	  by	  the	  surface	  chemical	  
and	   physical	   properties.	   The	   main	   objective	   of	   this	   study	   was	   to	   identify	   surface	   chemical	  
properties	  that	  impact	  nonspecific	  adhesion	  by	  H.	  pylori.	  
Self-­‐assembled	   monolayers	   (SAMs)	   of	   alkanethiols	   on	   gold	   are	   convenient	   and	   versatile	  
platforms	   for	  addressing	   this	   issue.	  Here,	  we	  used	  hydrophobic	  CH3-­‐SAMs	   (water	  contact	  angle	  
(θw	  >	  107°),	  hydrophilic	  OH-­‐SAMs	  (θw	  <	  20°)	  and	  typically	  non-­‐fouling	  and	  protein	  resistant	  EG4-­‐
SAMs.17,28,32	   The	  differences	  between	   these	   SAMs,	   regarding	   surface	   charge	   and	   roughness,	   are	  
very	  low	  (Table	  1).	  As	  expected,	  the	  values	  obtained	  for	  the	  surfaces	  zeta	  potential	  determination	  
are	  negative	  due	  to	  the	  influence	  of	  the	  gold	  support	  layer,	  being	  this	  described	  previously.33	  The	  
value	  for	  EG4-­‐SAMs	  is	  lower	  than	  the	  one	  obtained	  by	  Martins	  et	  al34	  (-­‐24	  ±0.9	  mV),	  which	  can	  be	  
explained	  by	  the	  different	  pH	  at	  which	  data	  was	  acquired	  (5.5),	  since	  this	  parameter	  affects	  the	  
zeta	  potential	  values.35	  The	  three	  H.	  pylori	  strains	  used	  were	  also	  characterized	  according	  to	  their	  
surface	  charge	  and	  wettability.	  No	  differences	  were	  observed	  between	  their	  surface	  charges	  and	  
obtained	   values	   are	   in	   accordance	   with	   others	   previously	   reported	   for	   other	   bacteria.36,37	  
Concerning	  wettability,	  values	  obtained	  were	  fairly	  similar	  (Table	  I),	  ranging	  from	  50°	  to	  57°	  and	  
cannot	  explain	  the	  differences	  found	  on	  bacterial	  adhesion	  to	  SAMs.	  H.	  pylori	  demonstrated	  to	  be	  
more	   hydrophobic	   than,	   for	   instance,	   S.	   epidermidis	   ATCC	   35984	   (23°)38,	   Serratia	   marcescens	  
ATCC	  13880	   (23°)36	  or	   Pseudomonas	  aeruginosa	  ATCC	  10145	   (24°).37	  Hydrophobic	  bacteria	  have	  
also	  been	  reported,	  such	  as	  P.	  aeruginosa	  #3,	  with	  a	  water	  contact	  angle	  of	  132°.36	  
Bare	  gold	  films	  were	  used	  as	  a	  control	  in	  the	  adhesion	  assay.	  As	  expected	  accordingly	  to	  its	  
non-­‐fouling	  properties,	  few	  bacteria	  adhered	  to	  EG4-­‐SAMs	  up	  to	  24	  hours,	  independent	  of	  the	  H.	  
pylori	   strain	   tested.	   Our	   findings	   showing	   that	   the	   different	  H.	   pylori	   strains	   did	   not	   adhere	   to	  
EG4-­‐SAMs	   are	   in	   accordance	   with	   previous	   studies	   describing	   similar	   resistance	   to	   nonspecific	  
protein17	  and	  bacterial	  adsorption.39-­‐41	  These	   results	   suggest	   the	  potential	  of	  using	  EG4-­‐SAMs	  to	  
immobilize	  different	  candidate	  ligands	  of	  H.	  pylori	  because	  all	  the	  observed	  interactions	  could	  be	  
exclusively	  attributed	  to	  the	  immobilized	  structures.	  
Initial	   bacterial	   adherence	   to	   the	   surfaces	   occurred	  within	   the	   first	  minutes	   of	   the	   assay.	  
Only	  H.	  pylori	   adhesion	   to	  EG4-­‐SAMs	  demonstrated	   to	  be	   statistically	   lower	  when	  compared	   to	  
other	  model	  surfaces,	  being	  this	  difference	  observed	  as	  soon	  as	  adhesion	  time	  of	  5	  min	  (p	  <	  0.05;	  
ANOVA).	  The	  fast	  bacterial	  adhesion	  within	  the	  first	  minutes	  is	  in	  agreement	  with	  the	  previously	  
described	  rapid	  adhesion	  of	  H.	  pylori	  to	  a	  human	  gastric	  adenocarcinoma	  epithelial	  cell	  line	  (AGS	  
cell	  line)	  in	  vitro.42	  The	  number	  of	  bacteria	  adhering	  to	  SAMs	  increased	  with	  time	  up	  to	  a	  limiting	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plateau,	  which	  was	  reached	  at	  2	  hours	  as	  described	  elsewhere.43	  The	  exception	  is	  the	  adhesion	  of	  
the	  17875babA1A2	  strain	  since	  adhesion	  kept	  rising	  until	  the	  end	  of	  the	  assay	  (24	  hours).	  
The	  H.	  pylori	   strains	  did	  exhibit	  differences	   in	   their	  nonspecific	  adhesion	   to	   the	  CH3-­‐	  and	  
OH-­‐terminated	   SAMs.	   J99	   and	   17875babA1A2	   showed	   greater	   adhesion	   to	   hydrophobic	   CH3-­‐
SAMs	  after	  2	  hours.	  This	  may	  be	  explained	  qualitatively	  since	  the	  adhesion	  energy	  depends	  on	  the	  
surface	   tensions	   of	   bacteria,	   substrate,	   and	   solvating	   medium	   (PBS).39	   According	   to	   the	  
thermodynamic	   theory44	   for	   two	   surfaces	   to	   come	   together,	   resulting	   in	   adhesive	   molecular	  
interactions,	   adsorbed	   water	   must	   be	   displaced.	   If	   the	   surface	   is	   highly	   hydrated,	   such	   water	  
displacement	   is	   energetically	   unfavorable	   and	   may	   be	   impossible	   to	   overcome	   by	   the	  
counteracting	   attractive	   interactions.20	   Therefore,	   increasing	   substrate	   hydrophobicity	   favors	  
bacterial	  adhesion,	  which	  corresponds	   to	   the	  hydrophobic	  CH3-­‐SAMs.	  The	  opposite	  occurs	  with	  
hydrophilic	   surfaces	   (OH-­‐SAMs).	   Hydrophilic	  materials	   are	   reportedly	  more	   resistant	   to	   protein	  
adsorption45	  and	  bacterial	  adhesion39	  than	  hydrophobic	  materials.	  
By	  contrast,	  after	  2	  hours,	  adherence	  by	  the	  17875/Leb	  strain	  was	  highest	  on	  gold	  (control	  
surface)	   and	   on	  OH-­‐SAMs,	   followed	   by	   CH3	   and	   finally	   by	   EG4-­‐SAMs.	   It	   is	   interesting	   that	   this	  
strain	   adsorbs	   preferentially	   to	   OH-­‐SAMs.	   At	   pH	   7.4	   the	   OH	   group	   of	   the	   hydrophilic	   SAMs	   is	  
uncharged45	  although	  the	  negative	  zeta	  potential	  of	  all	  the	  SAMs	  used	  that	  are	  influenced	  by	  the	  
zeta	  potential	  of	  the	  gold	  surface	  While	  electrostatic	  binding	  does	  not	  explain	  the	  adhesion	  of	  this	  
strain	  to	  OH-­‐SAMs,	  it	  is	  possible	  that	  this	  is	  due	  to	  hydrogen	  bonding	  between	  the	  terminal	  –OH	  
groups	   and	   hydrogen	   bond	   acceptors	   or	   donors	   on	   the	   bacterial	   cell	   wall	   that	   may	   be	   more	  
prevalent	  in	  this	  strain.	  
When	  bacteria	  adhered	   to	   the	   surfaces,	   cell	   viability	  was	  not	   significantly	  affected	  by	   the	  
surface	   chemistry,	   but	   there	  were	   differences	   in	   the	   cell	  morphologies.	   Among	   all	   the	   surfaces	  
tested,	  except	  for	  EG4-­‐SAMs,	  attached	  bacteria	  remained	  viable	  for	  as	  long	  as	  2	  hours.	  
According	   to	   electron	   microscopic	   studies	  H.	   pylori	   can	   exist	   in	   three	   different	   forms:	   a	  
viable	  spiral	  form,	  a	  coccoid	  form	  and	  a	  nonviable	  degenerative	  form.	  Because	  the	  stomach	  is	  the	  
natural	   habitat	   of	   this	   pathogen,	   when	   out	   of	   its	   optimum	   environment,	   this	   pathogen	   would	  
likely	   be	   stressed.	   Formation	   of	   coccoid	   forms	   has	   been	   described	   to	   happen	   under	   stress	  
conditions,	  such	  as	   in	  a	   low	  nutrient	  environment.46	   In	  human	  gastric	  biopsies	   the	  coccoid	   form	  
has	   been	   found	   in	   co-­‐existence	  with	   the	   spiral	   form	  when	   the	   bacteria	   is	   attached	   to	   severely	  
damaged	   gastric	   epithelial	   cells.47	   This	   coccoid	   form	   was	   also	   identified	   in	   93%	   of	   biopsy	  
specimens	   from	   patients	   with	   H.	   pylori-­‐associated	   adenocarcinoma.48	   The	   significance	   of	   the	  
different	   morphological	   stages	   and	   their	   role	   in	   pathogenesis	   are	   controversial.	   Some	   authors	  
claim	   that	   the	   coccoid	   stage	   represents	   a	   nonviable	   form	  because,	   following	   conversion	   to	   the	  
coccoid	   form,	   the	  bacteria	  become	  non-­‐cultivable	  and	  cannot	  be	  revived,	  even	  when	  subject	   to	  
	  Chapter	  III	   	  	  
	   93	  
optimum	  growth	  conditions.	  Other	  reports	  contend	  that	  the	  coccoid	  form	  might	  reflect	  a	  survival	  
strategy	  under	  extreme	  conditions48,49,	  since	  it	  is	  still	  capable	  of	  DNA	  synthesis47	  cell	  binding,	  and	  
the	  induction	  of	  cellular	  changes	  similar	  to	  spiral	  H.	  pylori,	   including	  tyrosine	  phosphorylation	  of	  
host	  proteins.42	  The	  coccoid	  form	  therefore	  appears	  to	  be	  alive	  and	  metabolically	  active,	  despite	  
the	  inability	  to	  culture	  this	  form.	  The	  morphological	  transformation	  always	  seems	  to	  occur	  when	  
cells	  are	  in	  adverse	  environments50-­‐54,	  such	  as	  increased	  oxygen	  tension,	  alkaline	  pH49,50,	  increased	  
temperature55,	   extended	   incubation56	   or	   following	   treatment	   with	   omeprazole57	   or	   antibiotics	  
such	   as	   amoxicillin58,59.	   Regarding	   the	   different	   surfaces	   evaluated	   in	   this	   study,	  H.	   pylori	   could	  
readily	   adhere	   to	   TCPE	   and	   CH3-­‐SAMs	   and	   some	   of	   the	   bacteria	   remain	   in	   the	   viable	   and	  
culturable	  spiral	   form,	  whereas	   in	  gold	  and	  OH-­‐	  and	  EG4-­‐SAMs	  the	  adhered	  bacteria	  were	  all	   in	  
the	   coccoid	   form.	   These	  morphological	   differences	   can	   not	   be	   attributed	   to	   culture	   conditions	  
since	  all	  H.	  pylori	  strain	  innocula	  used	  for	  the	  morphology	  assays	  in	  this	  study	  were	  from	  the	  same	  
plate	  and	  were	  manipulated	  identically.	  
	  
6.	  -­‐	  CONCLUSIONS	  
This	   work	   reports	   the	   adhesion,	   viability	   and	   morphology	   of	   H.	   pylori	   adsorbed	   to	   self-­‐
assembled	   alkanethiol	   monolayers	   (SAMs),	   displaying	   different	   functional	   groups,	   on	   gold.	  
Bacterial	   adhesion	   increased	   until	   2	   hours,	   after	   what	   tends	   to	   stabilize.	   Except	   for	   17875/Leb	  
strain,	   which	   adhered	   more	   to	   bare	   gold,	   the	   more	   hydrophobic	   surface	   CH3-­‐SAMs,	   had	   the	  
highest	  levels	  of	  H.	  pylori	  adhesion,	  while	  the	  EG4-­‐SAMs	  prevented	  bacterial.	  Moreover,	  the	  EG4-­‐
SAMs	   were	   the	   only	   surface	   that	   induced	   a	   significant	   loss	   of	   viability	   of	   the	   few	   adherent	  
bacterial	  cells.	  The	  typical	  H.	  pylori	  spiral	  shape	  was	  only	  maintained	  when	  bacteria	  was	  incubated	  
onto	  CH3-­‐SAMs	  and	  on	  the	  control	  (TCPE),	  although	  after	  2	  hours	  incubation	  time,	  the	  majority	  of	  
the	  adhered	  bacteria	  were	  in	  coccoid	  shape.	  
In	  conclusion,	  these	  investigations	  with	  model	  surfaces	  demonstrate	  that	  different	  H.	  pylori	  
strains	  do	  exhibit	  differences	  in	  nonspecific	  adsorption	  that	  depend	  on	  the	  surface	  chemistry	  and	  
specific	  functional	  groups	  exposed.	  The	  identity	  of	  the	  bacterial	  strain	  and	  the	  surface	  chemistry	  
can	  alter	  the	  adhesion	  kinetics,	  as	  well	  as	  the	  morphologies	  of	  the	  attached	  bacteria.	  
This	   study	   opens	   new	   avenues	   for	   the	   comprehensive	   application	   of	   these	   or	   chemically	  
similar	  materials	  for	  novel	  anti-­‐adhesive	  strategies	  for	  H.	  pylori	  treatment.	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1.	  -­‐	  ABSTRACT	  
Helicobacter	   pylori	   colonizes	   the	   gastric	   mucosa	   of	   half	   of	   the	   world	   population	   and	  
persistent	  infection	  is	  related	  with	  the	  increase	  risk	  of	  gastric	  cancer.	  Adhesion	  of	  H.	  pylori	  to	  the	  
gastric	   epithelium,	   that	   is	   essential	   for	   infection,	   is	  mediated	  by	  bacterial	   adhesin	  proteins	   that	  
recognize	   specific	   glycan	   structures	   (Gly-­‐R)	   expressed	   in	   the	   gastric	   mucosa.	   The	   Blood	   group	  
antigen	  binding	  Adhesin	   (BabA)	   recognizes	  difucosylated	  antigens	   such	  as	   Lewis	  B	   (Leb)	  and	   the	  
Sialic	   acid	   binding	   Adhesin	   (SabA)	   recognizes	   sialylated	   glycoproteins	   and	   glycolipids,	   such	   as	  
sialyl-­‐Lewis	  x	  (sLex).	  This	  work	  aims	  to	  investigate	  if	  these	  Gly-­‐Rs,	  (Leb	  and	  sLex),	  after	  immobilized	  
on	   synthetic	   surfaces	   (self-­‐assembled	   monolayers	   of	   alkanethiols	   on	   gold),	   can	   attract	   and	  
specifically	  bind	  H.	  pylori.	   Functional	  bacterial	  adhesion	  assays	  to	   (Gly-­‐R)-­‐SAMs	  were	  performed	  
using	  H.	  pylori	   strains	  with	  different	  adhesin	  proteins	  profile.	  Results	  demonstrate	  that	  H.	  pylori	  
binding	   to	   surfaces	   occur	   via	   interaction	   between	   its	   adhesins	   and	   cognate	   (Gly-­‐R)-­‐SAMs	   and	  
bounded	  H.	   pylori	  maintain	   its	   characteristic	   rod-­‐shaped	  morphology	   only	   during	   conditions	   of	  
specific	  adhesin-­‐glycan	  binding.	  These	  results	  bring	  new	  insights	  for	  innovative	  strategies	  against	  
H.	  pylori	   infection	  based	  on	  the	  scavenging	  of	  bacteria	  from	  the	  stomach	  using	  specific	  H.	  pylori	  
chelating-­‐biomaterials.	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2.	  -­‐	  INTRODUCTION	  
Helicobacter	  pylori	  (H.	  pylori)	  is	  one	  of	  the	  most	  common	  infectious	  agents	  worldwide	  and	  
infects	  50%	  of	  the	  mankind.1,2	  Infection	  induces	  an	  inflammatory	  response	  that	  does	  not	  manage	  
to	   eradicate	   the	   bacteria	   colonization,	   but	   which	   instead	   persists	   for	   the	   lifetime	   of	   the	  
individual.3	   H.	   pylori	   infection	   usually	   causes	   asymptomatic	   gastritis	   but	   10-­‐15%	   of	   infected	  
individuals	   develop	   more	   severe	   gastric	   lesions,	   such	   as	   peptic	   ulcers,	   and	   1-­‐3%	   of	   infected	  
individuals	  will	   come	  down	  with	  gastric	   cancer,	  which	  has	  a	   low	  5-­‐year	   survival	   rate.4,5	  To	  date,	  
this	  is	  the	  only	  malignancy	  with	  recognized	  bacterial	  etiology.5,6	  
The	  adhesion	  of	  H.	  pylori	  to	  the	  host	  gastric	  mucosa	  is	  an	  essential	  step	  for	  the	  success	  of	  
the	   infection.	   This	   event	   triggers	   the	  expression	  of	   several	   bacterial	   genes,	   including	   some	   that	  
encode	  virulence	   factors,	   and	  protects	   the	  pathogen	   from	  clearance	  mechanisms	   such	  as	   liquid	  
flow,	  peristaltic	  movements	  or	  shedding	  of	  the	  mucous	  layer.7	  Adhesion	  is	  mediated	  by	  H.	  pylori	  
adhesins	   that	   recognize	   glycan	   structures	   (Gly-­‐Rs)	   expressed	   on	   gastric	   mucosa.8,9	   The	   Blood	  
group	  Antigen	  Binding	  Adhesin	  (BabA)	  recognizes	  fucosylated	  blood	  group	  antigens	  including	  the	  
difucosylated	   Lewis	   antigens,	   such	   as	   the	   Lewis	   b	   (Leb)	   antigen.	   Infection	  with	  H.	   pylori	   strains	  
expressing	  functional	  BabA	  have	  been	  correlated	  with	  increased	  risk	  for	  gastric	  carcinoma.8,	  10,11	  H.	  
pylori	   persistent	   infection	   induces	   chronic	   inflammation	  with	   associated	  de	   novo	   expression	   of	  
sialylated	  structures	  on	  the	  gastric	  mucosa,	  such	  as	  sialyl-­‐Lewis	  x	  (sLex)12,	  that	  is	  recognized	  by	  the	  
Sialic	  Acid	  Binding	  Adhesin	  (SabA).9	  
Since	  its	  discovery	  in	  the	  early	  1980’s,	  the	  treatment	  of	  H.	  pylori	  with	  antibiotics	  has	  come	  a	  
long	  way.	   However,	   over	   the	   years,	   the	   increase	   in	   resistance	   to	   antimicrobial	   drugs	   has	   been	  
rising	   and	   it	   is	   currently	   estimated	   that	   antibiotic	   therapy	   fails	   in	   1	   out	   of	   5	   patients.1,	   2,13	  
Moreover,	   the	  difficulty	  of	   establishing	   a	   standard	   treatment	   regimen	  worldwide	   together	  with	  
the	  poor	  patient	  compliance	  to	  the	  complex	  therapeutic	  regimens	  and	  the	  side-­‐effects	  associated	  
with	  them,	  has	  led	  to	  the	  quest	  for	  alternative	  treatments	  to	  eradicate	  this	  pathogen.14,15	  
This	   study	   aims	   to	   investigate	   whether	   the	   carbohydrate	   structures,	   Leb	   and	   sLex,	   are	  
recognized	   by	   the	  H.	   pylori	   adhesins	   when	   immobilized	   on	   synthetic	   surfaces.	   The	   knowledge	  
obtained	  from	  this	  study	  can	  be	  applied	  in	  the	  future	  for	  the	  development	  of	  alternatives	  to	  the	  
conventional	   antibiotic	   therapies	   employed	   for	   H.	   pylori	   eradication,	   by	   combining	   gastric	  
mucoadhesive	   polymers	   with	   immobilized	   specific	   Gly-­‐Rs	   for	   the	   bacterium.	   This	   strategy	   will	  
ultimately	   design	   a	   decoy	   with	   the	   ability	   to	   attract,	   bind	   and	   remove	  H.	   pylori	   from	   infected	  
hosts.	  
In	   order	   to	   control	   surface	   Gly-­‐R	   immobilization	   at	   the	   molecular	   scale,	   namely	   glycan	  
density	   and	   its	   spatial	   orientation,	   self-­‐assembled	   monolayers	   (SAMs)	   of	   alkanethiols	   on	   gold	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were	  used.	  SAMs	  are	  well-­‐ordered	  organic	  surfaces	  that	  allow	  control	  over	  the	  properties	  of	  the	  
interface	  at	  a	  molecular	  scale.16,17	  SAMs	  have	  been	  widely	  used	  in	  studies	  with	  proteins,	  cells16,18-­‐20	  
and	  bacteria.21-­‐25	  Our	  previous	  results	  demonstrate	  that	  non-­‐specific	  H.	  pylori	  adhesion	  is	   low	  to	  
tetra	  (ethylene	  glycol)-­‐terminated	  SAMs	  (EG4-­‐SAMs).26	  The	  low	  background	  binding	  to	  EG4-­‐SAMs	  
makes	   it	   useful	   for	   studies	   of	   specific	   adhesion	   to	   surfaces.	   Furthermore,	   it	  was	   observed	   that	  
bacteria	  remain	  viable	  when	  incubated	  with	  SAMs.26	  
Biotin-­‐terminated	  SAMs	  provide	  a	  convenient	  and	  versatile	  surface	  for	  the	   immobilization	  
of	   biotinylated	   biomolecules	   by	   use	   of	  multivalent	   biotin-­‐binding	   proteins,	   such	   as	   neutravidin,	  
avidin	   or	   streptavidin,	   that	   have	   four	   biotin	   binding	   sites	   on	   two	   opposite	   sites	   of	   the	   protein	  
molecule	   (Figure	  1).27	  Mixed	  SAMs	  prepared	  with	  different	  ratios	  of	  biotin-­‐	  and	  EG4-­‐terminated	  
thiols	  (biotin-­‐SAMs)	  allow	  the	  control	  of	  the	  desired	  biotin	  density	  that	  ultimately	  determines	  the	  
amount	  of	  bound	  neutravidin	  and	  biotinylated	  Gly-­‐Rs.	  	  
	  
	  
Figure	  1	  -­‐	  Schematic	  drawing	  of	  immobilization	  strategy	  (not	  to	  scale).	  
	  
Biotin-­‐SAMs	   were	   characterized	   by	   analytical	   techniques	   such	   as	   ellipsometry,	   water	  
contact	  angle	  measurements	  and	  X-­‐ray	  photoelectron	  spectroscopy	  (XPS).	  Neutravidin	  and	  Gly-­‐Rs	  
binding	  to	  the	  monolayer	  were	  monitored	  by	  quartz	  crystal	  microbalance	  with	  dissipation	  (QCM-­‐
D)	   technique.	  H.	   pylori	   specific	   adhesion	   to	   Leb-­‐	   and	   sLex-­‐SAMs	  was	   evaluated	   by	   fluorescence	  
Gold
EG4-thiol Biotin-thiol Neutravidin Gly-R
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microscopy	   using	   bacterial	   strains	   and	   mutants	   with	   defined	   adhesin	   protein	   expression	  
properties.	   Bacterial	  morphology	   after	   adhesion	  was	   also	   evaluated	   resourcing	   to	   fluorescence	  
microscopy	  analysis.	  
	  
3.	  -­‐	  MATERIAL	  &	  METHODS	  
3.1.	  -­‐	  Surfaces	  preparation	  
3.1.1.	  -­‐	  Gold	  substrates	  
Gold	  substrates	  of	  1	  x	  1	  cm2	  and	  0.5	  x	  0.5	  cm2	  were	  used	  for	  surface	  characterization	  and	  
bacterial	   adhesion,	   respectively.	   These	   substrates	   were	   prepared	   as	   described	   elsewhere.16	  
Briefly,	   before	   use,	   gold	   substrates	   were	   cleaned	   with	   a	   fresh	   “piranha”	   solution	   (7	   parts	  
concentrated	  sulfuric	  acid	   (95	  %	  v/v,	  BDH	  Prolabo)	  and	  3	  parts	  of	  hydrogen	  peroxide	  (30	  %	  v/v,	  
Merck	   KGaA)	   for	   5	  min	   (caution:	   this	   solution	   reacts	   violently	  with	  many	   organic	  materials	   and	  
should	  be	  handled	  with	  care).	  Gold	  substrates	  were	  then	  thoroughly	  rinsed	  with	  absolute	  ethanol	  
(Merck,	   99.8	  %),	   ultrasonicated	   in	  Milli-­‐Q	  water	   and	   absolute	   ethanol,	   and	   finally	   dried	  with	   a	  
gentle	  argon	  stream.	  
	  
3.1.2.	  -­‐	  QCM	  gold	  crystals	  
Prior	   to	   incubation	   with	   the	   alkanethiol	   solutions,	   QCM	   crystals	   (QSX301-­‐Standard	   Gold,	  
4.95	   Hz.	   78mm2	   active	   sensor	   area,	   Q-­‐Sense	   AB,	   Sweden)	   were	   cleaned.	   First	   for	   10	   min	   in	   a	  
UV/ozone	  cleaner,	  followed	  by	  immersion	  in	  a	  freshly	  prepared	  solution	  containing:	  10	  mL	  Milli-­‐Q	  
water,	   2	   mL	   ammonia	   (25	   %,	   Merck	   KGaA)	   and	   2	   mL	   hydrogen	   peroxide	   at	   75	   °C,	   for	   5	   min.	  
Crystals	  were	  then	  rinsed	  with	  absolute	  ethanol,	  followed	  by	  Milli-­‐Q	  water	  and	  absolute	  ethanol	  
again.	  
	  
3.1.3.	  -­‐	  SAMs	  preparation	  
1-­‐Mercapto-­‐11-­‐undecyl	   tetra	   (ethylene	   glycol)	   (SH-­‐(CH2)11-­‐O-­‐(CH2-­‐CH2-­‐O)4-­‐H;	   EG4;	  
Asemblon,	   99	   %)	   and	   biotin-­‐terminated	   tri(ethylene	   glycol)	   undecanethiol	   (SH-­‐(CH2)10-­‐CO-­‐NH-­‐
(CH2)3-­‐O-­‐(CH2CH2O)2-­‐(CH2)3-­‐NH-­‐Biotin;	   biotin-­‐thiol,	   Asemblon;	   99	   %)	   were	   prepared	   as	   pure	  
solution	  at	  2	  mM.	  Biotin-­‐SAMs	  were	  prepared	  by	   immersion	  of	   the	  gold	   substrates	   in	   solutions	  
containing	  different	   ratios	  of	   these	   two	   thiols	  with	  a	   final	   concentration	  of	  0.1	  mM.	   Incubation	  
was	  performed	  at	  room	  temperature	  over	  20	  hours.	  After	  incubation,	  SAMs	  were	  rinsed	  3	  times	  
in	   fresh	   absolute	   ethanol)	   and	   dried	   with	   a	   gentle	   argon	   stream.	   SAMs	   were	   kept	   in	   an	   inert	  
environment	  (glove	  chamber	  saturated	  with	  dry	  nitrogen)	  and	  protected	  from	  light	  until	  used.	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3.1.4.	  -­‐	  SAMs	  characterization	  
3.1.4.1.	  -­‐	  Ellipsometry	  
To	   determine	   the	   monolayer	   thickness	   an	   Imaging	   Ellipsometer,	   model	   EP3	   (Nanofilm	  
Surface	  Analysis)	  was	  used.	   It	  was	  operated	   in	   a	   polarizer-­‐compensator-­‐sample-­‐analyzer	   (PCSA)	  
mode	   (null	  ellipsometry).	  The	   light	   source	  was	  a	   solid-­‐state	   laser	  with	  a	  wavelength	  of	  532	  nm.	  
The	  optical	   properties	   of	   the	   gold	   substrate,	   namely	   the	   refractive	   index	   (n)	   and	   the	   extinction	  
coefficient	   (k)	   were	   firstly	   experimentally	   determined	   using	   a	   delta	   and	   psi	   spectrum	   with	   a	  
variable	  angle	  ranging	  from	  66°	  to	  76°.	  These	  measurements	  were	  made	  in	  four	  zones	  to	  correct	  
for	  any	   instrument	  misalignment.	  To	  determine	  the	  SAMs	  thickness,	   the	  same	  kind	  of	  spectrum	  
was	  used	  and	  n	  and	  k	   for	   the	  organic	   layer	  were	   set	  as	  1.45	  and	  zero,	   respectively.	  Results	  are	  
expressed	  as	  the	  average	  of	  3	  measurements	  on	  each	  of	  the	  3	  replicates	  per	  sample.	  
	  
3.1.4.2.	  -­‐	  Water	  contact	  angle	  measurements	  
To	  determine	  the	  surfaces	  wettability	  after	  biotin-­‐thiol	   incorporation,	  water	  contact	  angle	  
was	   determined	   using	   a	   contact	   angle	   measuring	   system	   from	   Data	   Physics,	   model	   OCA	   15,	  
equipped	  with	  an	  electronic	  syringe,	  a	  video	  CCD-­‐camera	  and	  SCA	  20	  software.	  The	  contact	  angle	  
measurements	   were	   performed	   using	   the	   sessile	   drop	   method	   with	   distilled,	   deionized	   water	  
(Millipore).	  SAMs	  were	  placed	   in	  a	  closed,	   thermostatic	  chamber	  at	  25	   °C,	   saturated	  with	   liquid	  
sample	  in	  order	  to	  prevent	  evaporation	  from	  the	  drop.	  After	  deposition	  of	  the	  4	  µl	  drops,	  images	  
were	   taken	   every	   2	   seconds	   over	   300	   seconds.	   These	   images	   were	   prosecuted	   with	   SCA	   20	  
software	   for	   fitting	   the	   droplet	   profiles	   [contact	   angle	   =	   f	   (time)]	   of	   where	   it	   is	   calculated	   the	  
contact	  angle.	  The	  droplet	  profiles	  were	  fitted	  using	  the	  ellipse	  method	  in	  order	  to	  calculate	  the	  
contact	  angle.	  For	  each	  replicates,	  the	  water	  contact	  angle	  was	  determinate	  by	  extrapolating	  the	  
time	  dependent	  curve	  to	  zero.	  Results	  are	  expressed	  as	  the	  average	  of	  3	  measurements	  on	  each	  
of	  the	  3	  replicates.	  
	  
3.1.4.3.	  -­‐	  X-­‐ray	  photoelectron	  spectroscopy	  
To	  determine	  the	  biotin-­‐thiol	  incorporation	  onto	  SAMs,	  XPS	  measurements	  were	  carried	  at	  
CEMUP	   (Centro	   de	  Materiais	   da	   Universidade	   do	   Porto)	   on	   a	   VG	   Scientific	   ESCALAB	   200A	   (UK)	  
spectrometer	   using	   magnesium	   Kα	   (1253.6	   eV)	   as	   radiation	   source.	   The	   photoelectrons	   were	  
analyzed	  at	  a	  take	  off	  angle	  of	  55º.	  Survey	  spectra	  were	  collected	  over	  a	  range	  of	  0-­‐1150	  eV,	  with	  
an	  analyzer	  pass	  energy	  of	  50	  eV.	  High-­‐resolution	  C	  (1s),	  O	  (1s),	  N	  (1s),	  S	  (2p)	  and	  Au	  (4f)	  spectra	  
were	  collected	  with	  analyzer	  pass	  energy	  of	  20	  eV.	  All	  the	  spectra	  were	  fitted	  using	  an	  XPS	  peak	  
fitting	  program	  (XPSPEAK	  Version	  4.1)	  and	  were	  corrected	  for	  Au	  (84eV).	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3.2.	  -­‐	  (Gly-­‐Rs)-­‐SAMs	  preparation	  
3.2.1.	  -­‐	  Gly-­‐Rs	  
Biotinylated	   Gly-­‐Rs	   were	   received	   as	   lyophilized	   powder	   (Lectinity).	   Carbohydrates	   were	  
resuspended	   in	   PBS	   (phosphate	   buffer	   saline;	   pH	   7.4;	   Sigma)	   with	   a	   final	   concentration	   of	   1	  
mg/mL.	   The	   following	   Gly-­‐Rs	   were	   used:	   H-­‐type	   2	   (Fucα1-­‐2-­‐Galβ1-­‐4-­‐GlcNAcβ-­‐O(CH2)3NH-­‐
CO(CH2)5NH-­‐Biotin)	   which	   although	   is	   not	   a	   recognized	   H.	   pylori	   receptor,	   was	   used	   for	   the	  
optimization	   of	   the	   Gly-­‐R	   binding	   to	   SAMs;	   Leb	   (Fucα1-­‐2-­‐Galβ1-­‐3-­‐(Fucα1-­‐4)-­‐GlcNAc-­‐O(CH2)3NH-­‐
CO(CH2)5NH-­‐Biotin)	   and	   sLex	   (NeuAc(α2-­‐3)Galβ1-­‐4GlcNAc(Fucα1-­‐3)-­‐O(CH2)3NH-­‐CO(CH2)5NH-­‐
Biotin).	  
	  
3.2.2.	  -­‐	  (Gly-­‐Rs)-­‐SAMs	  preparation/characterization	  by	  QCM-­‐D	  	  
Gly-­‐Rs	   immobilization	  was	   followed	   using	   the	  QCM-­‐D	   technique	   that	   allows	   for	   the	   real-­‐
time	  monitoring	  of	  a	  biomolecule	  adsorption	  onto	  a	  quartz	  crystal,	  by	  following	  the	  alterations	  in	  
the	   resonance	   frequency	   and	   dissipation	   of	   the	   crystal.	   Frequency	   shifts,	   Δf,	   are	   related	   to	  
changes	  in	  adsorbed	  mass	  on	  the	  crystal	  surface,	  whereas	  dissipation	  shifts,	  ΔD,	  are	  related	  to	  the	  
viscoelastic	   properties	   of	   the	   layer	   adsorbed	   on	   the	   crystal	   surface.28-­‐30	   QCM-­‐D	  measurements	  
were	  performed	  with	  the	  Q-­‐Sense	  E4	  system	  (Q-­‐Sense	  AB,	  Gothenburg,	  Sweden)	  at	  25	  °C.	  Sterile	  
PBS	   (filtered,	   0.2	  µm	  pore	   size)	  was	   injected	   into	   the	   system	  at	   a	   0.1	  mL/min	   flow	   rate	   until	   a	  
stable	  signal	  was	  obtained.	  Neutravidin	  (Invitrogen,	  300	  µL	  at	  0.1	  mg/mL	  in	  PBS),	  was	  then	  added	  
to	  the	  system	  and	  allowed	  to	   incubate	  under	  static	  conditions	  for	  1	  hour	  at	  25	  °C.	  After,	  rinsing	  
was	  performed	  with	  PBS	  to	  remove	  any	  non-­‐adherent	  protein.	  Gly-­‐Rs	  (300	  µL	  at	  0.1mg/mL	  in	  PBS)	  
were	  then	   injected	   in	  the	  system.	   Incubation	  was	  performed	  under	  static	  conditions	   for	  1	  hour,	  
followed	   by	   rinsing	  with	   PBS	   to	   remove	   any	   non-­‐adherent	   carbohydrate.	   To	   further	   detect	   the	  
immobilized	  Gly-­‐Rs,	  Ulex	  Europaeus	  lectin	  (UEA	  lectin)(Sigma,	  300	  µL	  at	  5	  µg/mL	  in	  PBS)	  was	  used	  
to	   detect	   H-­‐type	   2	   (UEA	   lectin	   specifically	   binds	   to	   the	   α-­‐fucose	   moiety	   on	   the	   referred	  
carbohydrate).	  Immobilized	  Leb	  was	  detected	  with	  BG6	  antibody	  (65.9	  µg/mL;	  Signet)	  with	  300	  µL	  
at	  1:50	  in	  PBS.	  sLex	  was	  detected	  using	  KM93	  antibody	  (200µg/mL;	  Millipore)	  with	  300	  µL	  at	  1:60	  
in	  PBS.	  
The	   adsorbed	   mass	   of	   neutravidin,	   Gly-­‐Rs	   and	   antibodies	   was	   estimated	   using	   the	  




Δf(Hz)Δm ⋅−= )	  (equation	  I)	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where	  Δm	   is	   the	  adsorbed	  mass,	  Δf	   is	   the	   frequency	  shift	  due	   to	   the	  adsorption,	  n	   is	   the	  
overtone	  number	  and	  C	  is	  a	  constant	  characteristic	  of	  the	  sensor	  crystal	  (C	  =	  17.7	  ng	  Hz	  -­‐1cm	  -­‐2	  for	  
the	  5	  MHz	  crystals	  used).	  
For	   bacterial	   adhesion	   assays,	   biotin-­‐SAMs	   were	   first	   incubated	   with	   neutravidin	   (0.1	  
mg/mL	   in	   PBS),	   during	   1	   hour,	   under	   a	   dry	   nitrogen	   environment,	   at	   25°C	   and	   protected	   from	  
light.	  After	   rinsing	  3	   times	  with	  PBS,	   neutravidin-­‐SAMs	  were	   incubated	  with	  biotinylated	  Gly-­‐Rs	  
(0.1	  mg/mL	  in	  PBS)	  for	  1	  hour,	  under	  the	  same	  conditions.	  Afterwards,	  surfaces	  were	  thoroughly	  
rinsed	  with	  PBS	  and	  dried	  with	  a	  gentle	  argon	  stream.	  
	  
3.3.	  -­‐	  H.	  pylori	  adhesion	  assays	  to	  (Gly-­‐R)-­‐SAMs	  	  
3.3.1.	  -­‐	  Bacterial	  Culture	  
H.	  pylori	  strains	  17875/Leb,	  H.	  pylori	  17875babA1::kan	  babA2::cam	  (17875babA1A2)	  and	  H.	  
pylori	   097	   UK	   strain	   have	   been	   previously	   characterized	   regarding	   BabA	   and	   SabA	   expression	  
(Table	  I).	  H.	  pylori	  097	  UK	  strain	  was	  obtained	  from	  the	  Max-­‐Planck	  Institut	  für	  Infektionsbiology,	  
Berlin,	  Germany.	  
	  
Table	  I	  -­‐	  H.	  pylori	  strains	  adhesins	  profile.	  
H.	  pylori	  strain	   BabA	   SabA	   Reference	  
H.	  pylori	  17875/Leb	   (+)	   (+)*	   8,9	  
H.	  pylori	  17875	  babA1A2	   (-­‐)	   (+)	   8,9	  
H.	  pylori	  097	  UK	   (-­‐)	   (-­‐)	   50	  
(*)	  Non-­‐functional.	  It	  has	  been	  demonstrated	  that	  besides	  expressing	  both	  BabA	  and	  SabA	  the	  17875/Leb	  strain	  is	  unable	  
to	  bind	  to	  sialylated	  antigens,	  showing	  that	  this	  is	  a	  non-­‐functional	  SabA	  adhesin.	  
	  
Bacteria	  were	  cultured	   in	  Trypticase	  Soy	  Agar	   (TSA)	  plates	   supplemented	  with	  5	  %	   sheep	  
blood	   (BioMérieux),	   in	   a	   microaerophilic	   environment	   at	   37	   °C,	   48	   hours.	   Afterwards,	   some	  
colonies	  were	  transferred	  to	  Pylori	  Agar	  plates	  (BioMérieux)	  and	  incubated	  for	  another	  24	  hours	  
under	  identical	  conditions.	  
	  
3.3.2.	  -­‐	  Bacterial	  adhesion	  and	  morphology	  assays	  
3.3.2.1.	  -­‐	  Bacterial	  adhesion	  assays	  to	  Gly-­‐R	  SAMs	  
Bacteria	  were	  harvested	  from	  Pylori	  Agar	  (BioMérieux)	  plates	  with	  sterile	  filtered	  PBS	  (0.22	  
μm	   pore	   size)	   in	   the	   exponential	   growth	   phase.26	   The	   bacterial	   concentration	   was	   adjusted	   to	  
~107	   cfu/mL	   as	   previously	   described	   by	   our	   group.26	   Before	   incubation	   with	   bacteria,	   surfaces	  
	   Chapter	  IV	   	  	  
	   107	  
were	  hydrated	  with	  filtered	  PBS.	  Bacterial	  incubation	  on	  the	  SAMs	  was	  performed	  at	  37	  °C,	  with	  
agitation	   (100	   rpm),	   for	   2	   hours.	   After,	   SAMs	   were	   rinsed	   with	   filtered	   PBS	   to	   remove	   non-­‐
adherent	  bacteria	  and	  then	  the	  adherent	  bacteria	  were	  fixed	  with	  4	  %	  (v/v)	  p-­‐formaldehyde	  and	  
labeled	  with	  Vectashield	  with	  DAPI	  (Vector	  Laboratories).	  Adherent	  bacteria	  were	  visualized	  with	  
an	   Inverted	   Fluorescence	  Microscope	   (Zeiss	   Axiovert	   200	  MOT),	   1000x	  magnification.	   Bacterial	  
counts	  were	  manually	  determined	  from	  photographs	  of	  6	  random	  fields	  per	  sample.	  Counts	  were	  
expressed	  as	  number	  of	  bacteria/mm2	  for	  adhesion	  assays.	  The	  same	  methodology	  was	  applied	  to	  
the	  morphology	  assays	  and	   results	  were	  expressed	  as	  %	  of	  bacteria	   in	   rod/coccoid	  morphology	  
regarding	  to	  the	  total	  number	  of	  adherent	  bacteria.	  
	  
3.3.2.2.	  -­‐	  Gly-­‐R	  competition	  assays	  	  
Competition	  assays	  between	  Gly-­‐R-­‐immobilized	  on	  SAMs	  and	  Gly-­‐Rs	  in	  solution	  (Leb	  or	  sLex)	  
were	  performed	  using	  the	  H.	  pylori	  17875/Leb	  (BabA+)	  and	  the	  H.	  pylori	  17875babA1A2	  (SabA+)	  
strains.	  Gly-­‐R-­‐SAMs	  were	  hydrated	  with	  filtered	  PBS	  prior	  to	  the	  adding	  of	  the	  bacterial	  solution.	  
Besides	  adding	  the	  bacterial	  inoculum,	  a	  solution	  of	  Leb	  or	  sLex	  (1mg/ml	  in	  PBS)	  was	  also	  added	  to	  
each	  well.	   Bacterial	   adhesion	   assays	   proceeded	   as	   described	   in	   3.3.2.1.	   Bacterial	   adhesion	  was	  
expressed	   as	   adhesion	  %,	   assuming	   that	   100	  %	   adhesion	   corresponds	   to	   the	   condition	  without	  
Gly-­‐R	   in	  solution.	  The	  prevailing	  morphology	  of	  adherent	  H.	  pylori	  was	  also	  determined.	  Results	  
were	   expressed	   as	   %	   of	   bacteria	   in	   rod/coccoid	  morphology	   regarding	   to	   the	   total	   number	   of	  
adherent	  bacteria.	  
	  
3.4.	  -­‐	  Statistics	  
The	   experimental	   results	   are	   presented	   as	   the	   mean	   and	   standard	   deviation.	   The	  
significance	  of	  differences	  between	  mean	  values	  was	  assessed	  using	  a	  one-­‐way	  ANOVA,	  two-­‐way	  
ANOVA	  or	  Mann-­‐Whitney	  test	  (SPSS	  Software).	  Significance	  was	  defined	  at	  p	  <0.05.	  
	  
4.	  -­‐	  RESULTS	  
4.1.	  -­‐	  SAMs	  characterization	  
XPS	  studies	  demonstrated	  that	  no	  chemical	  element	  other	   than	  those	  expected	  based	  on	  
the	  chemical	  composition	  of	  the	  SAMs	  were	  detected.	  Gold,	  carbon,	  nitrogen,	  oxygen	  and	  sulfur	  
were	  detected	  in	  all	  SAMs,	  except	  for	  EG4-­‐SAMs,	  which	  contained	  no	  nitrogen	  (N1s).	  Therefore,	  
N1s	  was	  used	  to	  identify	  the	  biotin	  group	  on	  the	  biotin-­‐SAMs	  compared	  to	  pure	  EG4-­‐SAMs	  (0	  %	  
biotin).	   The	   estimated	   atomic	   percentage	   of	   N1s	   increased	   with	   the	   increase	   of	   biotin-­‐thiol	   in	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solution	   (Figure	   2A).	   Biotin	   was	   detected	   even	   when	   low	   amounts	   of	   biotin-­‐thiol	   were	   used.	  
Figure	   2B	   shows	   the	   estimation	   of	   biotin	   incorporation	   on	   SAMs	   regarding	   to	   its	   percentage	   in	  
solution.	   Calculations	   were	   performed	   considering	   that	   100	   %	   biotin	   incorporation	   was	   the	  
amount	   of	   N1s	   obtained	   when	   SAMs	   were	   prepared	   with	   a	   pure	   biotin-­‐thiol	   solution	   (100	   %	  
biotin-­‐thiol	   in	   solution).	   These	   results	   demonstrated	   preferential	   biotin-­‐thiol	   binding	   relative	   to	  
EG4-­‐thiol,	   because	   a	   solution	   containing	   equal	   amounts	   of	   both	   thiols	   yields	   a	   90%	  biotin-­‐thiol	  
surface	   coverage.	   These	  observations	   agree	  with	   results	   described	   elsewhere.31	   The	   increase	   in	  
the	   SAMs	   hydrophobicity	   (Figure	   2C)	   and	   thickness	   (Figure	   2D)	   with	   increasing	   biotin-­‐thiol	   in	  
solution	   was	   only	   detected	   for	   SAMs	   prepared	   from	   solutions	   with	   a	   biotin-­‐thiol	   percentage	  
higher	  than	  10.	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Figure	  2	   -­‐	  Biotin-­‐SAMs	  characterization.	  (A)	  relative	  surface	  nitrogen	  atomic	  %	  of	  biotin-­‐SAMs	  determined	  by	  XPS.	  (B)	  
percentage	  of	   incorporated	  biotin-­‐thiols	   on	   the	   surface.	   Calculations	  were	   	   performed	  using	   the	   amount	  of	   nitrogen	  
described	  on	  figure	  2A	  and	  considering	  100	  %	  biotin-­‐thiol	   incorporation	  as	  the	  amount	  of	  nitrogen	  obtained	  on	  SAMs	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Figure	  2.	  (continuation)	  -­‐	  Biotin-­‐SAMs	  characterization.	  (C)	  water	  contact	  angle	  of	  biotin-­‐SAMs;	  (D)	  thickness	  of	  biotin-­‐
SAMs	  determined	  using	  ellipsometry.	  #	  0	  %	  biotin	  (EG4)	  significantly	  different	  from	  10-­‐100	  %	  biotin	  (p	  <	  0.05;	  Mann-­‐
Whitney	  test),	  (*)	  significantly	  different	  (p	  <	  0.05;	  Mann-­‐Whitney	  test).	  
	  
4.2.	  -­‐	  Gly-­‐Rs	  immobilization	  on	  SAMs	  
Gly-­‐Rs	   immobilization	   on	   SAMs	  was	   established	   and	   optimized	   using	   the	  H-­‐type	   2	   glycan	  
structure.	  Immobilization	  was	  performed	  on	  SAMs	  with	  different	  percentages	  of	  biotin	  in	  order	  to	  
create	  surfaces	  with	  different	  amounts	  of	  receptors	  exposed.	  It	  was	  previously	  demonstrated	  that	  
streptavidin	  binding	  to	  these	  type	  of	  biotin-­‐SAMs	  increases	  up	  to	  5	  %	  of	  biotin-­‐thiol	  in	  solution.31	  
Based	  on	  that,	  neutravidin	  and	  H-­‐type	  2	  were	  bound	  to	  biotin-­‐SAMs	  prepared	  with	  0	  (EG4),	  1.5,	  
2.5	   and	   5	  mole	  %	  biotin-­‐thiol.	   The	  mass	   of	   neutravidin	   and	  H-­‐type	   2	   bounded	  on	   biotin-­‐SAMs,	  
estimated	  by	  the	  application	  of	  the	  Sauerbrey	  equation	  (equation	  I)	  are	  described	  at	  Table	  II.	  
Results	  demonstrated	  that	  biotin-­‐SAMs	  prepared	  from	  2.5	  %	  biotin-­‐thiols	  in	  solution	  allow	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differences	   were	   observed	   between	   SAMs	   prepared	   from	   1.5	   and	   5	   %	   biotin	   thiols	   in	   solution	  
regarding	   neutravidin	   and	   H-­‐type	   2	   immobilization.	   No	   binding	   of	   neutravidin	   and	   Gly-­‐R	   was	  
observed	  on	  EG4-­‐SAMs,	  which	  were	  used	  as	  the	  negative	  control.	  
	  
Table	  II	  -­‐	  Estimated	  adsorbed	  neutravidin	  and	  H-­‐type	  2	  mass	  by	  QCM-­‐D	  (Sauerbrey	  equation).	  
Surface	  
(%	  biotin-­‐thiol)	  
Adsorbed	  mass	  (a)	  
(ng/cm2)	  




909	  ±	  6	  
-­‐	  
21	  ±	  3	  
2.5	   978	  ±	  21	   96	  ±	  33	  
5	   714	  ±	  99	   27	  ±	  18	  
(a) Mass	  calculated	  using	  the	  Sauerbrey	  model	  applied	  to	  the	  3rd	  overtone	  that	  was	  chosen	  as	  the	  most	  stable	  and	  
reproducible	  overtone.	  
(b) n=	  8	  independent	  assays	  for	  each	  biotin	  %.	  
	  
Subsequently	   and	  based	  on	  H-­‐type	  2	   studies,	   biotinylated	   Leb	   and	   sLex	  were	   immobilized	  
onto	   biotin-­‐SAMs	   prepared	   with	   a	   maximum	   of	   2.5	   %	   biotin-­‐thiol	   in	   solution.	   The	   kinetics	   of	  
neutravidin	  and	  Leb	  binding	  onto	  2.5	  %	  biotin-­‐SAMs	  was	   followed	  by	  QCM-­‐D	  and	   it	   is	   shown	   in	  
Figure	  3.	   In	  Figure	  3A,	  the	  observed	  decrease	  of	  frequency	  and	  the	  slight	   increase	   in	  dissipation	  
after	   injecting	   the	  mentioned	   solutions	   indicates	   the	   surface	  adsorption	  of	  neutravidin,	   Leb	   and	  
BG6	  antibody	  (BG6	  Ab),	  which	  specifically	  detects	  the	  immobilized	  Leb.	  To	  confirm	  the	  specificity	  
of	  BG6	  Ab	   towards	   the	   immobilized	  Leb,	  neutravidin	  and	  BG6	  Ab	  were	  added	  to	  a	  2.5	  %	  biotin-­‐
SAM	   (Figure	   3B),	   demonstrating	   that	   there	  was	   no	   antibody	   binding	   to	   neutravidin.	   EG4-­‐SAMs	  
was	  also	  used	  as	  a	  negative	  control	   (Figure	  3C).	  No	  binding	  was	  observed	  on	   this	   surface,	  after	  
injecting	  the	  different	  solutions.	  
	  
Figure	   3	   -­‐	   	  QCM-­‐D	  kinetic	  of	   immobilization	  of	   Leb	  on	  SAMs.	   (A)	   immobilization	  of	  neutravidin	   /Leb/BG6	  antibody	  on	  
2.5%	  biotin-­‐SAMs.	  
(A) 




Figure	  3.	   (continuation)	  -­‐	  QCM-­‐D	  kinetic	  of	  immobilization	  of	  Leb	  on	  SAMs.	  (B)	  immobilization	  of	  neutravidin	  and	  BG6	  
antibody	  on	  2.5%	  biotin-­‐SAMs;	  (C)	  immobilization	  of	  neutravidin	  /Leb	  	  /BG6	  antibody	  on	  EG4-­‐SAMs.	  (1)	  neutravidin;	  (2)	  
PBS;	  (3)	  Leb	  (4)	  BG6	  antibody.	  
	  
The	  masses	  of	   immobilized	  Leb	  and	  sLex,	  as	  well	  as	  the	  respective	  antibodies	  (BG6	  Ab	  and	  
KM93),	  calculated	  using	  the	  Sauerbrey	  equation,	  are	  summarized	  in	  Table	  III.	  No	  differences	  were	  
found	  between	  the	  estimated	  mass	  for	  both	  Leb	  and	  sLex	  and	  for	  the	  specific	  antibodies.	  
	  
Table	  III	  -­‐	  Estimated	  adsorbed	  mass	  of	  Leb	  and	  sLex	  obtained	  by	  QCM-­‐D	  on	  2.5%	  biotin-­‐SAMs.	  Mass	  calculated	  using	  the	  









Leb:	  	  189	  ±	  84	   BG6:	  	  30	  ±	  6	  
sLex:	  159	  ±	  39	   KM93:	  45	  ±	  9	  
(B) 
(C) 
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4.3.	  -­‐	  Specificity	  in	  bacterial	  adhesion	  
4.3.1.	  -­‐	  Bacterial	  adhesion	  to	  Gly-­‐R	  SAMs	  
Bacterial	  adhesion	  to	  Leb	  and	  sLex-­‐terminated	  SAMs	  was	  determined	  using	  H.	  pylori	  strains	  
with	  different	  adhesin	  expression	  profiles	  (Table	  I).	  Results	  are	  shown	  in	  Figure	  4A-­‐C.	  
Figure	  4A	  showed	  that	  the	  H.	  pylori	  17875/Leb	  strain,	  which	  is	  a	  spontaneous	  mutant	  that	  
binds	  Leb	  but	  does	  not	  bind	  sialylated	  structures9,	  adhered	  significantly	  more	  to	  Leb-­‐	  than	  to	  sLex-­‐
SAMs	  (p	  <0.05;	  One-­‐way	  Anova).	  Bacterial	  adhesion	  increased	  with	  increasing	  Leb	  on	  the	  surface	  
(increasing	  biotin),	  except	  with	  the	  surfaces	  prepared	  with	  1.5	  and	  2	  %	  biotin,	  where	  there	  were	  
no	  apparent	  differences	   in	  bacterial	   binding.	  Adhesion	  of	   this	  H.	  pylori	   strain	   to	   sLex-­‐SAMs	  was	  
very	   low,	   independent	  of	  the	  amount	  of	  sLex	  on	  the	  surface;	  namely,	  adhesion	  was	  only	  slightly	  
higher	   than	   on	   the	   control	   surfaces	   EG4-­‐SAMs	   (0	  %	   biotin)	   and	   2.5	  %	   biotin-­‐SAMs	   coated	   only	  
with	  neutravidin.	  
H.	  pylori	  17875babA1A2	  is	  a	  babA	  deletion	  mutant	  with	  a	  functional	  SabA	  adhesin.	  Since	  it	  
binds	  to	  sialylated	  structures,	  it	  adhered	  more	  to	  SAMs	  with	  immobilized	  sLex	  relative	  to	  Leb-­‐SAMs	  
(Figure	   4B).	   Bacterial	   adhesion	   also	   increased	   with	   increasing	   sLex	   on	   the	   surface	   (increasing	  
biotin)	   (p	   <0.05;	   one	   way-­‐Anova).	   In	   the	   presence	   of	   the	   cognate	   receptor,	   the	   number	   of	  
adherent	  H.	  pylori	  17875babA1A2	  strain	  (SabA+)	  was	  always	  higher,	  approximately	  3	  times	  more,	  
than	   the	  adherent	  H.	   pylori	   17875/Leb	   (BabA+)	   and	   this	  difference	  was	   independent	  of	   surface	  
glycan	  density.	  However,	  in	  the	  absence	  of	  the	  complementary	  receptor,	  adhesion	  to	  the	  surfaces	  
was	  very	  low	  for	  both	  strains.	  
H.	  pylori	  097UK	  (BabA-­‐/SabA-­‐)	  was	  the	  negative	  control	  and	  adhesion	  to	  Leb	  and	  sLex-­‐SAMs	  
was	  close	  to	  background	  levels,	  independent	  of	  the	  glycan	  surface	  density.	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Figure	  4.	  (continuation)	  -­‐	  H.	  pylori	  adhesion	  to	  (Gly-­‐R)-­‐SAMs.	  (B)	  H.	  pylori	  17875	  babA1A2	  (SabA+).	  (C)	  H.	  pylori	  097	  UK	  
(BabA-­‐/SabA-­‐).	  (*)	  significantly	  different	  (p	  <	  0.05;	  One	  way-­‐Anova).	  
	  
4.3.2.	  -­‐	  Gly-­‐R	  competition	  assays	  
Results	   of	   bacterial	   adhesion	   to	   Gly-­‐R-­‐SAMs	   in	   the	   presence	   of	   competitive	   receptors	   in	  
solution	  are	  represented	  on	  Figure	  5.	  H.	  pylori	  adhesion	  to	  SAMs	  that	  expose	  the	  cognate	  Gly-­‐R	  
only	  decreased	  when	   in	  presence	  of	   the	   same	   receptor	   in	   solution,	  namely:	   the	  adhesion	  of	  H.	  
pylori	  17875/Leb	   (BabA+)	   to	  Leb-­‐SAMs	  decreased	   in	  15	  %	   in	   the	  presence	  of	  Leb	   in	  solution	  and	  
the	   adhesion	  of	  H.	   pylori	   17875	  babA1A2	   to	   sLex-­‐SAMs	  decreased	  41	  %	   in	   the	  presence	  of	   this	  
receptor	  in	  solution	  (p	  <0.05;	  one	  way-­‐Anova).	  Altogether,	  these	  results	  determine	  that	  bacterial	  
adhesion	   occurred	   mostly	   via	   specific	   interactions	   between	   the	   surface	   immobilized	   glycan	  

















Biotin (% in solution) 





















Biotin (% in solution)  










	   Chapter	  IV	   	  	  
	   115	  
	  
Figure	   5	   -­‐	  H.	  pylori	  Gly-­‐R	  competition	  assays	  with	   receptor	   ([1mg/ml]	   in	   solution;	   (*)	   significantly	  different	   (p	  <	  0.05;	  
One	  way-­‐Anova).	  
	  
4.4.	  -­‐	  Bacterial	  morphology	  in	  relation	  to	  specificity	  in	  binding.	  
It	   is	   known	   that	   H.	   pylori	   can	   assume	   either	   a	   spiral	   (rod)	   or	   stress-­‐associated	   coccoid	  
morphology	  (Figure	  6).	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Most	  of	  H.	  pylori	   17875/Leb	   (BabA+)	  bound	   to	   the	   Leb-­‐surfaces	  maintained	  a	   rod-­‐shaped	  
morphology	   with	   statistically	   significant	   differences	   (p	   <	   0.05;	   two	   way-­‐Anova)	   from	   coccoid	  
morphology	   (Figure	   7A).	   In	   contrast,	   coccoid	   shaped	   bacteria	   were	   prevalent	   when	   this	   strain	  
adhered	   to	   surfaces	   exposing	   the	   non-­‐cognate	   sLex	   receptor.	   H.	   pylori	   17875babA1A2	   (BabA-­‐
/SabA+)	   that	   bound	   to	   surfaces	   exposing	   the	   sLex	   structure	   are	   mostly	   in	   rod	   shaped,	   with	  
statistically	   significant	  differences	   (p	   <0	   .05;	   two	  way-­‐Anova)	   from	   the	   coccoid	  morphology.	  On	  
the	  other	  hand,	  bacteria	  displayed	  the	  coccoid	  stress	  associated	  morphology	  when	  in	  presence	  of	  
Leb-­‐SAMs	   (Figure	   7B).	   The	   H.	   pylori	   097	   UK	   strain	   (BabA-­‐/SabA-­‐),	   predominantly	   adopted	   the	  
coccoid	   form,	   independently	   of	   the	   receptor	   (sLex	   and	   Leb)	   on	   the	   surface	   (p	   <	   0.05;	   two	  way-­‐
Anova)	  (Figure	  7C).	  
	  
 
Figure	  7	  -­‐	  H.pylori	  morphology	  after	  adhesion	  to	  (Gly-­‐R)-­‐SAMs.	  (A)	  H.	  pylori	  17875/Leb	  (BabA+);	  (*)	  significantly	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Figure	  7.	  (continuation)	  -­‐	  H.pylori	  morphology	  after	  adhesion	  to	  (Gly-­‐R)-­‐SAMs.	  (B)	  H.	  pylori	  17875babA1A2	  (SabA+)	  (C)	  
H.	  pylori	  097UK	  (BabA-­‐/SabA-­‐);	  (*)	  significantly	  different	  (p	  <0.05;	  two-­‐way	  Anova).	  
	  
These	   results	   highlight	   that	  H.	   pylori	   maintain	   the	   pathogen	   characteristically	   rod	   shape	  
when	  in	  presence	  of	  the	  complementary	  receptor	  specific	  towards	   its	  adhesin	  profile.	  The	  same	  
behavior	   was	   observed	   even	   in	   the	   presence	   of	   the	   cognate	   receptor	   in	   solution	   towards	   the	  
bacterial	  adhesins	  (around	  70%	  in	  rod	  morphology,	  data	  not	  shown).	  
	  
5.	  -­‐	  DISCUSSION	  
Currently,	   the	  only	  effective	   therapy	   for	  H.	  pylori	   infection	   relies	  on	  antibiotics.	  However,	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conjunction	   with	   the	   associated	   side	   effects	   make	   patient	   compliance	   poor.	   Altogether,	   these	  
factors	   act	   as	   barriers	   to	   achieve	   the	   intended	   cure	   rates	   defined	   in	   the	  Maastricht	   consensus	  
report32,	  leading	  to	  the	  need	  for	  alternative	  treatments	  to	  the	  available	  conventional	  therapeutic	  
options.15	   Bacterial	   adhesion	   to	   the	   gastric	   cells	   represents	   a	   crucial	   event	   in	   disease	  
development.8-­‐10,	  33	   Therefore,	   targeting	   the	   bacterial	   binding	   process	   is	   an	   interesting	   possible	  
approach.	   This	   work	   demonstrates	   the	   proof	   of	   concept	   for	   studies	   aimed	   for	   developing	  
biomaterials	   that	   can	   diminish	  H.	   pylori	   adhesion	   to	   the	   host	   gastric	   mucosa	   by	   introducing	   a	  
competitive	  decoy	  for	  bacterial	  binding.	  SAMs	  were	  used	  as	  model	  surfaces	  because	  they	  enable	  
control	  of	  the	  surface	  chemistry	  at	  the	  molecular	  level,	  in	  contrast	  to	  polymers.16,17	  
Biotin-­‐terminated	   SAMs	  were	   used	   for	  Gly-­‐R	   immobilization	   using	   neutravidin	   as	   a	   linker	  
molecule.	   The	   chemical	   properties	   of	   SAMs	   comprising	   different	   ratios	   of	   biotin-­‐	   and	   EG4-­‐	  
terminated	  thiols,	  ranging	  from	  0	  %	  (pure	  EG4-­‐SAMs)	  to	  100	  %	  biotin-­‐thiol	  are	  in	  accordance	  with	  
prior	   results.31	   Combining	   EG4-­‐	   and	   biotin-­‐thiols	   improves	   the	   accessibility	   of	   biotin	   for	  
neutravidin	   binding,	   because	   this	   reduces	   steric	   crowding	   between	   biotins	   and	  minimizes	   non-­‐
specific	   adsorption.34-­‐36	   Moreover,	   the	   EG4-­‐thiol	   avoids	   denaturation	   of	   the	   adsorbed	  
protein.31,35,36	   It	  has	  been	  demonstrated	   that	   the	  composition	  of	   the	  SAMs	  differ	   from	  the	   thiol	  
composition	   in	   solution	   due	   to	   the	   influence	   of	   differences	   in	   intrinsic	   adsorption	   rates,	  
intermolecular	  interactions	  between	  the	  thiols,	  the	  solvent,	  and	  the	  surface	  during	  assembly.31,37-­‐
42	   In	   our	   experimental	   conditions,	   the	   biotin-­‐thiol	   incorporated	   faster	   than	   the	   EG4-­‐thiol	   and	  
results	  also	  demonstrated	   that	   there	   is	  an	  optimal	   ratio	  of	  biotin-­‐thiol	   in	   solution	   (2.5	  %	  biotin)	  
that	   improves	   both	   selective	   neutravidin	   and	   Gly-­‐R	   binding,	   as	   described	   for	   other	  
biomolecules.31,42	  SAMs	  prepared	  with	  2.5	  mole	  %	  biotin-­‐thiol	   in	  solution	  yields	  an	  estimated	  of	  
30	  %	  biotin-­‐thiol	  in	  the	  monolayer	  surface.	  
Neutravidin,	   a	   non-­‐glycosylated	   avidin,	   was	   chosen	   because	   of	   its	   reduced	   non-­‐specific	  
binding	  compared	  to	  streptavidin	  and	  avidin.	  This	  protein	  is	  still	  able	  to	  bind	  up	  to	  4	  biotins	  in	  a	  
high	  affinity	  (KD	  =10-­‐15	  M-­‐1),	  non-­‐covalently	  interaction.43-­‐46	  
Neutravidin	  and	  Gly-­‐R	  binding	  to	  SAMs	  prepared	  with	  different	  mole	  %	  of	  biotin-­‐thiol	  (0	  to	  
5	   %)	   in	   solution	   was	   calculated	   in	   real	   time	   by	   QCM-­‐D,	   using	   the	   Sauerbrey	   equation.	   This	  
equation	  can	  be	  applied	  for	  systems	  were	  ΔD/	  Δf	  is	  lower	  than	  0.4×10-­‐6	  Hz	  -­‐1	  47,48	  and	  assumes	  that	  
the	   adsorbed	   film	   is	   rigid	  with	  no	   internal	   loss	  of	   energy,	  which	   is	   translated	   in	   low	  dissipation	  
values	  on	  the	  system.47	  However,	  the	  obtained	  mass	  values	  are	  always	  influenced	  to	  some	  extend	  
by	  water	  and	  other	  buffer	  constituents	  that	  are	  trapped	  between	  the	  adsorbed	  molecules,	  which	  
is	   the	  major	   limitation	  of	   this	   technique.	  Based	  on	   results	  obtained	  with	  H-­‐type	  2,	   Leb	   and	   sLex	  
were	  immobilized	  onto	  biotin-­‐SAMs	  exposing	  different	  percentages	  of	  biotin	  and	  prepared	  with	  a	  
maximum	  of	  2.5	  mole	  %	  biotin-­‐thiol	   in	  solution	   (the	  %	  where	  the	  binding	  of	  neutravidin	  and	  H-­‐
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type	  2	  was	  higher).	  The	  ratio	  between	  Gly-­‐Rs/neutravidin	  based	  on	  the	  MW	  and	  estimated	  mass	  
obtained	   from	   QCM-­‐D	   measurements,	   was	   2.	   Theoretically,	   this	   indicates	   that	   neutravidin	   is	  
correctly	   oriented	   at	   the	   surface	   and	   that	   both	   binding	   pockets	   were	   available	   for	   the	   Gly-­‐R	  
binding.	  The	  ratio	  between	  Gly-­‐Rs	  and	  the	  antibodies	  used	  to	  detect	  H-­‐type	  2,	  Leb	  and	  sLex	  was	  far	  
lower,	   at	   ~1	   antibody/100	   immobilized	   glycans.	   This	   could	   be	   due	   to	   steric	   hindrance	   resulting	  
from	  an	  immobilized	  orientation,	  which	  masks	  the	  epitope.	  Another	  possible	  explanation	  is	  that,	  
because	  each	  adsorbed	  neutravidin	  molecule	  can	  bind	  up	  to	  two	  Gly-­‐Rs,	  the	  close	  proximity	  of	  the	  
carbohydrate	   structures	   sterically	   blocks	   antibody	   binding.	   Also,	   neutravidin-­‐biotin	   binding	   is	  
virtually	   irreversible	   whereas	   antibody-­‐antigen	   binding	   is	   mainly	   an	   equilibrium	   interaction.	  
Therefore,	   comparison	   between	   the	   immobilized	   obtained	   ratios	   is	   difficult	   since	   the	   binding	  
modes	  are	  distinct.	  
H.	  pylori	  strains	  expressing	  BabA,	  SabA	  or	  neither	  of	  the	  adhesins	  were	  used	  for	  studies	  of	  
bacterial	  adhesion	  to	  surfaces	  functionalized	  with	  Leb	  and	  sLex.	  Although	  other	  bacterial	  proteins	  
may	   be	   involved	   in	   adhesion	   to	   the	   host	   gastric	  mucosa,	   only	   BabA	   and	   SabA	   have	   been	  well	  
characterized	   regarding	   its	   host	   receptors.	   Moreover,	   it	   has	   been	   demonstrated	   that	   BabA	  
expression	   is	   clinically	   correlated	  with	   overt	   gastric	   disease.10	   Our	   results	   suggest	   a	   correlation	  
between	  the	  expressed	  H.	  pylori	  adhesin	  and	  bacterial	  adhesion	  to	  the	  cognate	  Gly-­‐R	  immobilized	  
on	   SAMs:	   H.	   pylori	   17875/Leb	   (BabA+)	   bound	   preferentially	   to	   Leb–SAMs	   and	   H.	   pylori	  
17875babA1A2	   (SabA+)	   adhered	  more	   to	   surfaces	  modified	  with	   sLex.	  This	  differential	  adhesion	  
indicates	   that	   bacterial	   adhesins	   also	   specifically	   recognize	   immobilized	   glycan	   structures	   on	  
SAMs,	   in	   agreement	   to	   previously	   reported	   binding	   to	   immobilized	   glycans	   when	   they	   are	  
presented	   as	   glycolipids	   separated	   on	   thin-­‐layer	   chromatography	   plates.9,	   49	   Higher	   bacterial	  
density	  was	  observed	  on	  SAMs	  with	  higher	  Gly-­‐Rs	  concentrations	  (higher	  %	  of	  biotin).	  
In	   the	   presence	   of	   its	   adhesins	   specific	   glycan	   receptor,	  H.	   pylori	   17875babA1A2	   (SabA+)	  
always	  adheres	  higher	  than	  the	  H.	  pylori	  17875/Leb	  (BabA+)	  strain.	  Persistent	  colonization	  with	  H.	  
pylori	   leads	   to	   gastric	   mucosa	   inflammation	   with	   concomitant	   de	   novo	   expression	   of	   charged	  
sialylated	   antigens,	   such	   as	   sLex	  on	   gastric	   epithelial	   cells.	   These	   antigens	   are	  recognized	  by	   the	  
SabA	  adhesin	  and	  this	   increased	  bacterial	  adherence	  may	  contribute	  to	  successful	   infection	  and	  
persistent	   colonization.9	  Other	   factors	   such	  as	  differences	   in	   the	  adhesive	   forces,	  as	  well	  as	   the	  
bacterial-­‐host	  interplay	  could	  also	  contribute	  to	  differences	  in	  infection	  and	  colonization	  and	  may	  
explain	  why,	  despite	  it	  has	  been	  reported	  that	  the	  SabA	  adhesin	  binds	  with	  lower	  affinity	  to	  sLex	  
than	  the	  binding	  between	  BabA	  and	  Leb	  9,	  it	  was	  observed	  that	  H.	  pylori	  17875	  babA1A2	  adhered	  
higher	  to	  sLex-­‐SAMs.	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The	  minimal	   adhesion	   of	  H.	   pylori	   097	  UK,	   that	   lacks	   both	   BabA	   and	   SabA	  adhesins50,	   to	  
surfaces	   functionalized	   with	   Leb	   or	   sLex	   supports	   that	   H.	   pylori	   adhesion	   was	   favored	   by	   the	  
specific	  interactions	  between	  the	  exposed	  glycan	  and	  bacterial	  adhesin.	  
The	  decrease	  of	  H.	  pylori	  adhesion	  to	  SAMs	  exposing	   the	  cognate	  Gly-­‐R	  only	  when	   in	   the	  
presence	  of	   the	   same	   receptor	   in	   solution	   confirmed	   their	   specific	   adhesin-­‐glycan	  binding	  onto	  
the	  surfaces.	  The	  difference	  observed	  for	  the	  adhesion	  decrease	  between	  H.	  pylori	  17875/Leb	  and	  
H.	  pylori	  17875babA1A2	  may	  be	  linked	  to	  the	  glycan	  spatial	  orientation	  on	  the	  surface	  as	  well	  as	  
its	  adopted	  conformation	  in	  solution.	  
Besides	   adhesion,	   the	   shift	   in	   morphology	   of	   adherent	   bacterial	   cells	   appears	   to	   be	  
dependent	  on	   specific	   receptor-­‐ligand	  mediated	  bacterial	   adhesion.	  H.	  pylori	  can	  be	   in	   a	   viable	  
spiral	  (rod)	  form	  or	  adopt	  a	  “nonviable”	  stress-­‐associated	  coccoid	  form.51	  The	  significance	  of	  the	  
different	  morphological	  stages	  and	  their	  role	  in	  pathogenesis	  are	  not	  fully	  understood.	  There	  are	  
some	   studies	   that	   support	   that	   the	   coccoid	   stage	   represents	   a	   less	   viable	   form,	   while	   others	  
contend	  that	   it	  may	  reflect	  a	  survival	  strategy	  under	  extreme	  conditions,	  based	  on	  the	  fact	  that	  
changes	   in	   bacterial	   morphology	   are	   usually	   associated	   to	   hostile	   environments.51-­‐59	   Previous	  
work	  has	  shown	  that	  H.	  pylori	  adsorbed	  non-­‐specifically	  to	  SAMs	  mainly	  adopted	  coccoid	  shape.26	  
In	   the	  present	   study,	  H.	  pylori	   that	   specifically	  bound	   to	   its	   cognate	   receptors	  maintain	   the	   rod	  
morphology.	  
This	  study	  demonstrates	  that	  immobilized	  ligands	  maintain	  the	  ability	  to	  specifically	  bind	  H.	  
pylori.	  From	  a	  therapeutic	  point	  of	  view,	  these	  Gly-­‐Rs	  could	  be	   immobilized	  onto	  mucoadhesive	  
biomaterials	   and	   used	   as	  H.	   pylori-­‐binders.	   It	   is	   expected	   that,	   after	   oral	   administration,	   these	  
bioengineered	   biomaterials	   will	   compete	   with	   the	   gastric	   mucosa,	   removing/decreasing	   the	  
amount	  of	  H.	  pylori	  in	  the	  stomach	  of	  infected	  patients,	  therefore	  improving	  the	  performance	  of	  
classical	  treatments.	  Although	  the	  use	  of	  soluble	  compounds	  to	  avoid	  H.	  pylori	  gastric	  adhesion	  is	  
not	   novel	   per	   se60,	   this	   is	   an	   innovative	   approach	   where	   biomaterials,	   specifically	   designed	   to	  
mimic	   the	  gastric	  mucosa,	   could	  be	  used	  as	  a	  decoy	   to	   the	  bacteria	  by	   taking	  advantage	  of	   the	  
natural	  occurring	  host-­‐pathogen	  interactions.	  
	  
6.	  -­‐	  CONCLUSIONS	  
The	  results	  herein	  obtained	  confirm	  the	  successful	  glycan	  structures	   immobilization	  in	  the	  
modified	  SAMs	  while	  maintaining	  the	  correct	  conformation	  for	  bacterial	  adhesins	  recognition	  and	  
binding.	   This	   work	   reports	   the	   proof	   of	   concept	   studies	   for	   the	   development	   of	  
alternative/complementary	  therapies	  for	  H.	  pylori	  eradication	  based	  on	  surface	  immobilization	  of	  
glycan	  structures	  onto	  mucoadhesive	  biomaterials.	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1.	  -­‐	  ABSTRACT	  
The	   strength	   of	   binding	   between	   the	   Helicobacter	   pylori	   Blood	   group	   antigen-­‐binding	  
Adhesin	   (BabA)	   and	   its	   cognate	   glycan	   receptor,	   the	   Lewis	   b	   blood	   group	   antigen	   (Leb),	   was	  
measured	  by	  means	  of	  atomic	  force	  microscopy.	  High-­‐resolution	  measurements	  of	  rupture	  forces	  
between	   single	   receptor-­‐ligand	   pairs	   were	   performed	   between	   the	   purified	   BabA	   adhesin	   and	  
immobilized	   Leb	   structures	   on	   self-­‐assembled	  monolayers	   (SAMs).	   Dynamic	   force	   spectroscopy	  
revealed	  two	  similar	  but	  statistically	  different	  bond	  populations.	  These	  findings	  suggest	  that	  the	  
BabA	   adhesin	   may	   form	   different	   adhesive	   attachments	   to	   the	   gastric	   mucosa	   in	   ways	   that	  
enhance	  the	  efficiency	  and	  stability	  of	  bacterial	  adhesion.	  
	  
Keywords:	  Helicobacter	  pylori;	  Blood	  group	  antigen-­‐binding	  Adhesin	  (BabA);	  Lewis	  b	  (Leb);	  SAMs,	  
Adhesion	  force;	  Atomic	  force	  microscopy.	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2.	  -­‐	  INTRODUCTION	  
The	  oncogenic	  pathway	  of	  gastric	  cancer	   is	  mainly	  associated	  with	  persistent	  Helicobacter	  
pylori	  (H.	  pylori)	  infection	  that	  causes	  a	  negative	  spiral	  of	  events	  including	  chronic	  inflammation,	  
gastric	  mucosal	  atrophy	  and	  may	  ultimately	  result	  in	  dysplasia	  and	  cancer.1,2	  H.	  pylori	  is	  a	  bacteria	  
highly	   adapted	   to	   the	   acidic	   gastric	   environment.	   Persistent	   infection	   of	   the	   gastric	   mucosa	   is	  
required	  to	  induce	  chronic	  inflammation.3	  For	  long-­‐term	  infection	  H.	  pylori	  have	  a	  large	  family	  of	  
outer	  membrane	  proteins,	  of	  which	  some	  are	  adhesins.4	   In	  particular,	   the	  Blood	  group	  Antigen-­‐
Binding	  Adhesin	  (BabA)	  has	  a	  high	  affinity	  (5×	  10	  11	  M-­‐1)	  for	  the	  Lewis	  b	  (Leb)	  determinant,	  which	  is	  
a	   fucosylated	   blood	   group	   antigen	   expressed	   in	   the	   human	   gastro-­‐intestinal	   epithelium.5,6	  
Individuals	   infected	   with	   strains	   that	   express	   BabA	   are	   considered	   to	   have	   higher	   risk	   for	  
duodenal	  ulcer	  and	  gastric	  cancer,	  i.e.	  overt	  disease.7-­‐9	  
The	   discovery	   of	  H.	   pylori	   opened	   up	   a	   new	   avenue	   for	   efficient	   therapy	   against	   gastric	  
disease.10,11	   However,	   there	   is	   an	   increasing	   prevalence	   of	   H.	   pylori	   resistance	   to	   common	  
antibiotics.12-­‐14	   Once	   the	   adhesion	   of	   H.	   pylori	   to	   the	   gastric	   mucosa	   is	   crucial	   for	   the	  
establishment	   of	   infection,	   the	   development	   of	   anti-­‐adhesive	   therapies	   that	   block	   or	   diminish	  
adhesion	  is	  of	  particular	  relevance.	  
Detailed	   studies	   of	   the	   binding	   of	   a	   ligand	   to	   its	   cognate	   receptor	   provides	   better	  
understanding	  of	  the	  molecular	  details	  regarding	  the	  local	  binding	  landscape	  which	  could	  aid	  the	  
design	   of	   new	   potential	   drug	   candidates	   or	   alternative	   therapies.	   We	   previously	   developed	  
bioengineered	   surfaces	   to	   investigate	   the	   Leb	   and	   other	   immobilized	   glycan	   structures	   i.e.	  
presented	   in	   solid	   phase	   as	   receptor	  mimetics	   for	  H.	   pylori.	  We	   reported	   that	   the	   immobilized	  
glycans	   maintained	   their	   active	   conformations	   and	   promoted	   specific	   bacterial	   attachment	  
(unpublished	  work).	  
To	  further	  characterize	  the	  adhesive	  properties	  of	  these	  immobilized	  ligands,	  we	  conducted	  
force	   spectroscopy	   experiments,	   which	   quantify	   the	   strengths	   and	   unbinding	   rates	   of	   single	  
molecular	  bonds	  in	  the	  range	  of	  piconewton	  (10-­‐12	  N)	  forces.15,16.	  Atomic	  force	  microscopy	  (AFM)	  
measurements	  have	   revealed	   sub	  nanometer	  properties	  of	   biomolecular	   interactions	   in	  diverse	  
scenarios	  ranging	  from	  molecular	  recognition	  to	  cell	  adhesion.17-­‐20	  
In	  dynamic	  force	  spectroscopy	  measurements,	  a	  biomolecular	  complex	  is	  subjected	  to	  a	  steadily	  
increasing	  force	  until	  the	  bond	  breaks.	  This	  technique	  is	  based	  on	  simple	  sample	  architecture:	  the	  
ligands	  of	   interest	  are	  attached	  to	  the	  AFM	  tip	  and	  the	  corresponding	  receptors	  are	  attached	  to	  
the	  surface	  of	  the	  substrate	  (Figure	  1).	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Figure	  1	  -­‐	  Schematic	  representation	  of	  the	  single	  molecule	  force	  spectroscopy	  assay	  (not	  to	  scale).	  The	  maleimide	  group	  
(MAL)	   from	  the	  NHS-­‐PEG-­‐MAL	   linker	   reacts	  with	  exposed	   thiols	  on	   the	  1,8-­‐octanedithiol	  monolayer	  and	   the	  exposed	  
NHS	   group	   covalently	   binds	   free	   amines	   in	   the	   BabA	   protein.	   The	   BabA	   activated	   cantilever	   can	   then	   be	   used	   to	  
measure	   binding	   force	   by	   probing	   the	   immobilized	   Leb	   glycans.	   Details	   of	   the	   cantilever	   modification	   and	   Leb	  
immobilization	  on	  biotin-­‐SAMs	  are	  given	  in	  the	  text.	  Single	  force	  measurements	  are	  obtained	  by	  appropriately	  defining	  
the	   BabA	   concentration	   immobilized	   onto	   cantilever	   in	   order	   to	   obtain	   a	   suitable	   binding	   frequency	   to	   perform	  
measurements	  at	  the	  single	  molecule	  level.	  
	  
The	  ligand-­‐modified	  tip	  is	  then	  brought	  into	  contact	  with	  the	  sparsely	  distributed	  receptors	  
immobilized	  on	  the	  surface,	  and	  this	  allows	  for	  bond	  formation.	  When	  the	  tip	  is	  pulled	  away	  from	  
the	  surface,	   the	  spring	  deflects	  under	  the	  steadily	   increasing	  force	  on	  the	  receptor-­‐ligand	  bond,	  
until	   the	   bond	   ruptures.	   The	   rupture	   force	   depends	   on	   the	   loading	   rate,	   such	   that	   the	   most	  
probable	  force	  to	  rupture	  a	  simple	  bond	  defined	  by	  a	  single	  activation	  barrier	  will	   increase	  with	  
the	   logarithm	   of	   the	   loading	   rate.21	   Analyses	   of	   the	   dependence	   of	   the	  most	   probable	   rupture	  
force	   on	   the	   logarithm	   of	   the	   loading	   rate	   −referred	   to	   as	   force	   spectroscopy−	   can	   be	   used	   to	  
characterize	   the	   dissociation	   of	   receptor-­‐ligand	   pairs.	   Examples	   include	   selectins	   and	  
glycoproteins,	  cadherins,	  neural	  cell	  adhesion	  protein,	  and	  many	  others.18,22-­‐25	  
Importantly,	   such	   single	   bond	   strength	  measurements	   quantify	   non-­‐equilibrium	   adhesive	  
properties	   that	   could	   govern	   attachment	   under,	   for	   example,	   fluid	   shear	   stress.	   They	   reveal	  
differences	   in	   dissociation	   rates	   or	   the	   existence	   of	   multiple	   binding	   interactions	   that	   could	  
contribute	   to	  equilibrium	  binding	   in	   solution.	  Force	   spectroscopy	  complements	   solution-­‐binding	  
measurements,	  which	   reflect	  equilibrium	  binding	   free	  energies	   in	   the	  absence	  of	   force,	   such	  as	  
the	  affinities	  reported	  by	  Fei	  et	  al.26	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Here,	  single	  bond	  rupture	  forces	  were	  measured	  between	  the	  purified	  BabA	  protein	  from	  
H.	   pylori	   and	   Leb	   immobilized	   on	   the	   self-­‐assembled	   monolayers	   (SAMs).	   Analyses	   of	   dynamic	  
force	   spectra	   with	   an	   atomic	   force	   microscope	   reveal	   two	   distinct	   adhesive	   states.	   The	   new	  
results	  suggest	  translational	  applications	  and	  therapeutic	  use	  of	  immobilized	  glycan	  receptors	  to	  
reduce	   or	   eliminate	   adhesion	   of	   the	  more	   virulent	   and	   disease	   associated	   BabA	   expressing	  H.	  
pylori	  strains.	  
	  
3.	  -­‐	  MATERIAL	  &	  METHODS	  	  
3.1.	  -­‐	  Leb	  immobilization	  onto	  biotin-­‐SAMs	  
The	  biotinylated	  Leb	  glycan	  was	  immobilized	  onto	  immobilized	  Neutravidin	  on	  biotinylated-­‐
SAMs,	  as	  described.	  This	  configuration	  was	  used	  because	  it	  follows	  a	  published	  protocol	  that	  was	  
fully	  optimized	  to	  promote	  H.	  pylori	  recognition	  of	  and	  binding	  to	  these	  thus	  immobilized	  ligands.	  
The	  SAMs	  were	  assembled	  onto	  gold	  substrates	  (0.5	  x	  0.5	  cm2),	  which	  were	  prepared	  as	  described	  
elsewhere.27	  Before	  use,	  the	  gold	  substrates	  were	  cleaned	  with	  a	  fresh	  “piranha”	  solution	  (7	  parts	  
concentrated	  sulfuric	  acid	  (95%	  (v/v);	  BDH	  Prolabo)	  and	  3	  parts	  of	  hydrogen	  peroxide	  (30	  %	  v/v;	  
Merck))	  for	  5	  min	  (Caution:	  this	  solution	  reacts	  violently	  with	  many	  organic	  materials	  and	  should	  
be	  handled	  with	  great	  care),	  thoroughly	  rinsed	  with	  Milli-­‐Q	  water	  (18	  megaOhm	  resistance)	  and	  
absolute	   ethanol	   (99.9%	   (v/v);	   Merck)	   in	   an	   ultrasound	   bath,	   and	   then	   dried	   with	   a	   gentle	  
nitrogen	  stream.	  
1-­‐Mercapto-­‐11-­‐undecyl	   tetra	   (ethylene	   glycol)	   (SH-­‐(CH2)11-­‐O-­‐(CH2-­‐CH2-­‐O)4-­‐H;	   EG4-­‐thiol;	   99	  
%,	  Assemblon)	  and	  biotin-­‐terminated	  tri(ethylene	  glycol)	  undecanethiol	  (SH-­‐(CH2)10-­‐CO-­‐NH-­‐(CH2)3-­‐
O-­‐(CH2CH2O)2-­‐(CH2)3-­‐NH-­‐Biotin;	  Biotin-­‐EG3-­‐thiol,	  99	  %,	  SensoPath	  Technologies)	  were	  prepared	  as	  
pure	   solution	   at	   2	  mM	   in	   absolute	   ethanol.	   Biotin-­‐SAMs	  were	   prepared	   by	   immersing	   the	   gold	  
substrates	   in	  solutions	  containing	  2.5	  %biotin-­‐thiol	   (97.5	  mole	  %	  EG4-­‐thiol)	  with	  a	  0.1	  mM	  total	  
final	  concentration,	  as	  previously	  described	  (unpublished	  work).	  Incubation	  was	  performed	  at	  RT	  
over	  20	  h.	  After	  the	   incubation,	   the	  SAMs	  were	  rinsed	  3	  times	  with	  fresh,	  absolute	  ethanol	  and	  
dried	  with	  a	  gentle	  nitrogen	  stream.	  
Neutravidin	  was	   used	   as	   a	   protein	   bridge	   to	   immobilize	   the	   biotinylated	   Leb.	  Neutravidin	  
(Invitrogen,	  0.1	  mg/mL	  in	  PBS)	  was	  immobilized	  by	  incubation	  with	  2.5	  %	  mole	  biotin	  SAMs	  for	  1	  h	  
in	  PBS	  buffer.	  After	  rinsing	  with	  PBS,	  Neutravidin-­‐SAMs	  were	   incubated	  for	  another	  hour	  with	  a	  
biotinylated	   Leb	   (Fucα1-­‐2-­‐Galβ1-­‐3-­‐(Fucα1-­‐4)-­‐GlcNAc-­‐O(CH2)3NH-­‐CO(CH2)5NH-­‐Biotin;	   Lectinity)	  
solution	  (0.1	  mg/mL	  in	  PBS)	  under	  the	  same	  conditions.	  Afterwards,	  the	  surfaces	  were	  thoroughly	  
rinsed	  with	  PBS	  and	  dried	  with	  a	  gentle	  nitrogen	  stream.	  Surfaces	  with	  immobilized	  Leb	  were	  used	  
immediately.	  These	  surfaces	  were	  previously	  characterized	  (unpublished	  work).	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3.2.	  -­‐	  AFM	  tip	  modification	  and	  surface	  chemistry	  
The	  AFM	  tips	  were	  modified	  as	  described	  previously,	  with	  only	  slight	  changes.28	  AFM	  Tips	  
(Si3N4	  V-­‐shaped,	  MLCT	  from	  Veeco	  Probes)	  were	  immersed	  in	  chloroform	  for	  10	  min.	  Afterwards,	  
the	   cantilevers	  were	  dried	  with	  nitrogen	  and	  placed	   in	   “piranha”	   solution	   for	  30	  min.	  After	   the	  
“piranha”	   treatment,	   the	   cantilevers	   were	   rinsed	   with	   Milli-­‐Q	   water,	   followed	   by	   drying	   with	  
nitrogen.	  Cantilevers	  were	   then	  coated	  with	  a	  gold	   film	  using	   the	   thermal	  evaporation	  method.	  
First,	  a	  chromium	  layer	  of	  ~30Å	  was	  deposited	  at	  a	  rate	  of	  ~0.1	  Å/s,	  and	  then	  a	  gold	  layer	  of	  ~600	  
Å	  was	  evaporated	  onto	  the	  chromium	  layer	  at	  a	  rate	  of	  ~1.0	  Å/s.	  
A	   monolayer	   of	   1,8-­‐octanedithiol	   (Sigma-­‐Aldrich)	   and	   6-­‐mercapto-­‐1-­‐hexanol	   (Sigma-­‐
Aldrich)	  was	  self-­‐assembled	  onto	  the	  gold-­‐coated	  cantilever	  by	   incubation	  in	  a	  mixture	  (10	  mM)	  
of	  these	  two	  thiols	  for	  20	  h.	  Changing	  the	  thiol	  ratios	  enabled	  control	  of	  the	  BabA	  density	  on	  the	  
cantilever	   surface.	   Ratios	   from	   1:10	   up	   to	   1:40	   (1,8-­‐octanedithiol:6-­‐mercapto-­‐1-­‐hexanol)	   were	  
evaluated	   in	   order	   to	   identify	   the	   surface	   composition	   that	   resulted	   in	   optimum	   binding	  
frequency	   for	   force	   spectroscopy	   measurements.	   The	   monolayers	   were	   then	   activated	   with	  
poly(ethylene	   glycol)	   -­‐α-­‐maleimide,	   ω-­‐N-­‐hydroxyl-­‐	   succinimide	   ester	   (NHS-­‐PEG-­‐MAL-­‐3500	   KDa,	  
JenKem).	   The	   maleimide	   group	   (MAL)	   reacts	   with	   exposed	   thiols	   on	   the	   1,8-­‐octanedithiol	  
monolayer	   and	   the	   exposed	  NHS	   group	   covalently	   binds	   free	   amines	   on	   the	  BabA	  protein.	   The	  
purification	  of	  the	  bacterial	  BabA	  adhesin	  protein	  from	  17875/Leb	  H.	  pylori	  strain	  was	  performed	  
in	  the	  Department	  of	  Medical	  Biochemistry	  and	  Biophysics,	  Umeå	  University,	  Sweden.	  
Instead	   of	   immobilizing	   the	   BabA	   adhesin	   directly	   to	   the	   cantilever	   tip,	   it	   was	   bound	   to	  
immobilized,	   linear	   PEG	   chains.	   The	   flexible	   PEG	   linker	   allows	   for	   rapid	   reorientation	   of	   the	  
protein	   when	   the	   AFM	   tip	   approaches	   the	   surface.	   In	   addition,	   PEG	   would	   reduce	   nonspecific	  
binding	  between	  the	  tip	  and	  substrate	  and	  the	  heterogeneity	  that	  can	  result	  from	  the	  distributed	  
orientations	   of	   proteins	   bound	   directly	   to	   the	   surface.	   The	   tether	   extension	   is	   also	   used	   to	  
determine	   the	   effective	   loading	   rates	   at	   bond	   rupture	   (see	   below).	   The	   optimal	   PEG	   and	   BabA	  
concentrations	  for	  these	  dynamic	  force	  spectroscopy	  studies,	  as	  determined	  from	  the	  frequency	  
of	   nonspecific	   binding	   events	   or	   multi-­‐point	   attachments,	   were	   experimentally	   determined	   by	  
testing	  different	  ratios	  of	  PEG	  and	  BabA.	  
	  
3.3.	  -­‐	  Force	  measurements	  and	  data	  analysis	  
The	   bond	   rupture	   forces	   were	   measured	   with	   the	   Molecular	   Force	   Probe	   (MFP)	   1-­‐D	  
(Asylum	   Research)	   using	   the	   Igor	   Pro	   software	   (WaveMetrics)	   for	   data	   acquisition	   and	   piezo	  
control.	  The	  optical	  lever	  sensitivity	  was	  first	  calibrated	  by	  pressing	  the	  tip	  against	  a	  hard	  surface	  
to	  obtain	   the	   tip	  deflection	   in	  nanometers.	  The	  cantilever	  spring	  constants,	  calibrated	  using	   the	  
	  Chapter	  V	   	  	  
	   133	  
thermal	   method,	   were	   0.01–0.025	   N/m.29	   Force	   measurements	   were	   performed	   as	   described	  
elsewhere.30	  
Briefly,	   we	   used	   a	   steady	   force	   ramp	   to	   rupture	   the	   bonds.	   In	   the	   measurements,	   the	  
cantilever	  was	  brought	   to	  contact	  with	   the	  surface	  with	  an	   impingement	   force	   less	   than	  30	  pN,	  
and	  then	  retracted	  at	  a	  constant	  velocity.	  Three	  to	  four	  thousand	  force	  curves	  were	  recorded	  at	  
each	   loading	   rate	   used.	   The	   “nominal	   loading	   rate”	   is	   the	   spring	   constant	   multiplied	   by	   the	  
cantilever	   velocity,	   but	   the	   “effective	   loading	   rate”	   is	   the	   actual	   loading	   rate	   on	   the	   bond,	  
determined	   from	   the	   elastic	   stretch	   region	   of	   the	   flexible	   PEG	   tethers.	   The	   slope	   of	   the	   latter	  
curve	  just	  prior	  to	  bond	  rupture	  determines	  the	  effective	  spring	  constant	  (keff).	  Thus,	  the	  effective	  
loading	  rate	  at	  rupture	  is	  keff	  ×	  v	  where	  v	  is	  the	  cantilever	  velocity.	  The	  nominal	  loading	  rates	  used	  
were	   250,	   1550,	   3550,	   5550	   and	   10500	   pN/s.	   The	   surface	   chemistry,	   and	   hence	   the	   protein	  
density	  on	  the	  tip,	  was	  adjusted,	  in	  order	  to	  achieve	  binding	  frequencies	  of	  10-­‐30	  %,	  such	  that	  not	  
more	  than	  30	  out	  of	  100	  touches	  to	  the	  surface	  generated	  an	  adhesion	  event.	  This	  increases	  the	  
likelihood	  that	  the	  detected	  binding	  events	  represent	  single	  bonds.	  Force-­‐extension	  curves	  were	  
analyzed	   with	   a	   custom	   written	   program.	   For	   each	   force-­‐extension	   profile	   displaying	   a	   single	  
rupture	  event,	  the	  rupture	  force	  and	  the	  effective	  loading	  rate	  were	  both	  determined.	  Histograms	  
of	  the	  rupture	  forces	  measured	  at	  each	  loading	  rate	  were	  fit	  to	  Gaussian	  distributions,	  in	  order	  to	  
determine	  the	  most	  probable	  rupture	  force	  at	  a	  particular	  loading	  rate.30	  Further	  details	  regarding	  
the	  data	  analyses	  are	  in	  the	  supplementary	  material.	  
	  
3.4.	  -­‐	  Bond	  kinetics	  
We	  analyzed	  the	  dependence	  of	  the	  BabA–Leb	  bond	  rupture	  using	  the	  model	  of	  Evans	  and	  






/−×= 	  (1)	  
where	  koff	   is	   the	   intrinsic	   dissociation	   rate	   of	   the	   unstressed	   bond.	   The	   so-­‐called	   thermal	  
force	  is	  fβ=kT/xβ	  where	  xβ	  is	  the	  projection	  of	  the	  transition	  state	  along	  the	  force	  vector.	  
When	  the	  applied	  force	  increases	  linearly	  with	  time,	  the	  distribution	  of	  rupture	  forces	  p(f)	  

























fp 	  (2)	  
The	  most	  probable	   force	   (MFP)	   is	   the	  maximum	   in	   the	   force	  distribution	  determined	  at	  a	  
given	  pulling	  rate,	  and	  is	  related	  to	  the	  loading	  rate	  rf	  by21:	  
	  Chapter	  V	   	  	  
	  134	  
( ) ( )βββ fkfrff offfmp ××−×= lnln 	  (3)	  
For	  a	  simple	  bond	  confined	  by	  a	  single	  activation	  barrier,	  fmp	  is	  predicted	  to	  increase	  linearly	  
with	  the	  ln	  (rf),	  and	  fβ	  and	  koff	  are	  obtained	  from	  MPF	  vs	  ln	  (rf)	  plots.	  
	  
4.	  -­‐	  RESULTS	  
4.1.	  -­‐	  Optimizing	  immobilization	  conditions	  
To	   increase	   the	  probability	  of	   forming	   single	   receptor-­‐ligand	  bonds	   (binding	   frequency	  of	  
10-­‐30	   %),	   the	   optimal	   ratio	   between	   1,8-­‐octanodithiol	   and	   6-­‐mercapto-­‐1-­‐hexanol	   was	  
experimentally	  determined	  to	  be	  1:20.	  This	  is	  important	  because	  1,8-­‐octanodithiol	  is	  used	  to	  form	  
the	   bond	   to	   the	   PEG	   linker	   that	   later	   binds	   the	   protein,	   being	   this	   chemical	   diluted	   in	   a	   6-­‐
mercapto-­‐1-­‐hexanol	  matrix,	  in	  order	  to	  avoid	  an	  excess	  of	  PEG	  linker	  and	  therefore	  BabA	  on	  the	  
cantilever	  surface.	  
Self-­‐assembled	  monolayers	  (SAMs)	  were	  first	  generated	  by	  a	  mixture	  composed	  of	  97.5	  %	  
EG4-­‐	   thiol	   and	   2.5	   %	   biotin-­‐thiol.	   The	   2.5	   %	   biotin	   SAMs	   formed	  was	   next	   used	   to	   immobilize	  
biotinylated	  Leb	  glycan	  via	  a	  Neutravidin	  bridge,	  which	  is	  a	  biotin-­‐binding	  protein.	  The	  SAMs	  used	  
in	   this	   study	   have	   been	  previously	   characterized	   and	   it	   provides	   higher	   Leb	   immobilized	   on	   the	  
surface	   (unpublished	  work).	   The	   optimum	   conditions	   resulted	   in	   the	   desired	   binding	   frequency	  
(10-­‐30	   %),	   which	   generally	   insures	   that	   bond	   rupture	   refers	   to	   single	   binding.30	   The	   range	   of	  
concentrations	   tested	   was	   based	   on	   previous	   work30	   and	   the	   optimum	   concentrations	  
experimentally	  determined	  for	  the	  BabA-­‐Leb	  assays	  were	  0.8	  mg/mL	  for	  the	  Leb	  glycan	  and	  0.08	  
mg/mL,	  for	  the	  BabA	  protein.	  
	  
4.2.	  -­‐	  Force	  Spectroscopy	  Measurements	  
In	   all	   experiments,	   the	   impingement	   force	   was	   kept	   at	   <30	   pN	   to	   minimize	   nonspecific	  
binding.	  In	  control	  measurements	  between	  Neutravidin-­‐SAMs	  without	  Leb	  and	  Leb-­‐SAMs	  assayed	  
with	  a	  cantilever	  without	  bound	  BabA	  the	  nonspecific	  binding	  frequency	  (#	  adhesion	  events/#	  tip-­‐
surface	  contacts)	  was	  <2-­‐3	  %,	  compared	  to	  the	  binding	  frequency	  of	  10-­‐20	  %	  obtained	  when	  BabA	  
protein	   was	   bound	   to	   the	   tip.	   Furthermore,	   the	   nonspecific	   forces	   were	   low	   and	   randomly	  
distributed.	  
In	  order	  to	  determine	  the	  number	  of	  bound	  states	  and	  their	  unstressed	  dissociation	  rates,	  
the	   cumulative	   distribution	   of	   rupture	   forces	   at	   each	   loading	   rate	  was	   fitted	  with	   a	  multi-­‐state	  
binding	  model	  (see	  supplemental	  information).	  The	  Most	  Probable	  Force	  (MPF)	  for	  each	  peak,	  as	  
determined	  from	  the	  calculated	  maxima	  in	  the	  force	  distributions,	  was	  plotted	  against	  the	  Log10	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of	  the	  nominal	  loading	  rates.	  
Figures	  2	  (A-­‐E)	  show	  the	  force	  histograms	  at	  the	  four	  loading	  rates	  tested.	  Visual	  inspection	  
of	  these	  histograms	  reveals	  a	  broad	  peak	  that	  shifts	  to	  higher	  forces	  with	  increasing	  loading	  rate.	  
This	   behavior	   indicates	   specific	   bond	   formation	   between	   the	   tip	   and	   surface.	   However,	   the	  
histograms	  are	  broader	  than	  predicted	  by	  the	  probability	  distribution	  for	  a	  single	  bond,	  and	  this	  
could	   be	   due	   to	   the	   formation	   of	   more	   than	   one	   type	   of	   bond.	   This	   observation	   was	   further	  
supported	  by	  the	  poor	  fit	  of	  the	  histogram	  to	  the	  probability	  distribution	  for	  single	  bond	  rupture	  
(supplemental	  information).	  Instead,	  the	  histograms	  are	  best	  described	  by	  a	  two-­‐state	  model,	   in	  
which	  two,	  independent	  bond	  rupture	  events	  contribute	  to	  the	  histogram.	  The	  best-­‐fit	  model	  was	  
justified	   using	   an	   F-­‐test,	   which	   compares	   the	   goodness	   of	   fit	   of	   two	   models	   with	   different	  
numbers	  of	  parameters.30	  
Figure	  2F	  shows	  the	  resulting	  force	  spectra,	  or	  plots	  of	  the	  MPF	  versus	  Log10	  (rf)	  for	  each	  of	  
the	  two	  peaks	  identified	  from	  the	  two-­‐state	  binding	  model.	  From	  linear	  fits	  of	  the	  force	  spectra	  to	  
equation	  3,	  one	  obtains	  the	  thermal	  forces	  (fβ),	  the	  parameter	  xβ,	  and	  the	  unstressed	  dissociation	  
rate	  (koff).30	  These	  fitted	  parameters	  are	  summarized	  in	  Table	  1.	  
In	   order	   to	   test	   whether	   the	   broad	   distribution	   of	   rupture	   events	   was	   instead	   due	   to	  
multiple,	  parallel	   tip-­‐surface	  bonds	  rather	   than	  to	   the	   formation	  of	   two,	  different	  bound	  states,	  
the	  data	  were	  also	  fit	  to	  a	  model	  for	  N	  parallel,	   identical	  bonds,	  as	  described	  previously.32	   If	  the	  
force	  were	  shared	  between	  N	  parallel	  bonds,	  then	  each	  bond	  would	  experience	  a	  force	  f/N,	  and	  
the	   failure	   of	   each	   of	   the	  N	   bonds	  would	   be	   uncorrelated.33	   In	   this	   case,	   the	   force	   distribution	  
(Equation	   2)	   is	   approximated,	   by	   replacing	   koff	   and	   fβ	   for	   a	   single	   bond	   by	   Nkoff	   and	   Nfβ,	  
respectively.24,32	   To	   determine	   whether	   the	   peak(s)	   at	   higher	   forces	   were	   due	   to	   multivalent	  
attachments,	   we	   used	   the	   bond	   parameters	   obtained	   for	   the	   low	   force	   peaks,	   in	   order	   to	  
calculate	  probability	  distributions	  for	  N,	  parallel,	  weak	  bonds,	  where	  N	  =	  2,	  3,	  or	  4.	  However,	  the	  
thus	   calculated	   probability	   distributions	   did	   not	   fit	   the	   second	   peak	   (not	   shown),	   and	   indicates	  
that	  the	  two	  peaks	  in	  the	  distribution	  are	  due	  to	  two,	  independent	  bonds.	  
A	  three-­‐state	  model	  was	  also	  tested,	  in	  order	  to	  determine	  whether	  the	  broad	  distribution	  
in	   the	   tail	  of	   the	  histogram	   in	  Figure	  2,	  particularly	  at	   the	  higher	  pulling	   rates,	   is	  due	   to	  a	   third	  
bound	   state.	   However,	   as	   the	   loading	   rate	   increased,	   the	  most	   probable	   force	   of	   the	   putative	  
third	  bond	  varied	  randomly	  with	  Ln(rf).	  This	  indicated	  that	  the	  tails	  at	  higher	  loading	  rates	  are	  due	  
to	  nonspecific	  binding	  rather	  than	  to	  the	  formation	  of	  an	  additional	  bound	  state.	  For	  this	  reason,	  
the	  force	  distributions	  were	  fitted,	  by	  using	  the	  2-­‐state	  model	  (Figure	  S2).	  Further	  details	  of	  the	  
data	  analyses	  are	  given	  in	  the	  supplementary	  material.	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Figure	  2	  -­‐	  Adhesion	  measurements	  between	  BabA	  and	  Leb.	  (A-­‐E)	  Histograms	  of	  the	  rupture	  force	  distribution	  measured	  
at	   the	  different	   tested	   loading	   rates.	   (F)	  The	   force	  spectra	   (Most	  Probable	  Force	   (MPF)	  vs.	   Log	   (rf)	  plots)	  of	  BabA-­‐Le
b	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Table	  I	  shows	  the	  fitted	  values	  for	  molecular	  bonds	  involved	  in	  the	  BabA/Leb	  interaction.	  
	  
Table	   I	   -­‐	  Dissociation	  rates,	  thermal	  forces	  and	  lengths	  of	  the	  BabA-­‐Leb	  bonds	  determined	  from	  linear	  fits	  to	  the	  force	  
spectra.	  fβ-­‐	  thermal	  force;	  koff-­‐	  dissociation	  rate;	  xβ-­‐	  bond	  length.	  








18.3	  ±2.3	   0.6±	  0.1	   0.26±0.03	  
Weak	  bond	  
	  
15.9	  ±1.7	   3	  ±0.7	   0.23±0.01	  
	  
5.	  -­‐	  DISCUSSION	  
H.	   pylori	   adhesion	   to	   gastric	   epithelial	   cells	   is	   important	   for	   establishment	   of	   a	   life-­‐long	  
persistent	  infection	  by	  the	  more	  virulent	  and	  adhesive	  H.	  pylori	  types.	  Bacterial	  adhesion	  induces	  
alterations	  of	   gene	  expression	  both	   in	  H.	  pylori	   and	   in	   the	  gastric	  host	   cells.34,35	   contributing	   to	  
establishment	  of	  a	  chronic	  mucosal	  inflammation	  and	  development	  of	  gastric	  diseases.7,8,36	  
Moreover,	   adhesion	   protects	   bacteria	   from	   host	   clearance	   mechanisms	   such	   as mucous	  
shedding	  and	   the	  peristaltic	  movements.	  Approximately	  20	  %	  of	  H.	  pylori	  present	   in	   the	  gastric	  
epithelium	  adhere	  to	  the	  surface	  of	  mucus	  epithelial	  cells.37	  BabA	  is	  an	  outer	  membrane	  protein	  
adhesin,	  which	  mediate	  adherence	  between	  H.	  pylori	  and	  the	  ABO/Leb	  histo-­‐blood	  group	  glycan	  
type	  of	  antigen	  expressed	  on	  the	  surface	  of	  gastric	  epithelial	  cells.5,38,39	  
In	   these	  AFM	   investigations	  of	   bonds	  between	   the	  BabA	  adhesin	  protein	   and	   its	   cognate	  
Leb-­‐receptor,	  several	  factors	  should	  be	  considered.	  First,	  the	  molecular	  anchorage	  to	  the	  surfaces	  
should	   be	   much	   stronger	   than	   the	   receptor-­‐ligand	   bonds	   being	   studied.	   Second,	   the	   surface	  
density	   of	   the	   molecules	   should	   be	   sufficiently	   low,	   in	   order	   to	   ensure	   single-­‐molecule	  
interactions.	  Third,	   tethering	  the	  molecules	  to	   flexible	  PEG	  spacers	   increased	  the	   likelihood	  that	  
the	  binding	   site	   of	   covalently	   bound	  protein	  would	  be	  more	   accessible,	   rather	   than	  blocked	  by	  
some	   immobilized	  orientations.	   Fourth,	   unspecific	   adhesion	   to	   the	  modified	   surfaces	   should	  be	  
minimized	  in	  order	  to	  increase	  the	  signal	  to	  noise	  in	  the	  measured	  receptor-­‐ligand	  bond	  rupture	  
forces.20,40	   The	  density	  of	   the	  BabA	  protein	  on	   the	  AFM	  cantilever	  probe	   tip	  and	   the	  glycan	   Leb	  
ligand	  on	   the	   substrate	   (SAMs)	  were	  experimentally	   adjusted	   to	  meet	   the	  expectation	   that	   the	  
surface	   layers	  were	  neither	  nonspecifically	  bound	  nor	   clustered.	  Also,	   a	  PEG	   linker	  was	  used	   to	  
tether	  the	  protein,	   to	   insure	  orientational	   flexibility	  and	  to	  provide	  a	  non-­‐fouling	  background	  to	  
avoid	  nonspecific	  tip-­‐surface	  adhesion.	  Moreover,	  binding	  frequencies	   in	  the	  20-­‐30	  %	  range	  and	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analyses	  of	   the	   force	  histograms	   indicated	   that	   the	   rupture	   forces	   likely	   corresponded	   to	   single	  
molecule	  events.	  
The	   experimentally	   determined	   bond	   rupture	   data	   suggested	   that	   a	   two-­‐state	   binding	  
model	  best	  describes	  the	  force	  data,	  measured	  between	  purified	  ligand	  and	  adhesin.	  A	  previous	  
report	   of	   BabA-­‐Leb	   bond	   strengths,	   based	   on	   optical	   tweezers	   measurements	   with	   bacteria,	  
identified	  a	   single	  slip	  bond.41	  There	  are	   important	  differences	  between	   the	  measurements	  and	  
analyses	   used	   in	   the	   two	   studies.	   First,	   the	   prior	   optical	   tweezers	   study	   measured	   binding	  
between	   a	   bead	   modified	   with	   Leb	   and	   a	   bacterium	   bound	   to	   an	   optically	   trapped	   bead.	  
Measurements	   with	   cells	   can	   be	   complicated	   by	   the	   complexity	   of	   the	   cell	   surface	   and	   the	  
potential	   for	   increased	  nonspecific	   binding.	   Indeed,	   the	   force	  histogram	  was	  more	   rugged	   than	  
reported	  here.	  To	  minimize	  nonspecific	  binding,	  in	  the	  tweezers	  study,	  the	  bead-­‐cell	  contact	  time	  
was	  kept	   short.	   The	   reported	  histogram	  was	  also	  broad,	  and	   the	   range	  of	   forces	  was	   similar	   to	  
that	  observed	   in	   these	  AFM	  measurements	  of	   Leb	  binding	   to	   the	  purified,	   immobilized	  adhesin.	  
Different	   from	   the	  prior	   study,	  however,	  here	  we	  analyzed	   the	  histograms	   in	  more	  detail	   using	  
established	   methods25,	   and	   found	   that	   the	   broad	   histograms	   could	   be	   attributed	   to	   a	   second	  
bound	  state.	  The	  separate	  analyses	  of	   the	  two	  peaks	  contributing	  to	  the	  force	  histogram	  would	  
necessarily	  give	  rise	  to	  differences	  in	  the	  estimated	  bond	  parameters	  in	  these	  two	  studies.	  
Interestingly,	  dissociation	  rates	  determined	  for	  the	  BabA-­‐Leb	  complexes	  were	  3	  ±	  0.7	  s-­‐1	  and	  
0.6	  ±	  0.1	  s-­‐1,	   respectively.	  Although	  the	  force	  histograms	  were	  similar,	   these	  rates	  are	  >100-­‐fold	  
than	   the	   rate	   estimated	   from	   optical	   laser	   tweezers	   data.	   The	   faster	   off-­‐rates	   are	   in	   the	   same	  
range	   as	   reported	   for	   the	   self-­‐association	   of	   mucins42	   and	   for	   single	   L-­‐selectin-­‐	   carbohydrate	  
bonds.22	  The	  values	  for	  xβ	  for	  the	  weak	  and	  stronger	  BabA-­‐Leb	  bonds	  are	  0.26	  ±	  0.03	  nm	  and	  0.23	  
±	   0.01	   nm,	   respectively.	   These	   are	   also	   within	   the	   range	   reported	   for	   other	   biomolecular	  
interactions,	   including	  glycosaminoglycan	  (GAG)	   interactions	  with	  cartilage	  aggrecan	  (xβ	  ≈	  0.31	  ±	  
0.08	  nm)43	  and	  individual	  mucin1-­‐	  antibody	  bonds	  (xβ	  ≈	  0.28	  ±	  0.02	  nm).44	  Another	  example	  is	  the	  
value	   of	   xβ	   ≈	   0.26	   nm	   determined	   for	   the	   mannuronan	   AlgE4	   polysaccharide−protein	   bond.45	  
These	  values	  are	  all	   lower	  than	  the	  0.86	  nm	  reported	  previously	   for	  BabA-­‐Leb	  binding.	  As	  noted	  
above,	  a	  possible	  reason	  for	  this	  difference	  may	  be	  due	  to	  the	  use	  of	  the	  one-­‐state	  versus	  two-­‐
state	  model.	  
It	  is	  worth	  considering	  alternative	  reasons	  for	  the	  apparent	  difference,	  beyond	  the	  models	  
used.	   First,	   one	  of	   the	   two	  bonds	  observed	   in	   the	  AFM	  measurements	   could	   form	  more	   slowly	  
than	  the	  short	  dwell	  time	  used	  in	  the	  optical	  tweezers	  experiments,	  and	  therefore	  may	  not	  have	  
been	  as	  prevalent	  in	  the	  previously	  reported	  force	  histograms.41,46	  Alternatively,	  the	  recombinant,	  
purified	  protein	  could	  be	  more	  conformationally	  heterogeneous	  than	  the	  membrane	  bound	  form.	  
In	   this	   case,	   the	   purified	   protein	   might	   adopt	   conformations	   with	   slightly	   different	   bond	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properties	   whereas	   the	   membrane	   bound	   BabA	   population	   could	   be	   more	   uniform.	   Exploring	  
these	  possibilities	  is	  beyond	  the	  scope	  of	  this	  work,	  but	  they	  are	  possibilities	  to	  be	  considered.	  
These	   results	   are	   also	   important	   for	   better	   identifying	   BabA-­‐Leb	   properties	   that	   may	  
contribute	   to	   the	  biology	  of	   infection.	  Multivalent	   interactions,	   for	   example,	   are	  well	   known	   to	  
enhance	   the	   lifetime	   and	   apparent	   affinity	   of	   particle-­‐cell	   or	   pathogen-­‐cell	   interactions.44,47	   In	  
addition,	  some	  E.	  coli	  exhibit	  catch	  bonds	  between	  adhesins	  on	  the	  pili	  tips	  and	  ligands	  on	  target	  
cell	   surfaces.48	  Recent	  single	  bond	  rupture	  studies	  of	  cadherins	  demonstrated	  that	   the	  adhesive	  
extracellular	  domains	  exhibit	  multiple	  bonds.49	  One	  of	  the	  cadherin	  bonds	  is	  a	  catch-­‐bond	  and	  a	  
second	  is	  a	  slip	  bond.50	  Together	  these	  could	  enable	  cadherins	  to	  adjust	  cell	  adhesion	  to	  changes	  
in	  the	  mechanical	  environment.	  How	  the	  two	  bound	  states	  identified	  in	  this	  study	  contribute	  to	  H.	  
pylori	  adhesion	  have	  yet	  to	  be	  determined.	  In	  the	  gastric	  environment,	  where	  shear	  stress	  at	  the	  
gastric	  wall,	   constant	  cell	   renewal,	  and	  mucus	   shedding	  make	   it	  difficult	   for	  bacteria	   to	  adhere,	  
different	  bonds	  with	  different	  kinetics	  and	  strengths	  could	  play	  an	  important	  role	  in	  initiating	  and	  
maintaining	  a	  chronic	  bacterial	  infection.51	  
This	  new	   insight	   into	  the	  adhesion	  complex	  BabA-­‐Leb	  also	  suggests	   that	   the	  BabA	  protein,	  
for	  which	   the	   structure	   has	   not	   been	   determined,	  may	   possess	   different	   domains	   for	   bacterial	  
binding	  to	  the	  host	  ABO/Leb	  binding	  sites	  in	  the	  gastric	  mucosa.	  
These	  findings,	  based	  on	  measurements	  with	  purified	  adhesin	  and	  ligand,	  further	  identified	  
additional	   biophysical	   properties	   of	   the	   BabA-­‐Leb	   interaction.	   The	   strong,	   specific	   binding	  
mediated	  by	  BabA	  suggests	   that	   translational	  applications	  by	  use	  of	   synthetic	   Leb	   structures,	  as	  
nanoadhesives	  for	  H.	  pylori	  binding	  is	  highly	  appropriate	  for	  the	  development	  of	  new	  therapeutic	  
strategies	  for	  infection	  management.	  
	  
6.	  -­‐	  CONCLUSIONS	  
The	  new	  results	   reveal	  new	   insights	   into	  the	  biophysical	  properties	  of	  BabA-­‐Leb	  adhesion,	  
and	  suggest	  that	  the	  H.	  pylori	  BabA	  adhesin	  protein	  can	  form	  different	  bonds	  with	  Leb	  glycans.	  By	  
disclosing	   some	   of	   the	   molecular	   features	   of	   the	   H.	   pylori	   binding	   mechanisms	   for	   glycan	  
structures	   expressed	   in	   the	   host	   gastric	   mucosa,	   the	   new	   results	   may	   further	   guide	   the	  
development	  of	  alternative	  therapies	  for	  H.	  pylori	  eradication	  based	  on	  immobilization	  of	  glycan	  
structures	  onto	  mucoadhesive	  biomaterials	  for	  clearance	  of	  H.	  pylori	  infection.	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9	  -­‐	  SUPPLEMENTAL	  MATERIAL-­‐	  AFM	  DATA	  ANALYSIS	  
Single	   bond	   rupture	   data	   can	   be	   influenced	   by	   several	   factors.	   A	   common	   factor	   is	   the	  
formation	   of	   simultaneous,	   parallel	   bonds	   between	   the	   tip	   and	   the	   surface.	   To	   determine	  
whether	   the	   broad	   force	   histograms	   could	   be	   explained	   by	   parallel	   BabA-­‐Leb	   bonds,	   the	  
histograms	  were	  analyzed	  using	  the	  approaches	  and	  tests	  described	  below.	  
	  
A)	  Histogram	  construction	  
Features	  in	  the	  histograms	  of	  the	  force	  distributions	  can	  depend	  on	  the	  bin	  size	  (h)	  and	  the	  
starting	  point	  of	  the	  histogram	  used	  to	  fit	  the	  data	  to	  models	  of	  bond	  rupture.	  Incorrect	  binning	  
can	   lead	   to	   errors	   in	   data	   interpretation,	   such	   as	   underestimating	   or	   overestimating	   of	   the	  
number	   of	   statistically	   significant	   peaks	   in	   the	   histograms.	   In	   this	   work,	   the	   histograms	   were	  
constructed,	  by	  calculating	  the	  bin	  size	  using	  the	  following	  equation:	  
3/1n5.3h −= σ 	  (Equation	  S1)1	  
where	  h	   is	   the	  bin	   size,	  σ	   is	   the	   standard	  deviation	  of	   the	   force	  distribution,	  and	  n	   is	   the	  
total	   number	  of	   single	   rupture	   events	  measured.2	   The	   start	   points	   of	   the	  histograms	  were	   also	  
altered,	   in	   order	   to	   estimate	   the	   standard	   error	   of	   the	  most	   probable	   force	   (MPF),	   which	  was	  
determined	  from	  fits	  of	  the	  histograms	  to	  probability	  distributions.	  
	  
B)	  Number	  of	  bound	  states	  
The	   number	   of	   bound	   states	   contributing	   to	   each	   force	   histogram	   was	   firstly	   estimated	  
from	  the	  number	  Nb	  of	  identifiably	  distinct	  peaks	  that	  were	  consistently	  evident	  in	  histograms	  at	  
all	   of	   the	   pulling	   rates	   tested.	   Next,	   an	   initial	   Nb-­‐state	   model	   was	   tested	   with	   dynamic	   force	  
spectroscopy3,	  to	  determine	  whether	  each	  of	  the	  bonds	  (peaks)	  exhibited	  a	  linear	  force	  spectrum,	  
over	  the	  range	  of	  experimental	  pulling	  rates	  used.	  The	  force	  histograms	  were	  then	  fit	  to	  the	  Nb-­‐
state	  model	   to	   test	   the	   goodness	   of	   the	  model	   fit.	   Finally,	   the	   dissociation	   rates	   and	   the	   bond	  
length	  parameters	  were	  determined	  from	  the	  linear	  fits	  of	  the	  resulting	  force	  spectra	  for	  each	  of	  
the	  fitted	  peaks	  (Table	  I,	  main	  text).	  
	  
C)	  Validation	  of	  the	  number	  of	  bound	  states	  
To	  determine	  the	  number	  of	  distinct	  bound	  states	  contributing	  to	  the	  force	  histogram,	  we	  
varied	  the	  bond	  number	  N	  in	  the	  N-­‐state	  model	  used	  to	  fit	  the	  cumulative	  distribution	  function.	  
Then,	  F-­‐tests	  were	  used	  to	  compare	  fits,	  in	  order	  to	  determine	  the	  best-­‐fit	  model.4	  The	  models	  for	  
different	   numbers	   N	   of	   bound	   states	   were	   nested	   within	   each	   other,	   so	   that	   the	   sum	   of	   the	  
square	  of	  residuals	  (SSR)	  resulting	  from	  fits	  of	  the	  cumulative	  distribution	  to	  each	  model	  follows	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the	  F-­‐distribution.5	  This	  enabled	  us	  to	  use	  F-­‐tests	  to	  compare	  two	  models,	  and	  determine	  which	  
best	  described	  the	  force	  data.	  
The	   cumulative	  distribution	   function,	   or	   the	   survival	   probability	   of	   an	   independent	   single	  




























β 	  (Equation	  S2)	  
where	  P(f)	  is	  the	  integral	  of	  the	  density	  probability	  of	  rupture	  forces,	  as	  described	  by	  Evans	  
and	  Ritchie.3	  
The	  overall	  force	  distribution	  for	  the	  N-­‐state	  model	  is:	  
)f(PA...)f(PA)f(PAPi(f) NN2211 ×+×+×= 	  (Equation	  S3),	  
where	   Pi(f)	   is	   the	   cumulative	   distribution	   of	   rupture	   forces	   (Equation	   S2);	   Ai	   is	   the	  
population	  weight	  of	   the	   i	   state;	  koff	   is	   the	  bond	  dissociation	  rate;	   fβ=kBT/xβ	  and	  rF	   is	   the	  pulling	  
rate	  as	  defined	   in	   the	   text.	  Only	  putative	  bonds	   that	  consistently	  appeared	  at	  all	  pulling	  speeds	  
used	   were	   considered	   in	   the	   force	   spectroscopy	   analysis,	   and	   the	   number	   of	   such	   bonds	  
determined	  the	  total	  N	  used	  in	  the	  analyses.	  
Fits	  of	  the	  cumulative	  distribution	  function	  for	  N	  bound	  states	  are	  shown	  in	  Figures	  S1	  (a-­‐c).	  
The	  small	   tail	  at	  higher	   forces	   in	  some	  of	   the	   force	  distributions	   is	  mostly	  overlooked,	  since	  the	  
tailing	   is	   common	   to	  many	   single	   bond	   force	  measurement	   and	   they	   are	   likely	   due	   to	  multiple	  
parallel	  bonds.	  Moreover,	  putative	  peaks	  in	  this	  tail	  region	  were	  not	  observed	  consistently	  at	  all	  
pulling	  rates.	  As	  an	  example	  of	  this	  systematic	  approach,	  the	  force	  distribution	  of	  the	  BabA/Lewis	  
B	  interaction	  at	  a	  loading	  rate	  of	  250	  pN/s	  shows	  a	  spread	  peak	  (Figure	  S1).	  The	  cumulative	  force	  
distribution	  was	  fitted	  with	  a	  1-­‐,	  2-­‐	  and	  3-­‐state	  model	  (N=1,2,3	  in	  Equation	  S2,	  Figure	  S1).	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Figure	  S1	  -­‐	  Comparison	  of	  data	  fit	  of	  cumulative	  force	  distribution	  at	  a	  loading	  rate	  of	  250	  pN/s	  with	  different	  models	  
(right	  panels).	  The	  corresponding	  force	  distribution	  histogram	  with	  fitted	  distribution	  curves	  is	  shown	  on	  left	  panels.	  (a)	  
1-­‐binding	  state;	  (b)	  2-­‐binding	  states;	  (c)-­‐	  3-­‐binding	  states.	  
	  
For	   the	  BabA/Leb	  binding	  data,	   in	  order	   to	   rigorously	   test	  whether	   an	  N-­‐state	  probability	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cumulative	   distribution	  of	  measured	   rupture	   forces	  was	   fit	  with	   Equation	   1.	   Statistically,	   R,	   the	  





	  (Equation	  S4)	  
where	  p	   is	   the	  number	  of	  parameters,	   σ	   is	   the	   standard	  deviation	  of	   the	  measurements,	  
and	  n	  is	  the	  total	  number	  of	  data	  points.	  







21 	  (Equation	  S5)	  
where	  R1	  and	  R2	  are	   the	  sum	  of	   the	  square	  of	   the	  residual	  SSR	   for	  model	  1	  and	  model	  2,	  
respectively.	  Here,	  q	  equals	  p2-­‐p1,	  and	   is	   the	  difference	  between	   the	  number	  of	  parameters	   in	  
model	  2	  (with	  p2	  parameters)	  and	  model	  1	  (with	  p1	  parameters),	  and	  α	  is	  the	  confidence	  level.	  
The	   calculated	   results	   are	   in	   Table	   S1.	   Model	   1	   has	   fewer	   parameters	   (p2	   >	   p1),	   and	  
therefore	  has	  a	   larger	  SSR	  (R1	  >	  R2).	   If	   the	  calculated	  value	  Fv	   is	   larger	  than	  F1-­‐α(q,n-­‐p),	   then	  the	  
addition	  of	  q	  parameters	  in	  model	  1	  improves	  the	  data	  fit,	  in	  a	  statistically	  significant	  manner	  (at	  
the	  α	  confidence	   level),	   so	   that	  model	  2	   is	  a	  better	  description	  of	   the	  data.	  Alternatively	   the	  p-­‐
value	  was	  calculated	  to	  represent	  the	  probability	  of	  selecting	  model	  1	  over	  model	  2	  (Table	  S1).	  
	  





SSR	   DOF	   Fv	   p-­‐value	  
250	  
3	  (1-­‐state)	   0.484508	   460	   	   	  
6	  (2-­‐state)	   0.019582	   457	   3616.823	   <0.001	  
9	  (3-­‐state)	   0.013771	   454	   63.86279	   <0.001	  
1550	  
3	  (1-­‐state)	   0.149908	   412	   	   	  
6	  (2-­‐state)	   0.047879	   409	   290.5244	   <0.001	  
9	  (3-­‐state)	   0.04515	   406	   157.0013	   <0.001	  
	  
Table	   S1	   shows	   two	   examples	   of	   the	   use	   of	   the	   F-­‐test	   to	   evaluate	   the	   obtained	   data	  
regarding	   interactions	   between	   BabA/Leb,	   and	   compares	   a	   1-­‐state	   (3	   parameters),	   2-­‐state	   (6	  
parameters)	  model,	  and	  a	  3-­‐state	  model	  (9	  parameters).	  As	  shown	  in	  Table	  1,	  the	  p-­‐values	  are	  <	  
0.001	  at	  different	  pulling	  rates,	  suggesting	  that	  the	  2-­‐state	  model	   is	  a	  statistically	  better	  fit	  than	  
the	  one-­‐state	  model,	  and	  a	  3-­‐state	  model	  fits	  the	  data	  better	  than	  the	  2-­‐state	  model.	  Of	  the	  force	  
distributions	  measured	  at	   five	  different	  pulling	   rates	   tested,	  all	   five	  are	  statistically	  better	   fitted	  
with	  3-­‐state	  than	  a	  2-­‐state	  model,	  and	  the	  2-­‐state	  model	  gives	  a	  better	  fit	  than	  the	  1-­‐state	  model.	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From	  the	  force	  maxima	  in	  the	  different	  histograms,	  we	  obtained	  the	  most	  probable	  force,	  
and	  plotted	  this	  as	  a	  function	  of	  the	  loading	  rate.	  Figure	  S2a	  compares	  the	  resulting	  force	  spectra	  
for	  the	  1-­‐state	  model	  and	  2-­‐state	  models,	  along	  with	  the	  linear	  fits	  to	  force	  spectra.	  
	  
Figure	  S2	  -­‐	  Force	  spectra	  of	  (a)	  2-­‐state	  model	  fit	  vs.	  (b)	  3-­‐state	  model	  fit.	  
	  
The	  3rd	   state	  did	  not	  exhibit	  a	   linear	   relation	  between	   the	  MPF	  and	  Log10	  of	   loading	   rate,	  
suggesting	  that	  this	  may	  be	  due	  to	  nonspecific	  binding	  or	  to	  multiple,	  parallel	  bonds.	  
Therefore,	  a	  2-­‐state	  model	  appears	  to	  give	  the	  most	  consistent	  description	  of	  the	  data.	  The	  
results	  given	  in	  the	  main	  text	  refer	  to	  the	  2-­‐state	  model,	  and	  the	  bond	  parameters	  for	  these	  two-­‐
states	  are	  given	  in	  Table	  I	  in	  the	  main	  text.	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1.	  -­‐	  GENERAL	  DISCUSSION	  
Gastric	  cancer	  is	  the	  second	  leading	  cause	  of	  cancer-­‐related	  deaths	  worldwide,	  accounting	  
for	  738.000	  deaths	  in	  2008.1,2	  In	  particular,	  the	  intestinal-­‐type	  carcinoma,	  the	  most	  frequent	  type	  
of	  gastric	  cancer,	  is	  considered	  to	  be	  the	  final	  stage	  of	  a	  cascade	  of	  carcinogenic	  gastric	  lesions3,	  
which	   is	   initiated	   by	   infection	  with	  Helicobacter	   pylori.4,5	   Although	   bacterial	   infection	   rates	   and	  
gastric	   cancer	   cases	   have	   been	   declining	   in	   the	   past	   few	   years,	   the	   pathogen	   prevalence	  
worldwide	  nowadays	   is	  still	  estimated	  to	  be	  50	  %.	  Namely,	  Portugal	  has	  a	  high	  prevalence	  of	  H.	  
pylori	  infection,	  being	  estimated	  that	  80	  %	  of	  the	  population	  is	  infected,	  as	  well	  as	  high	  incidence	  
of	   diagnosed	   gastric	   cancer	   cases	   per	   year.6	   To	   date,	   the	   only	   available	   options	   for	   H.	   pylori	  
infection	  treatment	  are	  based	  on	  antimicrobial	  therapy	  (antibiotics	  plus	  proton	  pump	  inhibitors).	  
Despite	   the	   pharmacological	   advances,	  with	   better	   formulations	   and	  more	   powerful	   drugs,	   the	  
need	   for	  newer	  and	  more	  effective	  options	   for	  H.	  pylori	   infection	  management	   remains.	  This	   is	  
motivated	  because	  of	   the	   increasing	  bacterial	   resistance	   to	  antibiotics,	  patient	  poor	  compliance	  
to	   the	   complex	   therapeutic	   scheme	   and	   the	   difficulty	   to	   establish	   a	   standard	   treatment	  
worldwide.7-­‐9	  
H.	  pylori	   infection	   is	  dependent	  on	  bacterial	  adhesion	  to	  the	  gastric	  mucosa,	  which	  occurs	  
via	  bacterial	  outer	  membrane	  proteins	  that	  act	  as	  adhesins,	  allowing	  bacterium-­‐cell	  contact	  and	  
mediating	  the	  adhesion	  event.	  The	  Blood	  group	  binding	  Adhesin	  (BabA)	  and	  the	  Sialic	  acid	  binding	  
Adhesin	  (SabA)	  are	  the	  most	  prominent	  adhesins	  that	  have	  been	  extensively	  studied,	  as	  well	  as	  its	  
cognate	  glycosylated	  receptors	  (Gly-­‐Rs),	  Lewis	  B	  (Leb)	  and	  sialyl-­‐Lewis	  x	  (sLex),	  respectively.	  Since	  
bacterial	  adhesion	  to	  the	  gastric	  mucosa	  is	  crucial	  for	  infection	  and	  disease	  course,	  it	  represents	  
an	  attractive	  therapeutic	  target.	  
The	  work	  here	  described	  provides	   the	  proof	  of	   concept	   studies	   for	   the	  development	  of	  a	  
bioengineered	  decoy,	  based	  on	  the	  possibility	  of	  Gly-­‐Rs,	  such	  as	  Leb	  and	  sLex,	  specific	  for	  H.	  pylori	  
adhesins	   BabA	   and	   SabA,	   to	   be	   specifically	   recognized	   by	   bacterial	   adhesins	   after	   surface	  
immobilization.	   Resourcing	   to	   mucoadhesive	   polymers	   decorated	   with	   these	   structures,	   will	  
ultimately	  allow	  to	  develop	  a	  bait,	  aiming	  to	  attract	  and	  bind	  the	  bacterium,	  therefore	  allowing	  its	  
removal	  from	  infected	  hosts.	  
As	   a	   first	   approach,	   the	   interaction	   between	   H.	   pylori	   and	   immobilized	   Gly-­‐Rs	   were	  
performed	  using	  models,	  where	   their	   surface	   structure	  was	   controlled	  at	  molecular	   level,	   since	  
polymeric	   materials	   do	   not	   allow	   studies	   at	   this	   scale.	   Self-­‐assembled	   monolayers	   (SAMs)	   of	  
alkanethiols	  on	  gold	  were	  chosen	  since	  they	  are	  well-­‐ordered	  organic	  surfaces	  that	  allow	  control	  
over	  the	  properties	  of	  the	  interface	  at	  the	  nanoscale.10	  
To	  study	  specific	  interactions	  between	  bacterial	  adhesins	  and	  Gly-­‐Rs,	  these	  receptors	  must	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be	   immobilized	  onto	  surfaces	  that	  avoid	  bacterial	  adhesion	  (non-­‐fouling	  surfaces).	  Therefore,	  H.	  
pylori	  non-­‐specific	  adhesion	  was	  firstly	  studied	  using	  SAMs	  with	  distinct	  chemistries,	  namely	  SAMs	  
terminated	  in	  hydrophobic	  CH3-­‐,	  hydrophilic	  OH-­‐	  and	  tetra(ethylene	  glycol)	  (EG4)-­‐	  as	  well	  as	  bare	  
gold	  surfaces.	  H.	  pylori	  strains	  with	  distinct	  BabA	  and	  SabA	  adhesins	  expression	  profile	  were	  used.	  
It	  was	  determined	   that	   the	   adhesion	  of	   these	  H.	  pylori	   strains	  was	  only	  minimal	   on	  EG4-­‐SAMs,	  
demonstrating	   that	   these	   SAMs	   can	  be	  used	  as	  background	   for	  Gly-­‐R	   immobilization.	   This	   non-­‐
fouling	   capacity	   of	   EG4-­‐SAMs	   is	   due	   to	   the	   ethylene	  oxide	   groups	   that	   provides	   a	   template	   for	  
water	   adsorption,	   thus	   creating	   a	   stable	   interfacial	   water	   layer	   that	   prevents	   direct	   contact	  
between	  the	  surface	  and	  the	  cells,	  conferring	  to	  this	  surface	  its	  non-­‐fouling	  properties.11-­‐14	  
The	  effect	  of	  surface	  chemistry	  on	  the	  morphology	  of	  adherent	  bacteria	  was	  also	  evaluated.	  
It	  is	  known	  that	  this	  gastric	  pathogen	  co-­‐exists	  in	  either	  spiral	  (rod)	  or	  coccoid-­‐shaped,	  being	  the	  
last	   often	   associated	   with	   environmental	   stress,	   such	   as	   low	   nutrient	   concentration	   and	   the	  
presence	  of	  antibiotics.15	  The	  importance	  and	  biological	  meaning	  of	  each	  of	  these	  morphologies	  is	  
still	   under	   discussion,	   since	   it	   has	   not	   yet	   been	   established	   if	   the	   coccoid	   shape	   is	   an	   adopted	  
bacterial	   survival	   strategy	  or	   if	   it	   is	  a	  degenerative,	  nonviable	  state.16-­‐18	  Bacteria	  non-­‐specifically	  
bound	  to	  the	  surfaces	  mainly	  adopted	  the	  coccoid	  morphology.	  It	  was	  also	  demonstrated	  that	  the	  
majority	  of	  adherent	  bacteria	  remained	  viable	  in	  all	  surfaces	  used.	  
In	   the	   subsequent	   part	   of	   this	   study,	   interactions	   between	   Leb-­‐	   and	   sLex-­‐functionalized	  
surfaces	   with	   H.	   pylori	   strains	   expressing	   BabA	   and/or	   SabA	   were	   performed.	   Nanostructured	  
surfaces	  were	  designed	   in	  order	   to	  control	  Gly-­‐Rs	  orientation	  and	  density.	  Mixed	  SAMs	  of	  EG4-­‐
terminated	   thiol	   and	   biotin-­‐terminated	   thiol	   (biotin-­‐SAMs)	   were	   used	   to	   immobilize	   the	  
biotinylated	  Gly-­‐Rs	  by	  means	  of	  a	  neutravidin	  bridge.	  This	  approach	  took	  advantage	  of	  the	  non-­‐
fouling	  EG4-­‐terminated	  thiol	  as	  well	  as	  of	  the	  molecular	  properties	  of	  the	  biotin-­‐binding	  proteins	  
system.	   Briefly,	   the	   terminal	   biotin	   group	   at	   the	   SAMs	   surface,	   protruding	   from	   the	   EG4-­‐thiol	  
nonfouling	  background,	  was	  used	   to	  bind	  neutravidin.	   This	   protein	  would	  bind	   the	  biotinylated	  
Gly-­‐Rs	   to	   the	   biotinylated	   SAMs,	   via	   a	   strong	  molecular	   interaction,	   due	   to	   its	   dyad	   symmetry.	  
Moreover,	  this	  immobilization	  strategy	  allows	  to	  control	  the	  Gly-­‐Rs	  orientation	  on	  the	  surface.	  
The	  surface	  coverage	  of	  the	  biotin-­‐thiol	  is	  the	  key	  point	  for	  manipulating	  the	  Gly-­‐Rs	  surface	  
density:	   if	   the	   biotin-­‐thiol	   density	   at	   the	   surface	   is	   too	   high,	   the	   binding	   between	   biotin	   and	  
neutravidin	   would	   be	   difficult	   due	   to	   the	   biorecognition	   sites	   close	   packing;	   if	   the	   biotin-­‐thiol	  
concentration	   is	   too	   low,	   then	   few	   neutravidin	  moieties	  would	   be	   adsorbed	   on	   the	   surface.	   In	  
both	  cases,	  only	   few	  molecules	  of	  Gly-­‐R	  at	   the	  surface	  would	  be	  achieved.	  To	   infer	   the	  optimal	  
biotin-­‐thiol	   amount	   for	   Gly-­‐R	   binding,	   samples	   with	   different	   ratios	   between	   biotin-­‐	   and	   EG4-­‐
thiols	  were	  prepared,	  ranging	  from	  0	  %	  (100	  %	  EG4)	  to	  100	  %	  biotin-­‐thiol.	  Surface	  characterization	  
analyses	  demonstrated	  that	  SAMs	  prepared	  with	  2.5	  %	  biotin-­‐/EG4-­‐thiol	  ratio	  induced	  the	  highest	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Gly-­‐Rs	  coverage.	  SAMs	  prepared	  using	  this	  (2.5	  %)	  and	  lower	  biotin-­‐/EG4-­‐thiol	  ratios	  (2	  %,	  1.5	  %	  
and	  1	  %)	  were	  used	  to	  create	  surfaces	  with	  different	  Gly-­‐Rs	  concentrations.	  
Adhesion	   studies	   evidenced	   an	   association	   between	   the	   expressed	   bacterial	   adhesin	   and	  
the	   analogous	   receptor	   at	   the	   SAMs	   surface.	   This	   binding	   selectivity	   suggests	   that	   even	   after	  
immobilized,	   glycan	   structures	   maintained	   the	   correct	   conformation	   for	   bacterial	   adhesins	  
recognition	   and	   binding.	   Observation	   of	   the	   morphology	   of	   adherent	   bacteria	   suggested	   that	  
specific	  binding	  is	  a	  required	  feature	  for	  the	  pathogen	  to	  keep	  its	  characteristically	  rod	  shape.	  
Understanding	  the	  biophysical	  properties	  of	  the	  bacterial	  BabA	  and	  the	  surface	  exposed	  Leb	  
bound	  is	  of	  particular	  interest,	  since	  this	  novel	  therapeutic	  option	  aims	  to	  target	  this	  complex,	  by	  
diminishing	  bacterial	  adhesion	  to	  the	  host	  gastric	  mucosa	  and	  enhancing	  the	  pathogen	  binding	  to	  
the	   decoy.	   For	   that,	   high-­‐resolution	  measurements	   of	   rupture	   forces	  were	   performed	  between	  
the	  purified	  bacterial	  BabA	  adhesin	  and	  immobilized	  Leb	  structures	  on	  biotin-­‐SAMs.	  Dynamic	  force	  
spectroscopy	  reveals	   two	  similar	  but	  statistically	  distinct	  adhesive	  states.	  These	  findings	  suggest	  
that	  the	  BabA	  adhesin	  may	  form	  multivalent	  attachment	  to	  the	  gastric	  glycosylated	  receptors	   in	  
ways	   that	   enhance	   the	   efficiency	   and	   stability	   of	   bacterial	   attachments.	   The	   multiple	   bonds	  
formation	   between	   a	   bacterial	   cell	   and	   the	   host	   surface	   can	   largely	   enhance	   the	   lifetime	   of	  
interactions	   with	   the	   surface,	   because	   one	   bond	   may	   hold	   the	   cell	   in	   place	   long	   enough	   for	  
another	  receptor	  to	  rebind.	  In	  the	  gastric	  environment,	  where	  the	  shear	  stress,	  the	  constant	  cell	  
renewal	  process	  and	  mucus	  shedding	  are	  obstacles	  for	  bacterial	  adhesion,	  this	  binding	  feature	  is	  
important	  for	  the	  bacterium	  survival	  and	  its	  colonization	  success.	  This	  also	  suggests	  that	  the	  BabA	  
protein,	   which	   structure	   has	   not	   been	   disclosed	   to	   date,	   may	   have,	   at	   least,	   two	   domains	  
responsible	   for	   binding.	   The	   use	   of	   the	   SabA	   adhesin	   to	   perform	   similar	   biophysical	  
characterization	  on	  the	  SabA-­‐sLex	  bound,	  although	  highly	  interesting,	  was	  not	  feasible,	  since	  this	  
glycosilated	   receptor	   has	   not	   yet	   been	   successfully	   purified	   from	   the	   bacteria.	   Also,	   the	   use	   of	  
whole	   bacterial	   cells	   expressing	   the	   BabA	   or	   SabA	   adhesins	   to	   perform	   dynamic	   force	  
spectroscopy	   studies	   was	   hypothesized.	   However,	   when	   using	   whole	   bacterial	   cells,	   there	   are	  
other	  possible	  interactions	  that	  may	  occur	  between	  the	  bacteria	  and	  the	  immobilized	  Gly-­‐Rs	  onto	  
the	   cantilever,	   making	   the	   interpretation	   of	   results	   and	   the	   biophysical	   characterization	   highly	  
difficult	  and	  less	  accurate.	  
Altogether,	  these	  results	  highlight	  that	  the	  Leb	  and	  sLex	  are	  still	  specifically	  recognized	  by	  H.	  
pylori	   after	   surface	   immobilization.	   Therefore,	   the	   use	   of	   these	   structures	   to	   decorate	  
mucoadhesive	   polymers,	   such	   as	   chitosan,	   is	   a	   resourceful	   strategy	   to	   be	   employed	   as	   an	  
alternative	   or	   as	   a	   coadjuvant	   to	   the	   current	   therapeutic	   scheme	   employed	   to	   treat	  H.	   pylori	  
infection.	   Although	   other	   anti-­‐H.	   pylori	   strategies	   are	   currently	   under	   development,	   such	   as	  
vaccines,	  the	  main	  advantage	  of	  the	  one	  herein	  presented	  is	  that	  it	  targets	  infection	  in	  the	  early	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stages	   and	   the	  most	   upstream	  possible,	   since	   it	   aims	   to	   diminish	   the	   bacterial	   adhesion	   to	   the	  
gastric	  mucosa.	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2.	  -­‐	  FUTURE	  PERSPECTIVES	  
Alternatives	  to	  the	  available	  pharmaceutical	  treatments	  for	  H.	  pylori	  infection	  are	  required	  
since	  their	  efficiency	  has	  been	  declining	  for	  several	  years	  now,	  mainly	  due	  to	  bacterial	  resistance	  
to	  antibiotics	  and	  patient	  poor	  compliance	  to	  the	  prescribed	  therapy.	  
The	  development	  of	  strategies	  that	  can	  interfere	  with	  bacterial	  adhesion	  to	  the	  host	  gastric	  
mucosa,	   an	   essential	   step	   for	   disease	   development,	   constitutes	   an	   innovative	   strategy	   for	   H.	  
pylori	  infection	  treatment	  and	  was	  the	  major	  aim	  of	  this	  thesis.	  
It	   was	   clearly	   demonstrated	   that,	   after	   being	   surface	   immobilized,	   Leb	   and	   sLex	   are	   still	  
specifically	   recognized	  by	  H.	  pylori.	  This	   finding	  opens	  new	  perspectives	   for	   the	  development	  of	  
biomaterials	   that,	   after	   coated	   with	   these	   Gly-­‐Rs,	   may	   compete	   for	   bacterial	   binding	   with	   the	  
glycans	  expressed	  on	  the	  gastric	  mucosa	  of	  infected	  individuals,	  ultimately	  enhancing	  its	  removal	  
from	  infected	  patients.	  However,	  since	  all	  these	  studies	  were	  performed	  in	  neutral	  pH	  (phosphate	  
buffer	  saline,	  pH	  7.4),	  it	  would	  be	  interesting,	  in	  the	  near	  future,	  to	  study	  the	  interaction	  between	  
bacteria	  and	  Gly-­‐Rs-­‐terminated	  SAMs	  at	  different	  pHs,	  resembling	  the	  ones	  of	  the	  gastrointestinal	  
tract.	  
Nevertheless,	   the	   knowledge	   obtained	   with	   this	   fundamental	   work	   is	   already	   being	  
translated	  onto	  a	  biocompatible	  polymeric	  system.	  Chitosan	  was	  the	  polymer	  chosen	  since	  it	  is	  an	  
outstanding	  carrier	  for	  stomach	  drug	  delivery,	  due	  to	  its	  mucoadhesive	  properties.19	  By	  modifying	  
the	  chitosan	  microspheres	  with	  Gly-­‐Rs	  that	  are	  recognized	  by	  the	  H.	  pylori	  adhesins,	  it	  is	  expected	  
to	   further	   minimize	   bacterial	   binding	   to	   the	   host,	   improving	   the	   conventional	   treatment	  
efficiency,	  since	  it	  minimizes	  the	  number	  of	  bacteria	  to	  be	  treated.	  Moreover,	  these	  microspheres	  
can	  also	  be	  applied	  as	  targeted	  drug	  delivery	  systems.	  
One	  of	  the	  drawbacks	  of	  these	  anti-­‐adhesion	  strategies	  is	  the	  high	  cost	  of	  Gly-­‐Rs	  chemical	  
synthesis.	  For	  making	  this	  strategy	  a	  widely	  applicable	  treatment	  option	  it	  is	  required	  to	  identify	  
glycan	   structures	   that	   can	  be	  obtained	   from	  natural	   sources.	  Other	  option	   is	   the	  production	  of	  
these	   structures	   by	   genetic	   engineering	   techniques,	   a	  more	   economical	   alternative	   to	   chemical	  
synthesis.	  Also,	  this	  bioengineered	  strategy	  is	  restrained	  to	  strains	  that	  functionally	  express	  either	  
or	   both	   BabA	   and	   SabA,	  mainly	   because	   these	   two	   adhesins	   are	   considered	   as	   the	  major	   ones	  
involved	   in	   the	   pathogen	   adhesion	   to	   the	   gastric	   wall.	   Furthermore,	   the	   clinical	   prognosis	   of	  
individuals	   infected	  with	  BabA+	  strains	  is	  also	  poorer	  than	  to	  those	  infected	  with	  strains	  that	  do	  
not	   express	   this	   adhesin.	   Nevertheless,	   it	   is	   likely	   that	   other	   bacterial	   molecules	   may	   also	   be	  
involved	   in	   the	  process	   of	   adhesion	   to	   the	   gastric	  mucosa,	  which	   is	   a	   hypothesis	   that	   could	   be	  
explored	  in	  the	  future.	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